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ABSTRACT OF THESIS
This is a study of the control of luteinising hormone (LH)
secretion in the marmoset monkey, Callithrix .jacchus. The way in
which the hypothalamo-hypophysial-gonadal system operates to regulate
LH secretion in primates is reviewed.
A double antibody heterologous radioimmunoassay for measuring
EH in marmoset plasma was developed and validated.
Intra-muscular administration of synthetic luteinising
hormone-releasing hormone (EH-RH) induces a marked increase in plasma
EH concentrations in the marmoset, suggesting that the releasing
hormone has an important physiological role in controlling EH
secretion in this species. The effects of steroid hormones on
pituitary response to exogenous EH-RH were examined. Pituitary
responsiveness to EH-RH was enhanced in long term, but not in short
term, gonadectomised animals. Whereas oestradiol-17/3 implants
inhibited pituitary response to EH-RH in long term castrates, implants
of progesterone augmented the response. A direct action of gonadal
steroids on the pituitary gland is therefore suggested.
The way in which steroid hormones influence the hypothalamo-
hypophysial system was further studied by examining their ability to
depress or increase circulating EH concentrations. Gonadectomy
resulted in an increase in plasma EH levels indicating that EH
secretion is normally suppressed by the action of gonadal steroids.
In the "open-loop" situation the.elevated LH levels are the result of
an episodic secretion of the hormone by the pituitary gland. Closure
of this feedback loop with oestradiol-1 7>g caused a chronic suppression
of EH secretion^suggesting that this steroid is an important component
V
of the negative feedback mechanism regulating tonic LH secretion.
The effects of progesterone, testosterone and dihydrotestosterone on
EH secretion in gonadectomised marmosets were also tested. Whereas
these hormones prevented the post-castration rise in LH concentrations,
they were apparently ineffective in suppressing EH levels in long
term gonadectomised animals. A decrease in the sensitivity of the
hypothalamic-pituitary system to negative feedback as the interval
from castration increases is suggested.
Positive feedback control of EH secretion was also examined.
A single injection of oestradlol benzoate had a biphasic effect on EH
secretion, with an initial negative feedback effect characteristically
preceeding the positive response. Oestrogen induced LH release was
observed in castrated and intact males as well as in castrated
females, suggesting that the positive feedback response to oestrogen
in the marmoset is not a sexually dimorphic characteristic. The
ability of progesterone, testosterone, and dihydrotestosterone to
induce, or modify oestrogen induced, positive feedback was also
assessed in gonadectomised animals.
The effects of inhibition of EH-RH were also examined. Active
immunisation against EH-RH induced a breakdown of the hypothalamo-
hypophysial-gonadal system, resulting in inhibition of gonadal and
pituitary function. EH-RH induced LH release was suppressed by the
use of competitive antagonist analogues of EH-RH. The potential
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1 .1 Introduction
The concept of endocrine control of the gonads probably
originates from an experiment performed by Hunter in 1787. Although
the results were misinterpreted at the time, they did in fact
show that hemiovariectomy in a sow led to compensatory hypertrophy
and increased ovulation rate in the remaining ovary. Direct
evidence for the involvement of the pituitary gland in gonadal
function was not obtained until over 100 years later, when Fichera
(1905) reported hypertrophy of the pituitary gland after castration.
Following a series of classical experiments involving hypophysectomy
and pituitary transplantation (Smith, 1926, 1927; Smith and Engle,
1927) the nature of the gonadotrophic stimulus was determined, and
the existence of two distinct gonadotrophins - follicle stimulating
hormone (FSH) and luteinising hormone (LH) - was finally confirmed
by Fevold, Hisaw and Leonard in 1931 . After many years of effort,
purification and structural elucidation of LH from various species
has now been achieved (see Sairam and Papkoff, 197h> for review).
Because the hypothalamus is the part of the brain nearest
to the pituitary gland (Fig. 1.1), it was reasonable to envisage
neural components in the control of pituitary hormone secretion.
In 1936 Marshall reviewed the information on the effects of both
physical and psychological factors on reproduction and postulated
that the anterior pituitary might be under the control of substances
manufactured in the brain and transported to the pituitary. Many
suggested that there was a direct innervation, but the true
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1933) who described a system of portal vessels connecting capillaries
in the median eminence with the sinusoid spaces of the anterior
pituitary. In his classic monograph Harris (1933) drew together
all the evidence from electrical stimulation, ablation, stalk-
sectioning and pituitary transplantation experiments and presented
convincing evidence for the neurochemical control of the anterior
pituitary via the portal vessels. Final confirmation of the
neurohumoral control of the anterior pituitary came from Porter
and Jones (1936), and four years later the presence of a luteinising
*
hormone-releasing factor was first described by McCann, Taleisnik
and Friedman (1 960).
During the 1960's a great deal of effort was applied to
the isolation and purification of luteinising hormone releasing
factor. These attempts culminated in the simultaneous structural
elucidation of porcine (Matsuo, Baba, Naur, Arimura and Schally,
1971) and ovine (Burgus, Butcher, Ling, Monahan, Rivier, Fellows,
Blackwell, Vale and Guillemin, 1971) luteinising hormone releasing
factor (now known as luteinising hormone releasing hormone, LH - RH)
both of which were decapeptides with the amino acid sequence
pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH^.
LH-RH has subsequently been synthesised (e.g. Matsuo
et al. , 1971; Sievertsson, Chang, Klaudy, Bogentoft, Currie, Folkers
and Bowers, 1972), and Matsuo et al (1971 ) reported that their
synthetic decapcptide showed the same physico-chemical and
biological properties as their isolated natural porcine hormone«
The exact localisation of LH-RH synthesis remains unclear.
The initial demonstration of a "hypophysiotrophic area" (HTA)
in the rat hypothalamus (Halasz, Pupp and Uhlarik, 1962) provided
»
the basis for many early studies designed to delineate the sites
of EH-RH production. Various techniques have been applied but
unfortunately the data are rather confusing (see Hodges, 1975* for
review). In recent years more sophisticated techniques (including
autoradiography, immunofluorescence and immunocytochemistry) have
been introduced, and although the results obtained using these
methods confirm the importance of the HTA as the region of EH-RH
synthesis, the actual distribution of EH-RH within the HTA seems
to depend upon which method is employed (see Ramirez and Kordon,
1975; Dubois, 1976, for reviews).
It is now well established that gonadal steroids can
regulate pituitary gonadotrophin secretion, and that depending upon
the circumstances their influence can be either stimulatory or
inhibitory. The concept of positive and negative feedback originated
from observations early in the 1930's. In 1932 Moore and Price,
and Hohlweg and Junkmann independently postulated a simple inverse
relationship between circulating gonadal steroid concentrations
and pituitary gonadotrophin secretion. Th:s was deduced from their
findings of gonadal atrophy following prolonged administration
of oestrogen^and increased gonadotrophic activity after gonad-
ectomy. Subsequently a great deal of information has accumulated
regarding negative feedback and much of the earlier work has been
reviewed (e.g. Hisaw, 19U7^ Van Rees, I96I4). More recent studies,
utilising radioimmunoassay methods, have demonstrated a marked
increase in circulating EH levels following castration in either
6
sex of numerous* species (see Labhsetwar, 1 973for review),
providing conclusive evidence that pituitary-LH secretion is
normally suppressed by gonadal steroids.
The existence of a positive feedback effect of gonadal
steroids was originally suggested when Hohlweg (193W demonstrated
that the administration of oestrogen resulted in the formation of
corpora lutea in prepubertal rats. Following the observation by
Everett (19U8) that oestrogen could advance ovulation in the rat,
Everett, Sawyer and Markee (191|9) suggested that oestrogens acting
(
on the central nervous system initiate the ovulatory release of
LH through a positive feedback action. This has since been con¬
firmed in a variety of species, including rats(Ferin, Tempone,
Zimmering and Vande Wiele, 1969)^ sheep (Goding, Catt, Brown,
Kaltenbach, Cumming and Mole, 1969); rhesus monkeys (Ferin,
Dyrenfurth, Cowchock, Warren and Vande Wiele, 197^) and women
(Vande Wiele, Bogumil, Dyrenfurth, Ferin, Jewelewicz, Warren,
Rizkallah and Mikhail, 1970). The existence of a dual feedback
'system regulating EH secretion is now well established. By acting
at the hypothalamic and hypophysial levels gonadal steroids
regulate LH secretion by means of negative (controlling tonic
secretion) and positive (controlling cyclic release of LH)
feedback mechanisms.
It is therefore possible to identify the three elements of
the system which is concerned with regulating LH secretion; the
central nervous system-hypothalamus complex may be regarded as a
signal generator, the pituitary as a signal transmitter, and the
gonadal steroid output as a signal modulator. Within this general
context, the regulation of the hypothalamo-hypophysial-gonadal
system in primates will be reviewed.
7
1 .2 The hypothalamic-hypophysial system
Administration of natural or synthetic LH-RH will elevate
plasma levels of EH, and in most cases FSH, due to direct stimulation
of the anterior pituitary gland (Schally, Kastin and Arimura, 1971).
This stimulatory effect of LH-RH involves stimulation of both
release and de novo synthesis of EH and FSH by the pituitary
gonadotrophs (Redding, Schally, Arimura and Matsuo, 1972).
The stimulatory action of EH-RH on EH secretion in primates
has been described by numerous investigators (e.g. Jaffe and Keye,
197^41 Wang, Lasley, Lein and Yen, 1976; Hoff, Lasley, Wang and
Yen, 1977 - human: Krey, Butler, Weiss, Weick, Dierschke and
Knobil, 1973; Ferin, Warren, Dyrenfurth, Vande Wiele and White,
197U - rhesus monkey). Although a relative insensitivity to
synthetic EH-RH has been reported in certain studies on the rhesus
monkey (Ehara, Ryan and Yen, 1972; Ar.imura, Spies and-Schally, 1973) it
is unlikely that this represents species differences in endogenous
LH-RH. Compelling evidence that the endogenous EH-RH in the
rhesus monkey must closely resemble, at least immunologically,
synthetic LH-RH has recently been provided by McCormack, Plant,
Hess and Knobil (1977) who demonstrated a marked suppression of
tonic EH secretion in ovariectomised animals following adminis¬
tration of antiserum to synthetic EH-RH.
1 .2.a The control of tonic (pulsatile) EH secretion
The hypothalamus and the pituitary form a closely coupled
functional unit which releases EH, often in the form of periodic
pulses characterised by a high frequency and amplitude. Short
term variations in EH secretion were first observed in gonadectomised
8
male and female rhesus monkeys^where the periodicity of episodic
»
EH release was approximately one hour (Atkinson, Bhattacharya,
Monroe, Dierschke and Knobil, 1970). A pulsatile pattern of EH
release (with a frequency of 1-2 hours) has also been observed in
hypogonadal (postmenopausal) and normal cycling women^and similar
observations have been made in intact bulls (Katongole, Naftolin
and Short, 1971 )> and castrated (Reeves, O'Donnell and Denorscia,
1972) and intact (Yuthasastrakosol, 1977) sheep. In the human
female pulsatile EH secretion is seen during all phases of the
menstrual cycle although there are significant variations in
amplitude and frequency of the pulses throughout the cycle. During
the luteal phase, frequency appears to be reduced as compared to
the follicular phase, whereas amplitude is smaller during the late
follicular phase than during the luteal phase or periovulatory
period (Midgley and Jaffe, 19715 Yen, Vandenberg, Tsai and Siler,
19710 • It is likely that these changes are caused by the steroid
hormone environment during the different stages of the cycle.
The relationship between gonadal steroids and pituitary
EH secretion has been investigated in part by measurements of the
change in circulating EH concentrations following gonadectomy in
male and female rhesus monkeys (Atkinson et al, 1970) and in
premenopausal women (Yen and Tsai, 1971b; Monroe, Jaffe and
Midgley, 1972). In both species EH concentrations increase
markedly within 2-3 days after gonadectomy and continue to rise
until a plateau is reached at approximately 10 times the initial
concentration 3 weeks after the operation. It has been shown in
the human that during the first week after ovariectomy, a sig¬
nificantly greater rise in EH is observed in those subjects
9
ovariectomised during the follicular phase than in those ovariec-
»
tomised during the luteal phase of the menstrual cycle (Yen and
Tsai, 1971b). Although indirect, these findings suggest that in
the human changes in synthesis, storage and release of pituitary
LH are influenced by circulating levels of oestrogen and/or
progesterone.
The elevated LH levels in gonadectomised rhesus monkeys and
humans appear to be maintained by an increase in the magnitude of
pulsatile pituitary discharges of the hormone (Yen, Vandenberg,
Rebar and Ehara, 1972; Santen and Bardin, 1973; Knobil, 1971;).
This accelerated release (and synthesis) of LH is probably, in
large measure, determined by the hypophysiotrophic effect of an
increased LH-RH secretion, since an elevated release of LH-RH in
the absence of gonadal feedback has been found in both humans
(Seyler and Reichlin, 1973) and rats (Ben-Jonathan, Mical, and
Porter, 1973).
Although the control of the pulsatile discharge of LH from
the adenohypophysis is not well understood it is reasonable to
assume a causal pulsatile release of hypothalamic LH-RH. The
finding of a pulsatile fluctuation of LH-RH in peripheral plasma
of hypogonadal women (Seyler and Reichlin, 197k a)and in the portal
blood of rhesus monkeys (Carmel, Araki and Ferin, 1973), and the
demonstration that antiserum to LH-RH abolishes pulsatile secretion
of LH (McCormack and Knobil, 1973) add credence to this assumption.
However, the precise neurons responsible for LH-RH synthesis and
the controlling system for LH-RH secretion remain unclear.
Since it is established that catecholamines, present in
abundance in the hypothalamus, serve as neurotransmitters for
10
critical steps i,n the regulation of hypothalamic LH-RH (Kamberi,
Mical and Porter, 1971), the mechanism governing the pulsatile
rhythm has been investigated through the use of adrenergic blocking
agents. Pulsatile LH release is abolished by c< (phentolamine)
but not by ft (propranolol) blocking agents in the ovariectomised
rhesus monkey (Bhattacharya, Dierschke, Yamaji and Knobil, 1972),
although this has not been confirmed in humans (Santen and Bardin
1973; Yen, Vandenberg, Tsai and Parker,197U)• This discrepancy
in findings may either be a consequence of dosage used (doses in
the human studies were one tenth of those in the rhesus experiments)
or possibly due to a partial blood-brain barrier to phentolamine.
In any event, it has now been shown that catecholamines are important
in the control of LH secretion in the human. Yen and his co-workers
(Leblanc, Lachelin, Ab-u-Fadil and Yen, 1976; Lachelin, Leblanc
and Yen, 1977) have clearly shown a marked inhibitory effect of
dopamine and dopamine agonists (L-dopa and 2-bromo-<x:-ergocryptine)
on EH secretion. The mechanism by which dopamine and dopamine
agonists exert their inhibitory action is unknown. It may be due
to a direct effect on hypothalamic LH-RH neurons as suggested by
Fuxe, Hokfelt, Agnati, Lofstrom, Everitt, Johansson, Jonsson,
Wuttke and Goldstein (1977), a direct action on the pituitary
responsiveness to LH-RH may also be operative.
While the exact nervous origin of the pulses in LH secretion
remains uncertain, a few studies have been undertaken in primates
in this direction. A type of experimental approach in rhesus
monkeys involves the use of a stereotaxically introduced modified
Halasz knife (Halasz and Gorski, 1967) to disconnect the
11
hypothalamus from other parts of the brain. The results, reported
>
by Krey, Butler and Knobil (1975)* indicate that centres controlling
LH secretion may reside in an area of the hypothalamus closely
related to the pituitary gland. The authors found that complete
deafferentation of the medial basal hypothalamus in five
ovariectomised rhesus monkeys did not inhibit the pulsatile release
of EH, nor did it affect the mean plasma concentration of the
hormone.
Although it is generally accepted that the hypothalamus and
central nervous system are intimately involved in the control of
pulsatile LH release, there is certain disagreement regarding the
degree of autonomy of the pituitary gland in this respect. The
demonstration of a pulsatile pattern of LH-RH activity in portal
blood of rhesus monkeys (Carmel et al, 1975) suggests that
secretion of LH by the pituitary may mirror the stimulation it
receives from LH-RH. In addition, Osland, Gallo and Williams
(1975) demonstrated that pulsatile LH release from superfused
.isolated rat pituitaries can be obtained only by pulsed delivery
and not by constant infusion of LH-RH. In contrast however,
Vande Wiele and Ferin (1975) reported that constant infusion of
LH-RH to rhesus monkeys resulted in a pulsatile type of LH release,
and that this effect was most pronounced in ovariectomised animals.
It is possible, but unlikely, that these results are due to a
pulsatile type of LH-RH metabolism. More realistically, the
possibility exists that an endogenous pulsatile secretion of LH-RH
is superimposed on the higher LH levels induced by the infusion.
This hypothesis was in fact tested by sectioning the hypothalamic-
pituitary stalk in an ovariectomised monkey, placing a silastic
12
barrier between the two cut portions, and measuring circulating
LH levels during constant EH-RH infusion (Vande Wiele and Ferin,
197U)- Surprisingly, the authors found that EH release remained
pulsatile. Although this suggests that the anterior pituitary gland
may be capable, by an unknown mechanism, of releasing EH in a
pulsatile fashion, it is not known how long it is able to do so
after separation from the brain. Since these results were derived
from an experiment on a single animal}caution must be exercised in
interpretation of these findings. Confirmation of an independent
role of the pituitary gland in pulsatile release of LH will there¬
fore have to await further in vivo and in vitro tests.
1.2.b The control of cyclic EH secretion
In females, superimposed upon the basic rhythm of EH
secretion is a cyclic pattern of LH release during reproductive
years associated with the menstrual cycle. The changes in EH
secretion during the menstrual cycle have a periodicity of
approximately one month, and appear to be consequent to cyclicity
inherent in the secretory' and gametogenic aspects of ovarian
function (Vande Wiele et al, 1970; Yen et al, 197iib). The pattern
of EH secretion during the menstrual cycle is basically similar in
all species of higher primates, and has been described by numerous
investigators (e.g. Swerdloff and Odell, 1968; Cargille, Ross
and Yoshimi, 1969 - human: Monroe, Atkinson and Knobil, 1970;
Hotchkiss, Atkinson and Knobil, 1971 - rhesus monkey: Goncharov,
Aso, Cekan, Pachalia and Diczfalusy, 1976 - baboon: Wilks, 1977 -
stump-tailed macaque). In the marmoset monkey menstruation does
not occur and there is no externally obvious indication of oestrus.
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In this species the "ovarian" cycle is considerably shorter
»
(16—17 days) than the menstrual cycle of higher primates, although
the cyclic pattern of EH secretion is broadly similar (Hearn and
Lunn, 1973)•
The patterns of EH secretion during the menstrual (human,
rhesus, baboon, macaque) and ovarian (marmoset) cycles can be
summarised^ EH levels are relatively low during the early follicular
phase of the cycle. lit secretion remains fairly low until just
prior to ovulation when a peak in EH levels occurs (the pre-ovulatory
surge). The midcycle EH peak is followed by a decline during the
luteal phase to peripheral levels which are similar to^or slightly
lower than those seen during the follicular phase.
The mechanisms responsible for the cyclic variation in EH
secretion., in particular the midcycle EH surge, are complex and not
yet fully understood. Steroid hormones play an important role
in this respect, and will be dealt with later in this review. Of
relevance to this section on the hypothalamic-pituitary axis is the
variation in EH-RH output during the menstrual cycle. It is now
generally accepted that the pre-ovulatory surge of EH is caused,
in part, by an increased release of LH-RH from nerve terminals
in the median eminence. In mature female rats it has been observed
that hypothalamic EH-RH content is highest late in di-oestrus and
declines at pro-oestrus (Chowers and McCann, 1965; Ramirez and
Sawyer, 1963), suggesting that a release of LH-RH into the portal
vessels may occur prior to and/or simultaneous with the ovulatory
EH peak on the afternoon of pro-oestrus. However, initially,
direct measurement of LH-RH in rat portal venous blood (Fink and
Harris, 1976; Fink and Jamieson, 1976) on the day of pro-oestrus
did not reveal any significant increase in LH-RH concentrations.
It has since been realised that as the anaesthetic used (urethane)
can block ovulation, it will be likely also to block or truncate
any surge of EH-RH. In a more recent study in which a different
anaesthetic was used, an increase in LH-RH concentration in
pituitary stalk blood has been shown to occur on the afternoon of
pro-oestrus (Sarkar, Chiappa, Fink and Sherwood, 1976). In women,
measurement of LH-RH by bioassay in peripheral blood revealed an
increase on the day of the midcycle LH peak (Malacara, Seyler and
Reichlin, 1972). This observation has since been confirmed using
a radioimmunoassay (Arimura, Kastin and Schally, 197U)«
It therefore seems likely that the preovulatory LH surge
is associated with an increased LH-RH output. However, from
quantitative measurements of LH-RH secretion during the pre¬
ovulatory period (Sarkar et al, 1976) it can be assumed that the
increase in LH-RH secretion is alone, insufficient to cause the
necessary rise in LH at mid cycle. Other factors are therefore
involved and will be discussed later.
Prostaglandins are known to be involved in many reproductive
processes (see Goldberg and Rairiwell, 1975 and Roberts, Carlson and
McCracken, 1976, for reviews), and there is now some evidence to
suggest that LH secretion may be influenced by prostaglandins
acting directly on the hypothalamic-hypophysial axis. Carlson,
Wong and Perrin (1977) demonstrated in the rhesus monkey that
prostaglandin or ©o will induce a small amount of LH release
when administered in the luteal (but not follicular) phase, and
that indomethacin (an inhibitor of prostaglandin synthesis)
markedly reduces the amount of LH released in response to an
injection of oestradiol benzoate. Although the stimulation of LH
»
release is not very convincing, and it may be argued that
indomethacin produces other effects than inhibiting prostaglandin
synthesis, these data suggest the possibility that prostaglandins
may be involved in the induction of the pre-ovulatory EH surge.
Where and how they act remains to be determined.
A summary of the hypothalamic-hypophysial function in the
control of LH release is shown in Figure 1 .2,which undoubtedly
represents an oversimplification of a highly complex system.
1.3 The role of steroid hormones in the feedback modulation of
LH secretion
While LH secretion is at all times directly related to
LH-RH stimulation, the function of the hypothalamic-pituitary
system is profoundly modified by the action of gonadal steroids.
In theory any steroid which possesses some intrinsic oestrogenic,
androgenic or gestagenic activity is capable of influencing
pituitary LH secretion. Such steroids may be secreted directly
by the gonads and/or adrenals, or they may arise from peripheral
conversion of precursors, which themselves can be of either gonadal
or adrenal origin. However, since many of the sex hormones
secreted by the adrenal glands possess only weak intrinsic bio¬
logical activity, and because the extent of precursor conversion is
usually relatively small, it seems unlikely that the adrenals play
a significant role in the feedback regulation of LH secretion.
Thus under physiological conditions, those steroids most intimately
involved in controlling LH secretion are probably entirely, or at









Diagrammatic illustration of the possible sequence of events
governing the pituitary discharge of gonadotrophins
(s-s-s = synthesis, storage and sensitivity of the gonadotrophs).
Modified from Yen et al, 1975.
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1 ,3.a Steroid hormones which may control LH secretion and their
»
site of origin
Most of the steroids in the biosynthetic pathway from
pregnenelone to oestradiol-1 7fi have been identified in the
peripheral circulation of the human (Baird, '\97h), rhesus monkey
(Resko, 1971) and baboon (Goni-.harnv et al, 1976). Confirmation of
a direct ovarian secretion has been obtained for pregnenelone,
progesterone, 1 704 -hydroxyprogesterone, dehydroepiandrosterone,
androstenedione, testosterone, oestrone and oestradiol-1 7/?
in women (Baird, 197U),and for progesterone, testosterone and
oestradiol-17/7 in the rhesus monkey (Hess and Resko, 1973). In
all female primates studies so far peripheral concentrations of
oestradiol-17/3 , progesterone and androstenedione show the most
marked changes during the cycle, and hence are probably the most
important with respect to feedback control of LH secretion.
In females of reproductive age circulating oestradiol-1 7ft
is almost exclusively derived from direct ovarian secretion. In
the absence of bilateral ovulation, the majority of oestradiol-1 7/3
is produced by the ovary containing the pre-ovulatory follicle or
corpus luteum (Baird and Fraser, 1 97U; Baird, Baker, McNatty and
Neal, 1975 - human; Hess and Resko, 1973 - rhesus monkey). The
remaining oestradiol-17f% is derived from extraglandular conversion
of oestrone (Baird, Horton, Longcope and Tait, 1969 - human;
Resko, 1971 - rhesus monkey).
During the early follicular phase of the cycle circulating
progesterone arises from at least three sources - direct ovarian
and adrenal secretion, and extraglandular conversion of pregnenelone
(Baird, 197U - human; Bosu, Johansson and Gemzell, 1973 - rhesus
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monkey). During the luteal phase of the cycle however, adrenal
secretion and extraglandular conversion contribute very little to
the total secretion rate, and virtually all of the progesterone
is now secreted by the ovary containing the corpus luteum.
Of the androgens secreted by the female, androstenedione
shows the most marked variation throughout the menstrual cycle ana
a midcycle rise has been detected in the human (Vermeulen and
Verdonck, 1976) and the baboon (Goncharov et al, 1976). During
most of the cycle,the adrenal gland is the major source of andro¬
stenedione, although in women the relative adrenal contribution
decreases at midcycle (Baird, 197U). A recent report by Martensz,
Baird, Scaramuzzi, and Van Look (1976) suggests that androstene¬
dione may play an important role in controlling the pre-ovulatory
LH release. These workers showed that immunisation against andro¬
stenedione inhibits the oestrogen induced LH surge in anoestrous
sheep.
Comparisons of the basal concentrations of steroid hormones
in the spermatic vein with those observed in the peripheral cir¬
culation indicate a direct testicular secretion of a wide range of
steroids in man (Vihko and Ruokonen, 197U; Pazzagli, Borrelli,
Forti and Serio, 197U). Apart from the testicular production of
unconjugated steroids, the human testis has recently been shown to
secrete considerable quantities of sulphate-conjugated steroids
(Vihko and Hammond, 1976), although the physiological significance
of these secretions largely remains undetermined.
The most important androgen secreted by the testis, both
qualitatively and quantitatively, is testosterone. Small amounts
of testosterone may also be derived from direct adrenal secretion
or from peripheral conversion of precursors. In the human,
dihydrotestosterone is derived mainly from the testis (Pazzagli
et al, 197b', Vihko and Hammond, 1976) although small amounts are
also produced from peripheral conversion of testosterone and andro-
stenedione (Mahodeau, Bardin and Lipsett, 19713 Pazzagli et al.
197U)• Dihydrotestosterone is a potent androgen and together with
testosterone probably represents the major component of the feed¬
back mechanism controlling LH secretion in the male.
Although it is well established that oestrogens are secreted
by the male (Baird, Galbraith, Fraser and Newsam, 19733 De Jong,
197U for review), little is known about the role of endogenous
oestrogens in controlling LH secretion.
No quantitative studies on in vivo testicular steroid
production in sub-human primates have been reported, although in
the rhesus monkey (Hoschoian and Brownie, 1967) and the marmoset
(Preslock and Steinberger, 1977), production of testosterone,
andro'stenedione, dehydroepiandrosterone and 1 7c<-hydroxy-
progesterone from simple precursors has been demonstrated in vitro.
To summarise, in the female, oestradiol-17/6 and progester¬
one are probably the most important steroids with regard to the
feedback regulation of LH secretion. The role of other ovarian and
adrenal steroids is not yet known although the possibility exists
that some of these hormones, in particular androstenedione, may
have a permissive action. In the male, testosterone and dihydro¬
testosterone appear to be the androgens most intimately involved
in controlling LH secretion.
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1 .3-b Feedback mechanisms
Steroid hormones are known to exert both negative and
positive feedback actions on LH secretion, and for many years
numerous attempts were made to sort out these effects. However,
owing to methodological problems, the information was necessarily
limited (see Vande Wiele et al 1970, for review). With the advent
of radioimmunoassays, a renewed effort was made and a clearer
picture of the quantitative and qualitative aspects of these feed¬
back mechanisms emerged.
In primates (Kelch, Kaplan and Grumbach, 1973; Dierschke,
Karsch, Weick, Weiss, Hotchkiss and Knobil, 19710,as well as in
rats (McCann, Ojeda and Negro-Vilar, 197U),negative feedback mech¬
anisms are present from an early age, although it is generally
believed that the sensitivity of the pituitary-hypothalamus complex
to negative feedback action of steroids is lower after the onset
"
r*of puberty (see Schonberg, 1975; Grumbach, Roth, Kaplan and Kelch,
197l|j McCann, et al, 197Uj for reviews). The finding that in
pre-pubertally castrated rhesus monkeys (Dierschke et al, 19710 and
children with gonadal dysgenesis (Conte, Grumbach and Kaplan, 1975),
plasma LH levels rise at the age of expected puberty indicates
that the pubertal change in hypothalamic feedback sensitivity occurs
independently of the presence of functional gonads.
The dynamics of the negative feedback control of LH
secretion has been examined in depth in the rhesus monkey-
Yamaji, Dierschke, Bhattacharya arid Knobil (1972) clearly demonstrated
that brief pulses of oestrogen, achieved by single injections of
oestradiol-17^ or physiologic step increases of the steroid
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effected and maintained by constant infusion, arrest within
minutes the pulsatile discharges of LH observed in ovariectomised
rhesus monkeys, with a resultant decline in plasma LH concentrations.
The duration of this inhibition persists for several hours beyond
the time when oestrogen ceases to be detectable in the peripheral
plasma. It is of interest in this regard that in the ovariec¬
tomised rat, the hypothalamus and pituitary bind tritiated
oestradiol-17/^ for approximately six hours after a single injection
of the labelled steroid (McGuire and Lisk, 1968).
In 1973 a more detailed analysis of the negative feedback
control of LH secretion in the rhesus monkey was performed by
Karsch, Weick, Hotchkiss, Dierschke and Knobil. These workers
showed that maintenance of circulating oestradiol concentrations
within the range observed before ovariectomy (50-80 pg/ml)was
usually ineffective in preventing the rise in circulating LH
following ovariectomy, but that slightly higher levels (100-150 pg/ml)
were effective. This observation together with the fact that
step increments or decrements of as little as 20-30 pg/ml from
threshold oestradiol concentrations elicited large (but reversible)
changes in circulating LH levels, suggests that the negative
feedback control system governing LH secretion is remarkably sensitive
to seemingly small changes in plasma oestradiol concentrations.
A similar inhibitory effect of oestradiol on LH secretion
has been demonstrated in the human female. Vande Wiele et al
(1970) continuously infused oestradiol into menopausal women at a
rate that approaches the physiological rate of secretion in the
early follicular phase (100-1^0 ug/21; hours) and observed a
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significant depression of LH levels. Oral administration of
»
oestradiol-1 7/S is also followed by a prompt decline in circulating
LH levels (Yen, Martin, Burnier, Gzekala, Greaney and Callantine,
1975).
During the follicular phase in women, most of the circulating
oestradiol-1 7/3 is derived from the developing follicle (Baird and
Fraser, 1975)* and the negative feedback action of oestradiol
during this phase is responsible for suppressing gonadotrophin
secretion and therefore inhibiting further growth of other
developing follicles. During the luteal phase oestradiol-1 7/3
which is now mainly secreted by the corpus luteum (Mikhail, 1 970^
Baird and Fraser, 1975) acts together with progesterone to suppress
the release of gonadotrophins and inhibit follicular development.
It is not until the corpus luteum regresses that the concentration
of gonadotrophins is sufficiently high to initiate the develop¬
ment of a new 'wave' of Graafian follicles. The secretion of
oestradiol-1 7/3 by the corpus luteum may therefore be one of the
main factors determining the length of the follicular phase in
women (Baird et al, 1975)-
In contrast to the efficacy of oestrogen, progesterone by
itself appears to be relatively inert with respect to a negative
feedback action on LH secretion. In the ovariectomised rhesus
monkey administration of progesterone in doses which achieve luteal
phase concentrations does not result in a decrease in circulating
LH levels (Karsch et al, 1973 a). Furthermore Yama.ji et al (1972)
demonstrated that supraphysiological levels of progesterone, even
when maintained for long periods^ are also inactive in influencing
LH secretion in ovariectomised rhesus monkeys. Similarly, the
injection of 10-100 mg of progesterone into postmenopausal women
produced no decrease in circulating LH levels (Franchimont and
Legros, 1970; Nillius and Wide, 1971). Recently Karsch, Foster,
Legan and Hauger (1976) have questioned the significance of results
obtained in long term ovariectomised animals, particularly with
respect to the negative feedback action of progesterone in the ewe.
These workers have demonstrated that although progesterone does
not markedly depress LH levels in the long term ovariectomised ewe,
the same dose of steroid when given as replacement treatment will
prevent the post castration rise in LH secretion. A further
report (Foster and Karsch, 1976) describes a similar inhibitory
action of progesterone on tonic LH secretion in intact and
ovariectomised immature ewes. Thus in contrast to the observations
in primates, progesterone by itself appears to have a negative
feedback effect on tonic LH secretion in female sheep. A species
difference in the feedback role of progesterone may exist, although
preliminary observations (this thesis, p.165 ) suggest that prog¬
esterone may inhibit LH secretion in the marmoset. Further
investigation into the negative feedback action of progesterone in
primates is obviously required, and this subject will be discussed
further in chapter 5 of this thesis.
Although in most cases progesterone alone seems to have no
significant inhibitory effect on LH secretion, physiological amounts
of progesterone can synergise with sub-threshold (i.e. ineffective)
levels of oestradiol-17/d in the inhibition of tonic LH secretion
in ovariectomised rhesus monkeys (Karsch et al, 1973a). A similar
synergistic action of synthetic oestrogens and gestagens in
suppressing pituitary LH secretion can be demonstrated in agonadal
2k
women (Wallach, Root and Garcia, 1970).
Little is known concerning the role of androgens in the
regulation of LH secretion in the female, although Martensz et al
(1976) demonstrated that immunisation against androstenedione in
the anoestrous ewe increased the frequency of pulsatile III discharges
and elevated mean LH concentrations compared to non-immunised
controls.
In the male testosterone and dihydrotestosterone are con¬
sidered to be the main androgens controlling LH secretion, but
few attempts have been made to quantify their effects. Testos¬
terone administration to normal men either by intramuscular
injection (Lee, Jaffe, Midgley, Kohen and Niswender, 1972) or by
infusion at physiological secretion rates (Sherins and Loriaux,
1 973; Stewart-Bentley, Odell and Horton, 1 97ii),produces a dose
related fall in LH levels. In contrast, physiological doses of
testosterone are ineffective in depressing plasma LH concentrations
in long term castrated male rhesus monkeys, and are equally
ineffective in preventing the post castration rise in LH in these
animals (Resko, Quadri and Spies, 1976). It is unlikely that this
discrepancy is entirely due to species difference but may simply
be a reflection of differing experimental procedures in terms of
method, rate and duration of testosterone administration. More
recently, the same group of workers (Resko, Quadri and Spies, 1977)
has confirmed that within the confines of the experimental protocol,
testosterone alone is unable to suppress LH in either long-term or
short-term gonadectomised male rhesus monkeys. They have however
provided evidence for a synergistic role for testicular oestradiol-17/3
25
with testosterone by showing that a combination of subthreshold
amounts of oestradiol and physiological levels of testosterone will
maintain precastration levels of LH in short-term gonadectomised
males.
It is possible however, that it is not testosterone itself
that operates the feedback mechanism but another steroid to which
testosterone may be converted. Administration of dihydrotestosterone
( a 5<* -reduced metabolite of testosterone) in man suppresses LH
secretion,although not as effectively as testosterone (Stewart-
Bentley et al, 197U). Oestradiol-1 7/3 can also inhibit LH
secretion in men (Stewart-Bentley et al, 1971;; Wang, LastLey and
Yen, 1975) although the physiological role of oestrogens in the
negative feedback control of LH in the male is not fully understood.
It is well established that the pre-ovulatory rise in
circulating oestradiol-17/3 represents the critical stimulus for
the initiation of the midcycle LH surge in women (Vande Wiele et al,
1970) and rhesus monkeys (Yamaji et al, 1971; Ferin et al, '\97ha),
as well as in rats (Ferin et al, 1969) and sheep (Goding et al, 1969).
Maturation of this type of response to oestrogen (positive feedback)
seems to occur at a much later age in primates than in the other
species. In rats (Ying, Fang and Greep, 1971) and sheep (Land,
Thimonier and Pelletier, 1970) oestrogen induced LH surges can be
evoked in immature animals, whereas in the rhesus monkey oestrogen
induced LH surges are not demonstrable until I4.-8 months after the
menarche, and spontaneous cyclic LH surges (resulting in ovulation)
do not occur until even later (Dierschke et al, 197U&). Similar
information suggests a late maturation of the positive feedback
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mechanism in gifls (Reiter,Kulin and Hamwood, 197U5 Presi,
Horejsi, Stroufova and Herzmann, 1976). Thus in primates maturation
of the positive feedback mechanism appears to be a late pubertal
event. Furthermore, the maturation process appears to be ind¬
ependent of gonadal steroid secretion, since it cannot be advanced
in pre-pubertal female rhesus monkeys by chronic treatment with
oestrogen or progesterone (Dierschke et al, 197hb).
The late maturation of the positive feedback mechanism (and
hence the ability to ovulate) results in a period of post pubertal
infertility, which may well turn out to be a uniquely primate
phenomenon. It certainly occurs in chimpanzees in the wild, where
1-2^- years may elapse between menarche and the first conception
(McGinnis, 1973); during this time the animals will show regular
periods of oestrus with frequent copulation (Tutin, 1973). It
could have been particularly valuable in primitive human com¬
munities since it would have allowed sufficient time for sexual
exploration and the establishment of a lasting pair bond before the
first conception (Short, 1976). Whether post-pubertal infertility
is still of advantage in developed countries today where' social,
and moral attitudes have changed dramatically is more doubtful.
Since pre- or neonatal androgen exposure of females of
both rhesus monkey (Goy and Resko, 19725 Treolar, Wolf and Meyer,
1972) and human (Wilkins, 1965) species appears not necessarily to
affect normal ovarian cyclicity (i.e. response to positive feed¬
back) in later life, it has been suggested that unlike rodents
(Gorski, 1971; Caligaris, Astrada and Taleisnik, 1971) or sheep
(Short, 1971;; Karsch and Foster, 1975; Clarke, Scaramuzzi and
Short, 1976), the ability of the hypothalamic-pituitary unit to
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discharge LH iq response to oestrogen may not be a sexually
dimorphic characteristic in primates. However, the data on this
point are inconclusive. Initial attempts (Yamaji et al, 1971) to
obtain a female-like LH surge in castrated male rhesus monkeys
in response to a single injection of oestrogen were unsuccessful.
It was only later (Karsch et al, 1973d),when EH levels in castrated
animals were chronically suppressed with oestrogen before the
oestradiol benzoate injection, that a positive feedback response
was obtained. In such a situation however, the fact that the
animals have been so far removed from their normal endocrine state
makes interpretation of the results difficult. Furthermore,
oestrogen induced LH release in intact male rhesus monkeys has
not yet been demonstrated. It has been claimed that oestrogen may
be capable of inducing LH release in normal (Kulin and Reiter,
1976) and homosexual men (Dorner, Rohde, Stahl, Krell and Masius,
1975),although the LH rises that were described are comparable in
neither magnitude nor duration to those seen in normal women. A
more detailed study by Van Look (1976) provided no evidence for
the presence of a positive feedback effect of oestrogen in either
normal or hypogonadal men.
Thus the data from men and intact rhesus monkeys provide
little support for the existence of a positive feedback mechanism
in male primates. In contrast however, recent observations in the
marmoset monkey (Hodges and Hearn, 1978; this thesis, chapter 6)
indicate oestrogen induced LH release in castrated and intact
males. Whether such a response is unique to marmosets or is in
fact present in other primate species has yet to be determined,
and this will be discussed fully in chapter 7 of this thesis.
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The hormonal requirements for the initiation of the pre¬
ovulatory EH surge are complex,and it is only fairly recently that
any detailed information concerning the dynamics of positive feed¬
back in primates has been obtained. In the rhesus monkey, the
strength duration characteristics of the increments in circulating
oestrogen required to elicit an EH surge have been investigated by
Karsch, Weick, Butler, Dierschke, Krey, Weiss, Hotchkiss, Yamaji
and Knobil (1973). During the early follicular phase of the
menstrual cycle plasma oestradiol concentrations below 100 pg/ml
were ineffective in inducing EH surges, even when applied for as
long as 120 hours. Similarly oestrogen concentrations of 100-200
pg/ml were incapable of inducing a positive EH discharge when
applied for less than lj.2 hours. However, threshold doses of
oestradiol (200-1|00 pg/ml) when maintained for 36 hours will
consistently induce an EH surge.
Although the minimum requirements for an oestrogen stimulus
to be effective in the human female are similar, a longer exposure
time to the oestrogen stimulus (3-U days) is required to consistently
evoke an EH discharge (e.g. Yen and Tsai, 1972; Yen et al, 197Ub;
Van Eook, 1976). In addition,Yen and his co-workers (Tsai and Yen,
1971a; Yen, Tsai, Vandenberg and Reb.ar, 1972) have demonstrated
that although oestrogen administration during the mid follicular
phase of the cycle elicits an acute release of EH, this does not
occur when oestrogen is given in the early follicular phase. This
would suggest that the hypothalamic-pituitary system becomes
increasingly responsive to the positive feedback of oestrogen as
the concentration of circulating (endogenous) oestrogen increases
during follicular development. However this explanation does not
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seem to apply to the rhesus monkey in which oestrogen induced LH
surges can be regularly evoked either in the early follicular phase
or in ovariectomised animals (Karsch et al, 1973c; Clifton, Sterner,
Resko and Spies, 1973). Further investigation in the rhesus monkey
may reveal that the threshold dose of oestrogen required to elicit
an LH surge differs slightly at different stages of follicular
development.
The stimulatory effect of oestradiol can be modified by
several factors, the most important of which (with respect to the
control of LH secretion) is probably progesterone. Administration
of progesterone will block the positive feedback action of oestradiol
in women (Netter, Gorius, Thomas, Cohen and Joubinaux, 1973) and
intact rhesus monkeys (Dierschke et al, 1973; Clifton et al, 1973).
The spontaneous ovulatory surge can also be prevented by continuous
treatment of regularly cycling women with low doses of synthetic
gestagens (e.g. Weiner, Johansson and Wide, 1976). This inhibitory
effect of progesterone on oestrogen induced LH release may account
for the failure to demonstrate oestrogen induced positive feedback
during the luteal phase of the rhesus menstrual cycle (Dierschke
et al, 1973). In contrast however, in ovariectomised rhesus
monkeys, simultaneous administration of progesterone and oestradiol
significantly advanced (rather than inhibited) the onset of LH
release (Clifton et al, 1973). The physiological significance of
this observation is difficult to assess, although the authors
suggest it may indicate that the ovary is necessary, either directly
or indirectly, for the blocking effect of progesterone.
Although progesterone by itself is not capable of inducing
positive feedback in primates, administration of this steroid will
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stimulate an LH surge providing oestrogen is also present. Thus
progesterone can trigger an acute surge of LH after oestrogen
priming in agonadal or post menopausal women (Odell and Swerdloff,
1968; Leyendecker, Wardlaw and Nocke, 1972) and castrated men
(Stearnsj Winter and Faiman, 1973)* and a similar effect has also
been demonstrated during the late follicular phase in normally
cycling women (Yen, Lasley, Wang, Leblanc and Siler, 1973>)»
Administration of 10 mg progesterone during the late follicular
phase was found to induce a relatively brief (12 hr) surge of LH.
This facilitatory action of progesterone was not demonstrable in
the low oestrogen phase of the cycle, but in the high oestrogen
phase appears to be operative in relatively low serum concentrations
(1-2 ng/ml) with a short latency of approximately I4.-6 hours. Since
in the human plasma progesterone concentrations have been shown to
be significantly elevated at the time of the midcycle LH surge
(Johansson and Wide, 1969; Abraham, Odell, Swerdloff and Hopper,
1972) the possibility that progesterone acts synergistically with
oestradiol must be considered.
From the available evidence it may be concluded that in the
intact female primate oestradiol-1 7/? provides the principal stimulus
for inducing the positive feedback response which results in the
preovulatory LH surge. The exact role of progesterone, or indeed
any other gonadal steroid, in relation to the positive feedback
action of oestradiol at midcycle remains to be determined.
1 .1± The site of action of steroid hormones in the feedback control
of LH secretion
During the past few years a major issue has been whether
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the feedback modulating function of steroid hormones acts on the
hypothalamus by changing the release of LH-RH, or on the pituitary
by modifying its sensitivity to EH-RH, or a combination of both
of these effects.
Since the existence of specific receptor sites for gonadal
steroids in the adenohypophysis is well established (see
Stumpf, Sar and Keefer, 1975* for review) a direct feedback
action on the pituitary gland seemed likely,, In vitro, oestradiol,
or a combination of oestradiol and progesterone have
been shown to suppress EH release in response to EH-RH (Schally,
Redding and Arimura, 1973). Early in vivo attempts to test
pituitary sensitivity to synthetic EH-RH during different phases
of the menstrual cycle (e.g. Yen, Tsai, Naftolin, Vandenberg and
Ajabor, 1972; Nillius and Wide, 1972 - human: Krey et al, 1973 -
rhesus monkey) revealed that a "window" of maximal sensitivity to
EH-RH occurs at midcycle. It seems likely that this apparent
increase in pituitary sensitivity to EH-RH stimulation is a
result of the feedback action of increased levels of circulating
oestrogen. The finding that pituitary responsiveness to EH-RH
during the mid luteal phase is at least as great as that seen in
the late follicular phase (Yen et al, 1972a; Krey et al, 1973)
suggests that the low circulating concentrations of EH typically
found during the luteal phase of the cycle are not due to a
pituitary insensitivity to EH-RH, but are perhaps the result of a
decrease in the secretion of hypothalamic EH-RH which in turn may
be occasioned by an inhibitory action of oestrogen and progesterone.
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Initial attempts to demonstrate oestrogen feedback directly
on the pituitary yielded puzzling results. Oestrogen administration
in the human was found to reduce rather than increase pituitary
responsiveness to EH-RH (Thompson, Arfania and Taymor, 19735
Keye and Jaffe, 197U). However these results are somewhat
difficult to interpret because time and dose related factors were
not considered. The effect of acute and chronic oestradiol
administration on pituitary response to EH-RH has been further
studied. Rapid increments in circulating oestradiol to levels of
700-900 pg/ml achieved by constant infusion of oestradiol-11JS
into hypogonadal women induced a marked diminution in pituitary
response to EH-RH (Yen, Vandenberg and Siler, 1971;). Short term
exposure to oe stradiol-1 7/3 (approximately 100 pg/ml) also resulted
in a marked reduction in EH release in response to intrapituitary
LH-RH infusion in the rhesus monkey (Spies and Norman, 1 973>).
On the other hand,a more prolonged exposure of the pituitary to
low levels of oestradiol appears to initially enhance (after 1 week)
pituitary sensitivity to EH-RH, followed by a progressive
inhibition (Yen et al, 197Uc). These findings lend support to the
concept that changes in pituitary sensitivity to LH-RH (during the
menstrual cycle) are at least partially determined by temporally
significant changes in oestradiol levels. Since exogenous oestrogen
can reduce or enhance pituitary sensitivity to LH-RH its role in
modulating EH secretion is obviously complex. Careful attention
must be paid to the strength- and duration characteristics of the
oestrogen stimulus before the true situation in the menstrual cycle
is revealed.
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Evidence that oestrogen is responsible for changes in
pituitary sensitivity has also been provided by the demonstration
that the usually augmented response of the pituitary to LH-RH seen
during high oestrogen phases of the menstrual cycle is completely
eliminated by the administration of clomiphene (Wang and Yen,
1975). Clomiphene also markedly reduces pituitary release of EH
in response to LH-RH in normal men (Wang et al, 1975)• Since it
has been shown that the oestradiol binding capacity is several
times greater for the pituitary than for the hypothalamus (e.g.
Korach and Muldoon, 197^1), and also the competition of clomiphene
for oestradiol receptors is greater at the level of the pituitary
(Maurer and Woolley, 1971)* the principal effect of the reduced
LH-RH responsiveness is likely to be due to the elimination of
the oestrogen effect by clomiphene on the pituitary, and the hypo¬
thalamic contribution to such an event is probably small. These
interpretations must be viewed with caution, and considerations of
dose and duration of clomiphene treatment should be given. In
this regard, an augmented pituitary response to LH-RH has been
found by Gonzalez-Barcena, Kastin, Schalch, Lee, Lander, Siller,
Torres-Zamora, Rivas and Schally (197U) after the administration of
a larger dose and longer duration of clomiphene to male subjects.
At any rate it appears that steroid hormones exert part of their
feedback action through a direct effect on the pituitary.
In addition, there is now convincing evidence to show that
steroids, or more precisely oestradiol-17^ * also modulate LH
secretion by acting on the hypothalamus. As in rodents
(Szentagothai, Flerko, Mess and Halasz, 1972, for review), the
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medial basal hypothalamus (MBH) appears to be an important site of
negative feedback action in the rhesus monkey. In 1972 Bhattacharya,
Dierschke, Yamaji and Knobil demonstrated that c< adrenergic
blocking agents could simulate the negative feedback action of
oestradiol-17/5 . M-ore precise localisation of neural sites
involved in the negative feedback effects of gonadal steroids was
obtained by Ferin, Carmel, Zimmerman, Waren, Perez and Vande Wiele
(197k)• These workers were able to depress circulating EH levels
by the injection of oestradiol-17/5 into various regions of the
MBH (including the supra-chiasmatic, infundibular, ventromedial and
the mammillary complex nuclei), but in general no effect was
observed when oestradiol was applied to other hypothalamic or to
extrahypothalamic sites. These findings have recently been
confirmed by Spies, Norman, Quadri and Clifton (1977) who dem¬
onstrated that oestrogen inhibits LH release in response to MBH-
electrical stimulation.
With regard to positive feedback however, the work of
Krey, Butler and Knobil (1975) suggests that fundamental differences
may exist between rodents and primates. In contrast to the rat,
complete deafferentation of the MBH did not prevent spontaneous
ovulation in the rhesus monkey, suggesting that the ovulatory
discharge of LH in the rhesus monkey might not require a signal
generated by the pre-optic area of the brain. However, Spies et al
(1977) were unable to demonstrate a positive effect of oestrogen
on the LH response to MBH-electrical stimulation in the rhesus
monkey., despite a wide range of physiological oestradiol levels and
intervals of exposure. It may be possible that shorter oestrogen
treatment (less than 2k hours) would facilitate electrically
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induced LH release, although this rationale is inconsistent with
the oestrogen regimen required to induce an EH surge (Karsch
et al. 1973c). Furthermore, these workers (Spies et_al, 1977) did
find that oestrogen treatment induced a small but unambiguous
facilitation of LH release in response to electrical stimulation
of the rostral hypothalamus (which includes the preoptic-
suprachiasmatic region). Since Knobil's work (Krey et al, 1975)
suggests that the MBH, and not the pre optic area is responsible
for the expression of oestrogen induced LH release, the precise
area controlling positive feedback in primates remains in doubt.
The situation is obviously complex and requires further detailed
investigation.
The above studies provide conclusive evidence that gonadal
steroids exert feedback effects at the hypothalamic level. That
the positive feedback action of oestradiol results in increased
LH-RH secretion has been shown indirectly by further studies in the
human. Malacara et al (1972) and Arimura et al (19710 have
demonstrated an increase in peripheral LH-RH concentrations on the
day of the midcycle LH peak. Also,by measuring pituitary responses
to large (150 ug) and small (10ug) doses of LH-RH^Yen et al (1975c)
showed that an oestrogen induced amplification of LH release by
the pituitary requires large doses of LH-RH and that the magnitude
of acute LH release in response to a small dose of LH-RH is not
significantly influenced by increments in oestrogen levels. These
findings suggest (although indirectly) that the increase in LH
secretion associated with the midcycle surge at least in part
depends upon an increased LH-RH output, and that this in turn may
be due to the positive feedback action of oestradiol.
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1 .5 The dynamics of LH release in relation to steroid feedback:
Pituitary sensitivity and capacity
It is now evident that pituitary LH secretion varies
dramatically according to the nature of the LH-RH stimulus» Early
studies measuring pituitary response to synthetic LH-RH used single,
relatively large dose's of the releasing hormone, and it is only
fairly recently that continuous infusion or pulsed delivery of
much smaller doses has been performed. These later techniques have
revealed several interesting and important characteristics of
pituitary LH secretion,and have provided a more complete under¬
standing of the relationship between steroids and the hypothalamic
pituitary system. There is evidence to suggest that the inter¬
action between LH-RH and oestradiol may reflect the functional
presence of two pools of LH in the pituitary; an immediately
releasable pool, and a storage pool. These two pools of LH may
help to elucidate the ideas of pituitary "sensitivity" and
"capacity" which have been the subject of some recent detailed
studies in the human.
Constant stimulation with small amounts of LH-RH can result
in a biphasic pattern of LH secretion in normal men (Bremner and
Paulson, in pubertal, but not prepubertal children (Reiter,
Duckett and Root, 197!?), in normally cycling women (Yen et al,1975>n;
Wang, Lasley, Lein and Yen, 1976; Hoff, Lasley, Wang and Yen,
1977) and hypogonadal women (Lasley, Wang and Yen, 1973). These,
and other studies, have led to the idea of multiple components of
LH release in.terms of two functionally separable pools of pituitary
LH: - one, immediately releasable, reflecting pituitary sensitivity;
the other requiring continued stimulus input, reflecting pituitary
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capacity (i.e. the storage pool which includes a component of
newly synthesised LH). Thus when LH-RH stimulation is small and
brief, EH increments may be a reasonable measure of pituitary
sensitivity, whereas estimation of pituitary capacity or reserve
will probably require a longer duration of stimulation, achieved
either by constant infusion or by pulsed delivery of the releasing
hormone^thereby simulating the (assumed) normal hypothalamic input.
Measurement of the response to a single large dose of EH-RH
primarily measures sensitivity although a variable and indefinable
degree of "capacity" may also be involved, and thus it is not
possible to obtain an accurate measurement of either component.
The techniques of constant infusion or pulsed delivery of
submaximal doses of EH-RH to study the functional] capacity of the
pituitary gland in the human have been mainly used by Yen and his
colleagues. Lasley et al (1975) clearly demonstrated that
pituitary response to pulses of LH-RH (10 ug at 2 hourly intervals)
was augmented in terms of both sensitivity and reserve by incremental
changes in circulating oestradiol levels achieved by daily
administration of oestradiol benzoate for U days during the early
follicular phase. These workers also showed that a brief exposure
(J4 hrs) to relatively low levels of progesterone at the end of the
oestradiol benzoate treatment induced a marked amplification of
the oestrogen augmented pituitary sensitivity and reserve. Thus
a direct action of progesterone on the gonadotrophs may explain
the facilitatory action of progesterone on EH release in oestrogen
primed conditions described by several laboratories (e.g. Odell and
Swerdloff, 1968; Yen et al, 1975a).
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A similar augmentation of pituitary sensitivity and
capacity by oestrogen treatment has been observed with constant
infusion of a small dose of LH-RH (0.2 ug/min for I4. hours) (Yen
et al. 1975a). Although oestrogen and progesterone can enhance
pituitary response to LH-RH in intact women,it has been demonstrated
that pituitary sensitivity is greatest in hypogonadal subjects
(Lasley et al, 1975; Wang et al, 1976),and that in hypogonadal
women oestrogen treatment for 7 days induces an impediment of
sensitivity but a marked augmentation of pituitary reserve (Lasley
et al 1975). It therefore appears that in an open feedback
situation such as is found in hypogonadal subjects (where the
hypothalamic pituitary system is influenced primarily by the hypo-
physiotrophic effect of increased endogenous LH-RH secretion (Seyler
and Reichlin, 1973)), there is a large pool of acutely releasable
LH with a relatively smaller reserve pool. In this context it is
of interest to note that Wang et al (1976) found that increased
doses of LH-RH to hypogonadal women were not able to elicit
additional LH release, suggesting that pituitary sensitivity is at
a maximum. It is probable that the decline of basal LH secretion
during oestrogen treatment in hypogonadal or agonadal subjects may
be a consequence of a decreased pituitary sensitivity (Yen et al
1 97l|C) concomitant with a reduction of hypothalamic LH-RH secretion
(Seyler and Reichlin, 1973). The preferential augmentation of
pituitary reserve during this event probably represents the principal
action of oestrogen directly on the gonadotrophs and is seen only
in the presence of an exogenous LH-RH stimulus (Lasley et al, 1975)-
Of relevance to the concept of pituitary sensitivity and
capacity is the "self-priming" effect of LH-RH. This effect,
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originally demonstrated in the rat by Aiyer, Chiappa and Fink
(197U), and since confirmed in humans (Wang et al. 1976; Hoff
et al. 1977) appears to be oestrogen dependent. During the high
oestrogen phases of the menstrual cycle (late follicular and mid
luteal) LH responses to a second pulse of EH-RH (2 hours later)
were significantly greater than those following the first pulse
of LH-RH, although this pattern of response was not observed
during the early follicular (low oestrogen) phase. Thus during
high oestrogen phases of the menstrual cycle the first pulse of
LH-RH appears to "prime" the pituitary to produce increased
responses to subsequent LH-RH pulses.
The physiological significance of oestrogen induced LH-RH
self priming^and attenuation and amplification of pituitary
sensitivity and capacity by ovarian steroids will be examined in
the final section of this review.
1.6 Functional characteristics of the hypothalamic-hypophysial-
gonadal system in the regulation of cyclic LH release
The cyclic release of LH to produce a normal menstrual
cycle is the result of complex interactions between the ovary, the
hypothalamus and the pituitary. It appears that in the human two
functional pools of LH are present in all phases of the menstrual
cycle and that the comparative pool size and activity is profoundly
influenced by ovarian steroid feedback, as well as by the pattern
of input of hypothalamic LH-RH (Wang et al, 1976; Hoff et al, 1977).
From the early to the late follicular phase, in synchrony
■with the rising levels of oestradiol, the size of the 2nd pool
liO
(capacity) is preferentially augmented. A small increase in the
1st pool (sensitivity) activity is not apparent until the late
follicular phase when a 5 fold increase in the size of the second
pool is also attained. The increase in the 1st pool size Seen
during the late follicular .phase probably results from a rapid
activation of the larger 2nd pool to the more readily releasable
1st pool. Although the precise mechanism responsible for this
phenomenon is not known, it may be due to an oestrogen induced
increase in endogenous LH-RH (Seyler and Reichlin, 1 97l|.b)and/or
to a development of a self-priming effect of LH-RH at this time
(Wang et al, 1976). During the mid luteal phase, and in association
with relatively high levels of oestrogen and progesterone, the large
2nd pool is maintained as in the late follicular phase, but the
1st pool is strikingly smaller. A possible explanation for this
may be that the pituitary gonadotrophs remain highly sensitive to
EH-RH under the combined influence of oestrogen and progesterone,
but that the extremely low endogenous release of LH-RH at the mid
luteal period obviates the self priming effect of LH-RH. This
explanation seems reasonable from the observation that infusion
(priming) with exogenous LH-RH during the luteal phase will result
in a massive augmentation to subsequent LH-RH stimulation (Hoff
et al, 1977).
It seems likely that the oestrogen induced LH-RH self
priming may serve to activate the reserve pool and render its LH
more readily releasable; this is then revealed as an increase in
pituitary sensitivity. This theory is substantiated by the finding
that during the days of the mid cycle LH surge, a dramatic reversal
of the relative activity of the two pools is observed which is
manifested by an enormous increase in the activity of the first
relative to the second pool. In contrast to the other phases of
the cycle, the release of LH from the 2nd pool is not sustained
and this premature decline in LH release despite continuous LH-RH
stimulation appears to be due to pituitary depletion of LH.
It therefore appears that LH-RH not only induces synthesis f
storage (2nd pool) arid release (1st pool) of LH, but also activates
the 2nd pool and renders its LH more readily available (self-
priming). These positive influences exerted by LH-RH are amplified
by the presence of oestrogen which appears to provide a permissive
action of LH-RH, except that oestrogen also functions to impede
the LH-RH mediated release of LH. At mid cycle, the increased
endogenous LH-RH release, together with the development of oestrogen
dependent self priming effect of LH-RH induces a dramatic shifting
of LH from the 2nd to the 1 st pool, with accelerated LH release
by overcoming the impeding action of oestrogen. Mid luteal levels
of progesterone do not inhibit the augmented activity of the 2nd
pool due to oestrogen, but may in fact greatly amplify the LH-RH
induced activation of the 2nd pool,with the enlargement of the
smaller 1st pool. The physiological significance of this extra¬
ordinary enhancement of pituitary responsiveness to LH-RH (after
priming) is not clear, for progesterone levels are not found to be
significantly elevated before the onset of the LH surge in humans
(Johansson and Wide, 1969). However the possibility of progesterone
functioning as a secondary signal in the maintenance of. the midcycle
surge should be considered.
In conclusion, this review has attempted to bring together
some of the information relating to the control of LH secretion
in primates. It can be seen that the secretion of LH by the
pituitary gland is governed by complex interractions between the
hypothalamus, the pituitary and the gonads. Although our under¬
standing of the mechanisms regulating LH secretion has increased
considerably in the last 10 years, our knowledge is far from
complete. The importance of catecholamines is realised, but how
and where they act is unclear, and little is known about the role
of prostaglandins in the control of LH secretion. Furthermore
there is little information on 'short-loop' (where the pituitary
influences LH-RH secretion, Kuhl and Taubert, 1975) and 'ultra
short-loop' (in which LH-RH controls its own secretion, Hyyppa,
Motta and Martini, 1971) ft dback mechanisms which are thought to
exist. These, and many other considerations may form the basis
of research into the control of LH secretion in the next 10 years.
1 .7 The aims and scope of the study
The importance of the hypothalamic-hypophysial-gonadal
system in regulating LH secretion in primates is well established
from studies mainly on the rhesus monkey and human. In these
species the secretory patterns of hypothalamic hormones, pituitary
gonadotrophins and gonadal steroids have been studied in detail,
although their interrelationships are not yet fully understood.
Knowledge of the physiology of the hypothalamic-hypophysial-gonadal
system in non-human primates may be of value in the understanding
of reproductive endocrinology in humans.
This study was undertaken to examine certain aspects of
the hypothalamic-hypophysial-gonadal system in the marmoset
monkey, with the aim of determining some of the mechanisms involved
in controlling the secretion of LH in this species. The marmoset
has certain advantages over larger, more conventional primates
which make it an attractive alternative as an animal for laboratory
research. Detailed knowledge of its reproductive endocrinology
is essential in assessing the potential of this species as a possible
model for the human. The present study has been designed to provide
some of this information, and, where possible, to extend previous
observations from studies in other primates.
In recent years there has been considerable interest in
developing new forms of fertility control, particularly by methods
directed at the hypothalamic-pituitary axis. Techniques for inhibiting
EH-RH action have been developed, although detailed study of their
effects in primates is required before use in humans can be envisaged.
Inhibition of LH-RH is one way in which its action can be studied,
and by using the marmoset the potential of this approach in human




2.1 Anima^ s h6
2.2 Management h6
2.3 Collection of blood U6
2.U Hormones for injection U8
2.3 Administration of hormones b8
2.6 Steroid implants 3o
2.7 Surgery 31
2.8 Surgical procedures 31
2.9 Immunisation against LH-RH 33
2.10 Radioimmunoassay for Luteinising Hormone 33
2.11 Validation of the assay for marmoset LH. 60
2.12 Radioimmunoassay for Progesterone 69
2.13 Radioimmunoassay for Testosterone 73
2.1U Radioimmunoassay for Osstradiol-1 7/5 77
2.13 Measurement of anti-LH-RH antibodies in plasma 78
2.1 Animals
The animals used in this study were common marmoset monkeys,
Callithrix jacchus. They were maintained at the MRC Unit of
Reproductive Biology Primate Laboratory at the Bush Estate,
Midlothian. Animals used were adults (over 2 years old and 280 gm
body weight) either obtained from the wild, more than 18 months
before their use in experiments and fully adapted to captive
conditions, or born in captivity.
2.2 Management
Marmosets were kept in male-female pairs in aluminium cages
(50 x 50 x 75 cm) containing a nest box and two perches. To
prevent boredom and to maintain animals in a healthy condition,
each pair of marmosets was allowed periodic access to a large
exercise cage (150 x 100 x 210 cm). The animals rooms were main¬
tained at a temperature of 2U°C (range 21 - 29°C) and 65$ relative
humidity (range 55 - 70$), and were ventilated at about 10 changes
of air per hour. Animals were given natural light with additional
illumination between 0500 hours and 1900 hours. Hearn, Lunn,
Burden and Pilcher (1975) have published full details of the
management of this colony.
2.3 Collection of blood
Blood samples were taken from the femoral vein using an
0.H6mm diameter (27 gauge) needle and a heparinised 1ml syringe,
and placed immediately on ice. The syringe was sealed with a
steriseal cap, centrifuged at 2500 rpm for 20 minutes at i|°C, and
plasma stored at -20°C until assayed. Animals were either restrained
manually by a handler (Figure 2.1) or in a restraining device that
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Figure 2„1
Collection of blood from a marmoset, restrained
manually by a handler
allowed a single person to manipulate the monkey and collect the
blood sample (Hearn, 1977) (Figure 2.2).
When either system was in use, the marmosets remained
relaxed and appeared to be under little stress even during serial
bleeds. After collecting the blood sample ,the animals were given
0.1 - 0.2 ml of iron syrup ("Fersamal", Glaxo Laboratories Ltd.)
as a reward, and for replacement of iron.
2 .b Hormones for injection
1. Progesterone in arachis oil, 10mg/ml (Organon Laboratories, Ltd.),
diluted further as required in arachis oil.
2. Oestradiol benzoate in arachis oil, 1mg/ml (Organon Laboratories,
Ltd.), diluted further as required in arachis oil.
3. Testosterone and dihydrotestosterone were obtained from Sigma
Ltd., as crystalline preparations, and were dissolved in
arachis oil.
1|. Luteinising hormone releasing hormone (LH-RH) in saline,
100 ug/ml, was kindly donated by Hoechst Pharmaceuticals and
was further diluted in 0.9$ saline before use. A freeze-dried
preparation of LH-RH (Hoechst Pharmaceuticals) was conjugated
to bovine serum albumen (Sigma Chemical Co.) for use as an
immunogen.
The following hormones were used for injection:-
5. Analogues of LH-RH (D-Phe2Phe3DPhe LH-RH, and
Phe^LH-RH) were generously donated by Dr. A.V. Schally, and
were dissolved in 20$ propylene glycol (in 0.9$ saline).
2 .3 Administration of hormones
All steroids, injected in 0.1ml of oil, were given sub-
cutaneously in the ventrolateral region of the abdomen.
 
LH-RH and LH-RH analogues were given as rapid intra¬
muscular injections in 0.1ml of 0.9% saline or 20% propylene glycol
respectively.
2.6 Steroid implants
25>mg and 50mg crystalline progesterone implants were obtained
from Organon Laboratories Ltd. 0estradiol-17/3 implants were
prepared using a modification of the technique described by Dzuik
and Cook (1966):-
One end of a llynm length of Silastic Medical Grade tubing
(1 .96mm o.d. x 1 0l;7mm i.d., Dow Corning Corporation) was sealed
with a 2mm plug of silastic medical grade adhesive (Silicone type
A, Dow Corning). The length of tubing, in a small plastic dish,
was carefully lowered into a kilner jar containing about 15ml of
distilled water. After the lid of the kilner jar had been tightly
closed and the inlet valves clamped, the jar was placed in a water
bath and incubated at 37°C for 2k hours. This procedure creates
a water saturated atmosphere inside the jar and hardens the
adhesive. The silastic tube was then removed and packed with
crystalline oestradiol-17/3 (Sigma Ltd.), leaving a 2mm gap at the
open end. The tube was then sealed and incubated as described above.
The implants produced in this way contained a 1 .0cm long column
of oestradiol-1 7/3 .
To test the rate of release of oestradiol-1 7/3 , six implants
were incubated in vitro as follows:-
Each implant was placed in a glass jar containing 5>0ml
phosphate gelatin buffer (see page 69 ) incubated (with constant
shaking) in a water bath at 37°C for 3 days. Every 2k hours the
incubation medium was changed and a small aliquot diluted in buffer
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and assayed for oestradiol-17/3 (see page 77 )• The concentration
of oestradiol (pg/sample) was then used to calculate the approximate
amount of oestradiol-17/5 released into the medium in 2k hours.
Mean (with range) release rates for each of the three days were
17.6 (12.1-22.6), 13.7 (10.U-18.6) and 13-5 (I0.1-I6.lt) Ug
oestradiol-1 7/3 /day.
2„7 Surgery
Surgery was performed under aseptic conditions. All animals
for surgery were anaesthetised with an intramuscular injection of
0.5ml "Saffan" (I8mg/kg) (Alphaxalone 0„9% w/v, Alphadolone acetate
0.3$ w/vj Glaxo Laboratories Ltd.), and received an intramuscular
injection of 0o2ml penidural (Fortified Injection Veterinary -
Join Wyeth and Brother). The dose of anaesthetic was sufficient to
maintain animals under controlled, deep anaesthesia for a period of
about 1 hour. When the anaesthetic had taken effect the animals
were shaved in the appropriate region, the skin disinfected with
Hibiscrub (I.C.I. Pharmaceuticals Ltd.), and the surrounding area
covered with surgical dressing.
2.8 Surgical procedures





k • Insertion of implants.
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1. Orchidectomy
The base of the testis was clamped to project the testis
forward tightly against the scrotum. A 5-8mm incision was made in
the scrotal skin with a scalpel blade. The testis and epididymis
was gently squeezed out through the incision using forceps. The
spermatic cord was ligated in two places (about 2-3mm apart) about
10mm along its length from the epididymis, and the testis and
epididymis removed after cutting between the ligatures. A thin
film of penicillin powder was applied to the wound and the incision
in the scrotal sac was closed with one or two stitches. 3/0 Chromic
sutures with a 16mm cutting needle (Ethicon Ltd.) were used.
2. Laparotomy
A 10-15mm vertical incision was made through the skin in the
ventral region of the abdomen, immediately to the right of the
midline. A similar incision was made through the muscle layer,
taking care to leave the peritoneum intact. The abdominal cavity
was then exposed by cutting through the peritoneum using scissors.
The ovaries and uterus were measured using calipers and their
appearance noted. The incisions in the peritoneum and muscle layer
were closed with a continuous stitch (It/0 Chromic suture) and the
tissue carefully aligned. After the application of penicillin
powder the incision in the skin was closed with a continuous




The procedure was as described for laparotomy except that
the ovarian pedicles, arteries and veins were Id gated with 3/0
Chromic suture and the ovaries removed after cutting through the
attachments with scissors.
1|. Insertion of implants
A 3-5mm incision was made through the skin and connective
tissue in the ventrolateral region of the abdomen. The incision was
held open with forceps while the implant was introduced with a
second pair of forceps to lie at least l5mm below the incision.
Penicillin powder yas applied and the incision closed with a single
stitch.
2 .9 Immunisation against LH-RH
1 . Preparation of immunogen
LH-RH was conjugated to bovine serum albumen (BSA, Sigma
Chemical Co. Ltd.) using 1-ethyl-3(3-dimethyl-amino-propyl-
carbodiimide (Sigma) according to the method of Fraser, Gunn,
Jeffcoate and Holland (197Ub). For each animal to be immunised
1mg LH-RH, 1mg BSA and 1 Qmg carbodiimide were used.
Method
(a) LH-RH was weighed into a 5ml bottle, 0.5ml distilled water and
BSA were added and the reagents mixed for 1-2 mins.
(b) Carbodiimide was weighed into a separate container, dissolved
in 0.25ml distilled water and added to the EH-RH/BSA solution.
The reagents were mixed gently for 1 minute.
(c) After leaving the mixture at room temperature in the dark for
at least 12 hours, the contents were transferred to a dialysis sac
(about 15cm long, Viscing Tubing; Scientific Instruments Centre
Ltd.), and the container washed With 1ml of distilled water.
(d) The contents of the tubing were dialysed against distilled
water at l4°C for 1|8 hours and against 0.15M saline at i|°C for a
further 2h hours.
(e) The contents of the dialysis sac were transferred to a 10ml
container and made up to the required volume with 0.1 saline.
To enhance the immunological response to the LH-RH
immunogen, the conjugate was emulsified with Freunds complete
adjuvant (FCA) (Difco Laboratories) for primary immunisations, and
with Freunds incomplete adjuvant (FIA; Difco Laboratories) for
booster injections, The procedure was as follows:-
(a) Equal volumes of adjuvant and antigen solution were added in
a universal container (30 ml) to give a total volume sufficient to
allow 1 ,0ml of emulsion to be given to each animal (allowing
1 0-20$ loss during emulsification).
(b) The mixture was emulsified with an electric homogeniser at
medium speed for 2-3 minutes, or until the required viscocity
had been obtained.
(c) The emulsion was tested by allowing a few drops to fall into
a beaker of cold water. A sufficiently emulsified preparation
remained as a white drop on the surface.
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An emulsion of equal volumes of BSA in saline and FCA was
used for control immunisations.
2. Immunisation
Marmosets were anaesthetised and 1ml of emulsion was
distributed in 8-10 intradermal injections along the dorso-ventral
region. A single intramuscular injection of 0.25ml Bordetella
pertussis vaccine (Burroughs Wellcome and Co., London) to act
as an additional adjuvant was then administered.
2.10 Radioimmunoassay for Luteinising Hormone
Plasma luteinising hormone was measured using a double
antibody radioimmunoassay which is a modification of the assay for
rat LH described by Welschen, Osman, Dullaart, De Greef,Uilenbroek
and De Jong (1975). The system which was finally adapted to
measure EH in marmoset plasma utilises NIAMDD-rat LH 1-1 for
iodination, NIAMDD-rat LH RP-1 as standard, and anti-ovine LH
610 V as antiserum. The antiserum was raised in a rabbit by
immunisation with NIH-LH S17.
2.10.a Buffers
1 . Phosphate buffered saline (PBS) (0.01M; pH 7.8) was made from
stock solutions of O.ljM disodium hydrogen orthophosphate (A)
and O.IjM sodium dihydrogen orthophosphate (B). Sodium chloride
(36 gm), 91 .6ml of A and 8.14ml of B were made up to I4 litres with
distilled water. Sodium thiomersalate (Hopkins'and Williams, Ltd.)
(O.OUgm) was added as preservative.
2. Phosphate buffered saline (PBS) (0.05M; pH 7.8): This buffer
was prepared exactly as above except that the solution was made up
to 80Gml.
56
3. Phosphate buffered saline plus bovine serum albumen (PBS +
BSA): BSA was added to 0o01M PBS to give a concentration of 1gm
per 100ml (1£ BSA).
I4.0 "Special buffer"
3.72gm ethylenediaminetetra-acetic acid (EDTA, Sigma)
were dissolved in 1 litre of 0.01M phosphate buffered saline. The
pH of this solution was adjusted to 7.5 using 3N sodium hydroxide.
Normal rabbit serum (6.7ml) (NRS; Wellcome Reagents, Ltd.) and
2gm BSA were added.
5. Barbitone buffer (0.12M; pH 8.5): Diethyl barbituric
acid (110gm) was dissolved in U.5 litres of distilled water^ and 1 9gm
of sodium hydroxide in one litre of deionised water was added to
the main solution and stirred for 2 hours. The solution was then
made up to 5 litres with distilled water and stirred for 2k hours.
6. Barbitone buffer plus BSA: 5gm BSA were dissolved in 100ml
Barbitone buffer (i.e. 5$ BSA).
Unless otherwise stated all reagents were of Analar grade
from'BDH Chemicals Ltd. All buffers were stored at U°C.
2.10.b Iodination of Rat LH
Rat LH preparation NIAMDD-rat LH 1-1 was labelled with
125
Na I (Radiochemical Centre, Amersham) by a modification of the
chloramine-T method of Greenwood, Hunter and Glover (1963). Two
*25
microgrammes of hormone were reacted with 0.5-1 .0m Ci Na I
and 50ug chloramine T in a plastic tube (11 x 63mm, Sarstedt).
The chloramine T was made up immediately before use to a concentration
of 5mg/ml in 0.05M phosphate buffer; 10ul of this solution was
used in the reaction. The reaction was stopped after 30 seconds
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by adding 125 ug sodium metabisulphite in 0.5ml 0.05M phosphate
buffer. Potas.sium iodide (lOmg) was then added in 0.5ml 0.12M
barbitone buffer (pH 8.6). Labelled LH was isolated from the reaction
mixture by adsorption chromatography on a small column (1 x 5cm)
of Whatman CF II grade cellulose (Whatman Phamaceuticals). The
reaction mixture was applied to the column which was then washed
with 30ml 0.12M barbitone buffer. The ^ ^1 labelled LH was eluted
from the column by passing through 10ml of barbitone buffer contain¬
ing 5$ BSA, and collecting 1ml fractions. The most immunoreactive
fractions were pooled, and no further purification was necessary.
2.10.C Standards
Standard LH solutions were prepared from 50 ul aliquots
(10ug hormone) stored at -20°C by diluting to a total volume of
12.5ml in PBS + 1$ BSA buffer. This gave a concentration of 800
ng/ml, and standard solutions were prepared as doubling dilutions
of this solution. For each assay standards were aliquoted in
duplicate so that tubes contained 160 - 0.6 ng in a volume of
200 ul.
2.10.d Antiserum
Anti-ovine LH 61 0V was stored at -20°C in 50ul aliquots
at a dilution of 1 :10. This was diluted to 1 :1000 with 0.01M PBS
and stored at U°C. For each assay this solution was diluted further
in special buffer to give an initial concentration of 1 :70000.




All samples were assayed in duplicate using plastic 63 x 11
mm tubes. The protocol of each assay included:-
1. Total counts tubes (TC): ^ 2*^I-EH (lOOul).
2„ Non-specific binding tubes (NSB): special buffer (lOOul);
PBS + 1% BSA (200ul)j
12^I-LH (1 OOul).
3. Total bound tubes (TB): PBS + 1% BSA (200ul); antiserum (lOOul);
12^I-EH (1 OOul)
U. Standards: standard EH (200ul); antiserum (lOOul);
12^I-LH (1 OOul)
5. Unknowns and quality controls: plasma (50ul); PBS + 1%BSA (l50ul);
antiserum (100ul); ^2^I-LH (100ul).
Standards were dispensed in a volume of 200ul PBS + BSA
buffer. Test samples were dispensed in 50ul aliquots and made
up to 200ul with PBS + 1% BSA buffer. Antiserum (lOOul) was added
and the contents of each tube mixed and incubated at 1|°C for 3 days.
1 2^
I-labelled EH (approximately 10OOOcpm in 100ul PBS + ^% BSA
buffer) was added to all tubes which were mixed and incubated at
I|°C for a further 2 days. Separation of antibody bound and free
hormone was achieved by adding 200ul of donkey anti-rabbit gamma
globulin (1 :$0 V/v, in 0.01M PBS) (Burroughs Wellcome, RD 17) and.
incubation was continued at i|°C for 12 hours. The unbound radio¬
activity was diluted with 1ml 0.01M PBS and the tubes centrifuged
at lj.0C for 30 minutes at 2500 rpm. The supernatants were discarded,
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the tubes dried with tissue paper, and the antibody-bound I-
labelled LH in the precipitate was measured in an automatic
gamma spectrometer (Wallac Decern - GT2).
Eppendorf pipettes with disposable tips were used throughout
the assay for dispensing the standards and plasma samples. Buffer
was added to assay tubes with a semi-automatic dispenser (Lumix:
Chem. Lab. Instruments Ltd.), and repettes (Jencons) were used to
add iodinated hormone and antiserum to the tubes.
2.10.f Precision
The precision of the assay was assessed by repeated assay
of two pools of marmoset plasma from male and female marmosets
following LH-RH administration. One pool was used to measure intra-
assay variation and had a value of 80.1 - 2C86 ng/ml, with a
coefficient of variation of 3.5>7$ (n=12). A second plasma pool
was used for determining inter-assay variation and had a value of
87*2l|. - 6.U9 ng/ml, with a coefficient of variation of 7 »b%
(n=l£).
2.10.g Sensitivity
The limit of detection of the assay (B/BO = 9(%) ranged
from 0.7 - 0.9. ng/tube. Since the dilutions of marmoset plasma
and rat standard became non-parallel at above 87$ B/Bo (see
page 62), a working sensitivity of the assay of 1ng/tube was
adopted. With a 5>0ul plasma sample the detection limit was there¬
fore 20ng/ml LH RP-1 equivalent.
2.10oh Calculations
A typically sigmoid standard curve was obtained using a
J axis of B/Bo (where B = counts in the standard tubes - counts in
the NSB tubes; and Bo = counts in the TB tubes - counts in the NSB
tubes), and an X axis of the nanogram values of the standards on a
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log scale at a dose interval of two. Figure 2.3 shows a typical
specimen curve. The curve was drawn to pass through the mean value
of each dose of standard. Since dilutions of marmoset plasma
and NIAMDD rat EH RP-1 became non parallel above 87% B/Bo. and below
31$ B/Bo,LH concentrations were calculated only for samples falling
within these limits.
2.11 Validation of the assay for marmoset LH
2.11.a Methods
1. Specificity of the LH assay
200ul of doubling dilutions of rat LH 1-1, human LH
(hLH-Stockell-Hartree IRC2), human FSH (hFSH - Butt CPDS 13),
human TSH (hTSH - Stockell-Hartree De 32-3), ovine LH (oLH-S10),
and bovine FSH (bFSH-CH-1-76) were subjected to the same assay
procedure as described above. Since no purified marmoset pituitary
hormone preparations are available, the antiserum was tested for
cross reaction with TSH by measuring the response to an intra¬
muscular injection of 20ug thyrotrophin releasing hormone (TRH;
Roche). Plasma obtained from blood samples taken at various times
(0, 10, 30 and $0 minutes) after the injection were measured in the
LH assay.
2. Measurement of LH in plasma
Physiological validation of the assay was obtained by
measuring (1 ) LH concentrations after LH-RH administration to intact
and LH-RH immunised male marmosets; (2) the LH response to gonad-
ectomy (see Chapter £)•
The parallelism between dose response curves for rat LH
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Figure 2.3
Standard curve for LH
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and plasma samples containing endogenous marmoset LH from LH-RH
treated and LH-RH immunised marmosets was assessed to validate the
assay for the measurement of LH in marmoset plasma.
2.11.b Results
1. Specificity of the LH assay
Figure 2.U shows the cross reactivity of all the standard
hormones investigated in the heterologous LH assay. The slope of the
dose response curve using oLH-S10 standard was slightly greater than
in the system which used an LH standard of rat origin (NIAMDD rat
LH RP-1). The highly purified iodination grade NIAMDD rat LH 1-1
preparation was used to assess the cross reactivity of the various
hormones tested, and was given a potency value of 100$. Cross
reaction was calculated as the amount of hormone (w/w) giving %0%
inhibition of binding. NIAMDD rat LH RP-1 gave a cross reaction of
3$ while cross reactions with bFSH-CH-1-76 and NIAMDD rat FSH 1-1
were 0.17$ and <0.3$ respectively (cross reaction with NIAMDD rat
FSH 1-1 was measured by Welschen et al„ , 1975). Although all human
preparations gave non parallel inhibition curves, the antiserum clearly
had a much higher affinity for hLH-lRC2 than for either h FSH-CPDS
15 or h TSH De 32-3, both of which showed no significant inhibition
of binding (<0.05$). There was no marked increase-in the concentration
of plasma LH after administration of TRH (Fig 2.5).
2 o Measurement of LH in marmoset plasma
Serial dilutions of marmoset plasma and a marmoset crude
pituitary extract were parallel to the inhibition curve obtained with
NIAMDD rat LH RP-1 standard (Fig. 2.6) over the range 31$ B/Bo to
87$ B/Bo (no significant departure from parallelism, p>0.05, ANOVAR).
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Figure 2.U
Cross-reaction of ovine, bovine, rat and human pituitary hormone
preparations in the heterologous LH assay. » , rat LH (NIAMDD
rat LH RP-1); □ , rat LH (NIAMDD LH 1-1; ■, ovine LH (oLH-S10);
X, bovine FSH (bFSH CH-1-76); Oj human LH (hLH Stockell-Hartree
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Figure 2.5
Mean (- S.E.M.) LH concentrations in male
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Figure 2.6
Inhibition curves for NIAMDD rat LH RP-1 ( • ), pooled plasma
from LH-RH treated marmosets ( A ) and LH-RH immunised
marmosets ( □ ), and a marmoset crude pituitary extract ( A ).
Although parallelism was not found at the extremities of the curves
all plasma samples measured in this study fell within the limits of
parallelism quoted. There was no significant departure from para¬
llelism (p>0.2, ANOVAR) between serial dilutions of marmoset plasma
and the marmoset pituitary extract over the complete range of r
dilutions. The non-parallelism above 87$ B/Bo and below 31$ b/Bo
seen when comparing marmoset plasma with niamdd rat lh RP-1 standard
is therefore a feature of the hormone and is not due to a plasma
effect. Fifty microtitres of marmoset plasma (the volume used in the
assay) showed no non-specific interference. The slight inhibition
of binding produced by 200 ul of plasma was probably caused by low
levels of residual lh which can occur in lh-rh immunised animals.
Mean (- s.e.) lh concentrations before and 30 minutes after
lh-RH administration to normal male marmosets were 29.1 - 2.5 ng/ml
and 102.1 - 6.U ng/ml respectively (n = 15) (Fig. 2.7). The change
in the concentration of lh in the plasma (Alh) during this period
was therefore 73.0 ng/ml. Immunisation against LH-RH inhibited LH
release in response to an LH-RH injection. Pre-treatment levels in
immunised males were no longer detectable (< 20ng/ml) and mean (-s.e.)
concentration 30 minutes following the LH-RH injection was 25.7
- 1.7 ng/ml (n = 3). As pre-injection LH levels were undetectable in
immunised animals, it was not possible to obtain a value forALH.
Nevertheless it is clear that in animals immunised against LH-RH,
circulating LH levels are depressed, and the pituitary response to
exogenous LH-RH stimulation is inhibited.
Note
Although absolute validation of the heterologous assay for
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Figure 2.7
Plasma LH concentrations (-S.E.M.) immediately before and
30min after LH-RH administration (Uug) to normal and LH-RH
immixnised males
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the data obtained here indicate that the assay measures marmoset LH.
Comparison of dilutions of marmoset plasma and crude marmoset
pituitary extract with NIAMDD rat LH RP-1 shows that the assay
measures marmoset LH in plasma. The slight inhibition of binding
obtained with hTSH DE 32-3 is probably due to contamination of this
preparation with LH. Although it is not anticipated that marmoset
TSH and hTSH DE 32-3 would show immunochemical similarity, the data
relating hTSH and hLH are relevant in showing that the LH assay
described here clearly has a much higher affinity for hLH than for
hTSH. Since there was no significant increase in the concentration
of LH in the plasma of marmosets after administration of TRH, it is
assumed that the LH assay is not measuring significant amounts of
marmoset TSH (providing TRH does release TSH in the marmoset). The
data on hTSH DE 32-3 and the administration of TRH therefore provide
indirect evidence that significant cross reaction with TSH in the
heterologous LH assay is unlikely.
Physiological validation of the assay (response to administration
of LH-RH and gonadectomy) shows .that the heterologous assay effectively
measures marmoset gonadotrophins, but it does not give any indication
of how much FSH is being measured. Cross reaction studies with FSH
preparations of human, rat and bovine origin showed a maximum cross-
reaction of <0.3$ with NIAMDD rat FSH 1-1 . Since this assay uses a
rat LH tracer, it is unlikely that the cross-reactivity of FSH from
any other species will be greater than that of rat FSH. Thus,
although a precise determination of the degree of cross-reaction with
marmoset FSH cannot be made at present, it is reasonable to assume
that it will not exceed 0.3$. These results indicate that this
heterologous LH assay provides a reliable and precise method for
measuring plasma LH concentration in the marmoset monkey, although
until purified marmoset EH becomes available the accuracy of the
assay cannot be determined.
2.12 Radioimmunoassay for Progesterone
Plasma progesterone was measured by a radioimmunoassay method
similar to that described by Scaramuzzi, Corker, Young and Baird
(1975). The system utilises an antiserum (number 35-3(7)) (kindly
provided by Dr. K. Dighe) which was raised in a rabbit against
progesterone-11 °c-hemisuccinate-bovine serum albumen conjugate.
The specificity of the antiserum has been previously tested by
Dighe and Hunter (1975).
2.12.a Reagents
Unless stated otherwise, all reagents used were analar grade
from BDH.
Assay buffer: 0.05M phosphate gelatin buffer.
55gm of sodium chloride, 53gm of disodium hydrogen orthophosphate,
35gm of sodium dihydrogen orthophosphate and $gm of gelatin were
dissolved in 5 litres of distilled water. Sodium thiomersalate
(0.001$ W/v) was added as a preservative.
Solvents: Analar grade petroleum ether (B.P. 50-60°C), methanol
and Aristar grade ethanol were used.
Stripping agents: Activated charcoal Norit A was obtained from Sigma,
and dextran T 70 was supplied by Pharmacia Fine Chemicals.
Steroids: Non radioactive progesterone was obtained from Sigma and
accurately weighed amounts were dissolved in ethanol and stored at 5°C.
Radioactive progesterone (1,2,6,7- H-progesterone, approximately
311/iCi/^g; Radiochemical Centre, Amersham) was diluted to a concent¬
ration of 10 uCi/ml in ethanol and stored at 5°C.
Scintillation fluid: This was prepared by adding 1Ogm of 2,5-
diphenyl-oxazole (PPO; Koch-light) and 75>Omg of p-tris-(2-(2phenyl-
oxazolyl))-benzene (POPOP; Koch-Light) to 2.5 litres of toluene
(analytical grade; Koch-Light) . 1.25 litres of Triton X-100
(analytical grade; Koch-Light) were also added and the mixture stirred
until a homogenous solution was obtained. 10ml of this fluid were
added to each scintillation vial (plastic disposable, New England
Nuclear) before counting, using a semi automatic dispenser (Zipette:
Jencons).
Disposable glass tubes and eppendorf pipettes with disposable
plastic tips were used throughout the assay. The antiserum and
tracer were dispensed with 2ml capacity repettes (jencons) and
petroleum ether added using a semi-automatic dispenser (Lumix).
2.12.b Assay procedure
1. Extraction of progesterone from plasma
20ul or 50ul aliquots of plasma were pipetted into glass
extraction tubes (75 x 15mm; Gallenkamp) and phosphate gelatin buffer
added to produce a total volume of 100ul. 1 ,0ml of petroleum ether
(distilled not more than 2k hours previously) was added and the tubes
mixed vigorously in a multivortex mechanical shaker (Baird and
Tatlock) for three minutes. When the aqueous and solvent phases had
separated out, the aqueous phase was frozen quickly by placing the
tubes into methanol containing dry ice. The solvent phase was then
decanted into 75 x 12mm glass tubes (Kimble). These tubes were placed
in a heated block (Driblock DB3, Tecam) and the solvent evaporated
to dryness under a regulated flow of nitrogen.
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2. Radioimmunoassay
The dried residue from the extraction procedure was
redissolved in 0.3ml of buffer. The contents of the tubes were
mixed thoroughly and left to stand at room temperature for at least
one hour. The contents of the tubes were mixed for a second timej
after which duplicate aliquots of 1 00 ul of the solution were
transferred to glass assay tubes (75> x 10mm; Kimble). 50ul aliquots
were transferred directly to counting vials for recovery determination
(see below).
For each assay a standard curve was constructed using
progesterone standards which had been dissolved in ethanol and diluted
in buffer. Standards were serially diluted and aliquoted in duplicate
so that tubes contained 31 .23 - 1000 ug of progesterone in a volume
of 100ul. 1 OOul of antiserum in buffer (initial dilution 1 :10000)
3
and 100ul of 1,2,6,7- H-progesterone in buffer {^> 30pg) were added
to all tubes containing standards and unknowns, to give a final
incubation volume of 300ul. In addition, duplicate sets of total
counts (TC), non-specific binding (NSB) and total bound (TB) tubes
were set up as follows:-
TC: ^H-progesterone (100ul)
NSB: ^H-progesterone (100ul) + buffer (200ul)
■a
TB: H-progesterone (100ul) + buffer (100ul) + antiserum
(1 OOul).
Tubes were incubated overnight at i|.0C and then placed on
ice while a suspension of dextran coated charcoal in buffer was
prepared (25>mg dextran and 230mg charcoal per 10Omls of buffer).
1 .0ml of this suspension (kept on ice and continuously stirred) was
added to all tubes, except the TC tubes which received 1 .0ml buffer.
The tubes were mixed and left on ice for 15> minutes. All tubes were
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centrifuged at 2500 rpm for 10 minutes at l4°C, and the supernatants
immediately decanted into counting vials. Following the addition
of 10mls of scintillation fluid, the vials were allowed to equilibrate
in a cooled (U°C) scintillation counter (Packard, Model 3375) for
30-60 minutes before counting.
3. Recovery
The recovery of hormone from plasma was calculated for each
sample during the first six assays. Thereafter, recoveries were
determined for 6 aliquots of plasma from samples included in the
assay. A mean recovery was then applied to all samples in the assay.
In the initial six assays mean recoveries ranged from 611.-75$ and
the coefficient of variation for recovery between samples within an
assay was 9.76$.
The amount of progesterone extracted from plasma was estimated
■3
by adding 20ul of 1 ,2,6,7- H-progesterone in ethanol 2000 cpm)
to the plasma/buffer mixture (100u1) in 75 x 15mm glass extraction
tubes. Extraction and evaporation to dryness were carried out as
described for the assay. Following the addition of 300ul of buffer
to the residue, the tubes were mixed and left to stand at room
temperature. 50ul aliquots of this solution were then transferred to
scintillation vials which were counted as before. Two 20ul aliquots
of the tracer (total counts) were also counted.
2.12.C Inter-assay variation
This was determined by repeated assay of duplicate aliquots
from a pool of human plasma (Quality controls). A mean (-S.E.M.)
value of 12.U - 0.5 ng/ml was obtained with a coefficient of variation
of 11.2$ (9 assays).
2.12.d Calculations
A program for the construction of a standard curve and the
determination of the amounts of progesterone in plasma samples was
written for a desk computer (9821A Calculator: Hewlett Packard) by
Mr» R.M. Sharpe. The program was written to construct a straight
line from the typically sigmoid standard curve. A standard curve
was calculated using a Y axis of the logit transformation of B/Bo,
and an X axis of the pg values of the standards on a log scale at a
dose interval of 2. Values for logit B/Bo versus dose of standard
were plotted by the computer. The calculation of a standard curve
omitted the points >90$ of Bo and <10$ of Bo, and a straight line
of best fit for the data points was drawn. Progesterone concen¬
trations were calculated by the computer as pg/tube. The results
were then corrected to give ng/ml plasma. A typical standard curve
obtained by this procedure is shown in Figure 2.8.
2.13 Radioimmunoassay for Testosterone
The radioimmunoassay for testosterone is similar to that
described for progesterone, and full details of the methodology and
specificity of the assay have been described by Corker and Davidson
(1977). The antiserum to testosterone (E.O.I., supplied by
Dr. S.A. Tillson, Aliza Corporation, Palo Alto, U.S.A.) was raised
in a goat immunised with testosterone-3-oxime coupled to bovine serum
albumen. Gross reactions of other steroids tested included:
5«<-dihydrotestosterone (25$), oestradiol-17/5 (0.20$) and andro-
stenedione (0.08$).
The assay for testosterone differs from that for progesterone
















Standard curve for progesterone
Non radioactive testosterone (Sigma) was dissolved in
ethanol to give a concentration of 1ug/ml, and stored at i|°C.
I4.OO11I were removed, evaporated to dryness, and the residue dissolved
in 10Qmls of buffer, to give a concentration of liQOpg/1 OOul. Suitable
dilutions of this solution were then prepared to produce concen¬
trations of J4OO, 200, 100, 50, 25> and 12i.^pg/1 OOul buffer. These
were used as standards.
3Radioactive testosterone (1,2- H-testosterone) with a specific
activity of 294- -pCi/yw^ was obtained from New England Nuclear and stored
at l4°C in ethanol. For use in the assay, an aliquot of this solution
was dried down under nitrogen and redissolved in buffer to give a
3solution containing 6000 cpm of 1,2- H-testosterone per 1 OOul of
buffer.
The antiserum was used at an initial dilution of 1:6000 in
buffer.
Analytical grade hexane (BDH) and diethyl ether (BDH) were
distilled separately (not more than 2l± hours before use) and mixed
in a ratio of hexane:ether (U:1). 1 .0ml of this mixture was used to
extract testosterone from plasma.
320ul 1,2- H-testosterone in ethanol (^1200 cpm) were added
to the plasma (made up to 100ul with buffer) to test the recovery of
testosterone.
The coefficient of variation for recovery between samples
within an assay was approximately 6.7$. . The range of recoveries was
69-82$ over the first six assays.
Repeated assay of a pool of human plasma gave a mean value-
-S.E.M. of 5.1 —0.2 ng/ml, and inter-assay variation, expressed as
the coefficient of variation was 12.7$ (11 assays).
A typical standard curve for the testosterone assay is shown
in Figure 2.9.
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Figure 2.9
Standard curve for testosterone
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2.1U Radioimmunoassay for Oestradlol-11M
0estradiol-1 7/3 was measured by the method described by
Baird, Swanston and Scaramuzzi (1976). The antiserum (OR - 14.22/7)
was raised in sheep injected with oestradiol-6-keto-bovine
serum albumen.
Cross reactions tested with other steroids included:-
6-keto-oestradiol, 1 00$ j oestrone, 9.6%, oestradiol-1 Toe. ,2
other steroids, <1%. The oestradiol-17/3 assay method is also similar
to that described for progesterone apart from the following
differences:
Non radioactive oestradiol-17/3 (Sigma) was stored in ethanol
at li°C at a concentration of 1 ug/ml. f>12 ul were removed, evaporated
to dryness, and the residue dissolved in 100 mis of buffer. Suitable
dilutions of this solution were then prepared to give concentrations
of 512, 296, 128, 6b, 32, 16 and 8 pg/100 ul buffer. These were
used as standards.
3
Radioactive oestradiol-1 7/5 (6,7- H-oestradiol-1 7/3 ) with a
specific activity of 17 ^ fCl/jutj was obtained from New England Nucl ar
and stored at 1|0C in ethanol. In the assay, approximately 6000 cpm
3
of 6,7- H-oestradiol-1 7/ (i.e. 35>-l|0 pg) per 100 ul buffer were added
to each tube.
Aliquots of 30 ul plasma were made up to 100 ul with buffer.
3
To test recovery of oestradiol-11/3 from plasma 20 ul of 6,7- H-
oestradiol-17/? in ethanol (^ 1200 cpm) were added, and extracted as
for progesterone.
Oestradiol-1 7/3 was extracted from plasma with 1 .0 ml of
analytical grade diethyl ether (BDH) which had been washed with %0%
(W/v) ferrous sulphate (BDH) in 9>% C/v) sulphuric acid (BDH) and
distilled water, and redistilled within 2b hours of use.
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The coefficient of variation for recovery between samples
within an assay was approximately 6.1$. The range of recoveries was
76-87$ over the first 6 assays.
Repeated assay of a pool of marmoset plasma gave a mean (-S.E.M.)
value of 20.9 - 0.9 ng/ml, with a coefficient of variation of 11.9$
(8 assays).
A typical standard curve for the oestradiol-17/7 assay is
shown in Figure 2.10.
Cross-reaction of oestradiol benzoate in the oestradiol-1 7/3 assay
20mg oestradiol benzoate (Sigma) were dissolved in absolute
ethanol (10 ml). 20 ul of this solution were diluted to 30 ml in
buffer to give a concentration of 100 ng/100 ul. Serial dilutions
of this solution were prepared and used to construct a standard
curve. A normal standard curve for oestradiol-17/3 was also included.
90$ inhibition of binding was achieved with 76pg oestradiol-1 7/5
and 20 ng oestradiol benzoate. Cross reaction of oestradiol benzoate
in the assay is therefore 0.38$ (Fig. 2.1 1).
2.15 Measurement of anti LH-RH antibodies in plasma
2.13.a Iodination of LH-RH
1 23
Synthetic LH-RH was labelled with Na I by a modification
of the chloramine-T method of Greenwood, Hunter and Glover (1963).
Iodinations were carried out with the help of Dr. H.M. Fraser.LH-RH
(0.8 - 1 .0 ug in 100 ul 0 01M PBS, pH 7-3 + 23 ul 0.3M PBS) were
1 23
reacted with ^ 1 .OmCi Ha I and 10 ug chloramine-T (in 10 ul 0.01M
PBS). The reaction was stopped after 30 seconds by adding 30 ug
sodium metabisulphite in 100 ul 0.01M PBS. Potassium iodide (2mg)
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Figure 2 ,,10
Standard curve for oestradiol-1 7A




Standard curve for oestradiol benzoate
isolated from the reaction mixture by adsorption chromatography on a
column (1x8 cm) of Whatman CF 11 grade cellulose. The reaction
mixture was applied to the column which was then washed with 30 ml
1 25
0.01M PBS. The I-labelled LH-RH was eluted from the column by
passing through 15 ml of 0.1; M PBS containing 1$ BSA, and collecting
1ml fractions. The most immunoreactive fractions were pooled and
repurified immediately before use, as follows:
A 5 - 10 cm column of CF 11 cellulose was equilibrated with
1 25
0.01M PBS. I-LH-RH was added to the column which was eluted with
20 ml of 0.01M PBS to remove free ^ ^1 and damaged ^^I-tH-RH. 10 ml
of O.ijM PBS containing 1$ BSA were then passed through the column
and the early fractions (1 ml) collected. In this way about 30$ of
1 25
the I-LH-RH is recovered.
2.15-b Radioimmuno as s ay
Plasma was diluted tenfold with 0.01M PBS containirg 1% BSA
and stored at -20°C. For use in the assay this solution was diluted
to 1 : 500 with 0.01M PBS containing 0.1$ BSA. Samples were assayed
in duplicate as follows:-
Each tube (1 0 x 75 mm plastic disposable) received 10Oul of
diluted plasma (i.e. antiserum), 100 ul of 0.01M PBS + 0.5$ BSA, and
100 ul ^ ^I-LH-RH (approximately 10000 cpm (10 pg) in 0.01M PBS +
0.1$ BSA). The contents of the tubes were mixed and incubated
overnight at 1|°C. Separation of antibody bound and free hormone was
achieved by adding 1.5 mis of absolute ethanol (U°C), mixing thoroughly,
and centrifuging at 1|0C and 2500 rpm for 20 minutes. The supernatants
were decanted, the tubes dried with tissue paper, and the antibody-
1 25bound I-LH-RH in the precipitate was measured in an automatic
gamma spectrometer.
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Two tubes received 100 ul tracer (Total counts) and two tubes
received 100 ul tracer, 100 ul PBS + 0.1 £ BSA and 100 ul PBS +
0*%% BSA (Non-specific binding). The mean non-specific binding value
1 2^
was subtracted from all plasma values. The amount of I-labelled
LH-RH bound by the plasma (expressed as a % of the total counts) was
used as a measure of antibody titre.
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3.1 Introduction
Pituitary gonadotrophin release is stimulated by luteinising
hormone-releasing hormone (LH-RH) isolated from hypothalamic extracts
and characterised in 1971 as a decapeptide (Matsuo, et al, 1971).
Administration of natural or synthetic EH-RH causes release of LH and
a comparatively slight release of FSH in several species (Schally,
Arimura and Kastin, 1973). One way in which the action of LH-RH may
be studied is by its inhibition or elimination in vivo. One approach
has been the production of lesions or islands in selected areas of
the hypothalamus (Halasz, 1969; Donovan, 1970) but recently, after
the synthesis of LH-RH (Matsuo et al, 1971) more specific forms of
inhibition by chemical means have become possible. In this way
selective control of pituitary gonadotrophin secretion can be achieved
either immunologically by the production of specific antibodies, or
by the use of peptide analogues of LH-RH which antagonise the action
of the endogenous hormone.
Selective neutralisation of LH-RH by specific antibodies can
be achieved by active (long term) and passive (short term) immunisation.
Active immunisation against LH-RH, which has been reported in rodents
(Fraser, Gunn, Jeffcoate and Holland, *\9lh» Fraser, 1976a,b; Arimura
Shino, de la Cruz, Rennels and Schally, 1976) and more recently in
sheep (Clarke, Fraser and McNeilly, 1977) results in gonadal atrophy
and inhibition of reproductive function. Antagonistic analogues of
LH-RH competitively inhibit the action of LH-RH on the pituitary gland.
In this way some of the more active peptides are able to suppress
LH-RH induced LH release and block ovulation in rats (Corbin and
Beattie, 1975; de la Cruz, Vilchez-Martinez, Arimura and Schally, 1976;
Nishi, Coy, Coy, Arimura and Schally, 1976). In view of the possible
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implications of specific LH-RH inhibition in terms of human fertility-
control, it would be useful to test these new methods in primates.
The present chapter is concerned with inhibition of EH-RH
in the marmoset monkey. It deals firstly with active immunisation
against EH-RH and outlines some of its effects on gonadal activity
and pituitary function. In addition, a pilot study was performed to
test the effectiveness of two of the more recently synthesised inactive
analogues of LH-RH in inhibiting EH-RH induced EH release.
3.2 Active immunisation against LH-RH
3.2.a Procedure
Immunisation against EH-RH conjugated to BSA was performed
in two stages: Group 1 (3 males, 3 females) was immunised in
February, 1975; Group 2 (2 males, 2 females) was immunised 11 weeks
later, in April 1975° Booster injections were given 10 weeks (group
1) and 11 and weeks (group 2) after primary immunisation. Control
animals (2 males, 2 females) were immunised against BSA.
Blood samples were taken and testicular and uterine dimensions
were measured using calipers, according to the following schedule:-
EH-RH immunised animals: once weekly for 25 weeks (group 1) or 11;
weeks (group 2), and then once every 5-10 weeks for the rest of the
study (90 weeks).
BSA immunised animals: once every 2 weeks for 20 weeks.
Blood samples were assayed for antibody titres, progesterone,
testosterone, and initially, EH. The presence of antibodies to
LH-RH was assessed by measuring the percentage binding of approximately
1Opg radioiodinated LH-RH by plasma at a dilution of 1 :500 . The
volumes of left testes were calculated from measurements of their
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1 — 2
length and breadth using the formula V = /6nB L, where V = volume
(of an oblate spheroid), B = breadth and L = length.
Unilateral orchidectomy was performed after 53 weeks (group
1) and after 67 weeks (group 2). The size and appearance of ovaries
were noted either during laparotomy after 20 weeks (group 1), or
fallowing unilateral ovariectomy after 53 weeks (group 1) and after
73 weeks (group 2). Testes and-ovaries were removed from controls
approximately 30 weeks after immunisation. Testes and ovaries were
trimmed and fixed in Bouin's solution for histological examination.
Sections were stained with haematoxylin-eosin. The diameters of 30
seminiferous tubules from each testis were measured using a calibrated
micrometer eye-piece.
EH-RH immunised animals received rapid i.m. injections of
synthetic EH-RH (U, 10, and 50 ug in 0.1ml saline) 37-^0 weeks after
immunisation. Controls received l;ug LH-RH only, after 20 weeks. All
animals were bled immediately before, and 1;5 mins after the EH-RH
injection, and plasma samples were assayed for EH.
Group 1 animals will subsequently be referred to as d* or j
1, 2 and 3; group 2 animals as cf or j U and 5, and control animals as
d* or ^ 6 and 7.
Animals were initially caged in male-female pairs according
to their numbers, i.e. 61 1 with j 1, d*2 with 5 2, etc. Four animals
were later separated and placed with non-immunised partners to test
their fertility (6*1 and j 1 68 weeks after immunisation^ d*2 and
5 2 after 61 weeks).
3.2.b Results
All animals immunised with EH-RH-BSA conjugate produced
antibodies to EH-RH. In 6 animals (3 males, 3 females) antibody titres
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were relatively high binding), whereas in the other four, titres
remained low (<.15$ binding). Towards the end of the study problems
were experienced in the preparation of suitably iodinated EH-RH,
resulting in alteration of the characteristics of the assay for
antibody titres. Consequently some of the results have not been
included and the data on antibody titres are complete only for the
first 65-75 weeks after primary immunisation.
No antibodies to LH-RH were produced by BSA immunised controls
( < 1$ binding) (Figs. 3.1 and 3.2). In the males (d* 6, rf 7) there
was no apparent inhibition of testosterone secretion and although
testicular volume fluctuated slightly, there was no overall decrease.
Both females (j 6, j 7) were found to be pregnant U weeks after
immunisation, and in each case pregnancies were continued to term
after gestation periods of 20 and 21 weeks respectively.
In all three males which developed high antibody titres
(d*1, (? hj d*5) there was suppression of testosterone secretion and
marked testicular atrophy (Figs. 3.3 and 3«U). Antibodies were
detected in the circulation iq—5 weeks after immunisation and levels
continued to rise steadily until approximately week 20. Antibody
titres rose following the first booster injection, although the
second booster (d*l|., 0*5) appeared to have little effect on the levels
of antibody. As titres increased, testes became softer and smaller,
eventually shrinking to less than 20$ of their original volume. The
development of high levels of antibody was also associated with a
marked inhibition of testosterone secretion, and by 10-12 weeks after
immunisation, plasma testosterone concentrations were no longer
detectable (< 1ng/ml).
Figure 3.1
Testis volume, testosterone concentrations and antibody titres

























































































































































e 0 TESTIS VOLUME
Figure 3.3
Testis volume, testosterone concentrations and antibody titres
in two LH-RH immunised males




Testis volume, testosterone concentrations and antibody titres
in two LH-RH immunised males
Both high antibody titres
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The reduction in size and secretory activity of the testes
was maintained throughout the period of high antibody titres. Levels
of circulating antibodies began to fall approximately one year after
primary immunisation in all three males, and an increase in testicular
volume and testosterone production at this time could clearly be seen
in cfl and Although there was also a slight increase in testis
volume in 8* lj., testosterone secretion had not noticeably increased
before the animal died 67 weeks after immunisation. Sixty eight weeks
after immunisation <5*1 was placed with a non-immunised partner. This
female was not observed to be pregnant until I4.8 weeks later, and 8
weeks after conception the pregnancy terminated in spontaneous abortion.
Low levels of circulating antibodies (8*2, d* 3) were relatively
ineffective in suppressing testicular function (Fig. 3»h & 3.9). Although
a reduction in testis volume was observed in both animals (shrinkage
was less than l\.0%), it was considerably less than in males with high
antibody titres. The testes remained firm throughout the period of
study, and began to grow again 60 (873) and 70 (8" 2) weeks after
immunisation. Sixty five weeks after immunisation 8*2 was placed
with a non-immunised partner. Within 2 weeks this female became
pregnant and gave birth to normal twins after a gestation period of
approximately 20 weeks.
The effects of high levels of circulating LH-RH antibodies
in females (<j> 1 , <j> Ij., <j> 5) are shown in Figures 3.6 and 3.7. One
animal (<j> 1 ), which was 2 weeks pregnant at the time of
immunisation, showed a much more rapid build up of antibody titres
than the other two females. Antibody titres became relatively stable
after 8 weeks and the booster produced no further increase. During
the first 8 weeks the pregnancy continued normally, after which
progesterone concentrations began to decrease and then fell rapidly
Figure j.g
Testis volume, testosterone concentrations and antibody titres
in an LH-RH immunised male
Low antibody titres
—i 1 1 1 1 1
o o o
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Uterine diameter, progesterone concentrations and antibody










































































































Uterine diameter, progesterone concentrations and antibody titres
in two EH-RH immunised females
Both high antibody titres
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at week 12, as the animal aborted. Progesterone concentrations
remained low (<f>ng/ml) for up to 1;5> weeks after immunisation, showing
that ovulation had ceased. Antibody titres then fell sharply and
elevated progesterone levels indicated that ovarian cycles had
recommenced. At this time (68 weeks after immunisation ), j 1 was
placed with a normal male and within 7 weeks pregnancy was noted,
thus confirming the return to normal ovarian function in this animal.
The pregnancy continued to term and healthy twins were born. Eighteen
weeks later this animal was again pregnant and gave birth to triplets.
In the other two females I|., j the initial gradual
increase in antibody titres was accelerated by the first booster
injection although there was no apparent further increase following
the second booster. No signs of ovarian cyclicity were observed in
2 U during the period of study, and high antibody titres were
maintained until the animal died U8 weeks after immunisation.
Progesterone levels in j 5 show that ovulation had ceased by 6 weeks
after immunisation, and no further evidence of ovarian cyclicity could
be observed throughout the rest of the study.
Of the two females with low antibody titres (Fig. 3.8),
2 3 failed to show any evidence of ovulation between the time of
immunisation and death 38 weeks later. The other female (<j> 2) was
clearly experiencing ovulatory cycles during the first 12 and last
£q weeks of the studjr although progesterone levels suggest that
ovulation did not take place during the intervening period. Although
there were signs of ovarian cyclicity soon after £ 2 was paired with
a normal male (61 weeks after immunisation),conception did not occur
until lj.0 weeks later, and the pregnancy was terminated in spontaneous
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Uterine diameter, progesterone concentrations and antibody titres
in two LH-RH immunised females
Both low antibody titres. N.B. Antibody scale has been enlarged
to avoid excessive overlap.
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Basal levels of LH in marmosets are often below or only
slightly above the limit of sensitivity of the LH assay. Consequently,
it was not possible to detect any decrease in circulating LH
concentrations after immunisation.
Histological examination of the testes revealed that spermato¬
genesis was proceeding normally in control animals (Fig. 3.9). In
the three males with high levels of antibody there was a considerable
reduction in seminiferous tubule diameter (Table 3.1)» and spermato¬
genesis was severely impaired (Fig. 3-10). The tubules were lined
with spermatogonia and contained spermatocytes up to the pachytene
stage. There was however little spermatogenic development beyond
this stage. There was also a reduction in the amount of inter¬
stitial tissue, and some of the cells contained condensed nuclei.
Animals with low antibody titres showed intermediate effects. Although
seminiferous tubules in these animals were also reduced in size, they
were considerably larger than the tubules in animals with high anti¬
body titres (Table 3-1 )} and there were no signs of spermatogenic
arrest (Fig. 3.11).
Ovaries in females with high antibody titres were much reduced
in size compared with ovaries in either control animals or animals with
low antibody titres (Table 3.2). Compared with controls ovaries in
animals with low titres were also reduced in size, but the difference
was not significant. Ovarian histology revealed the presence of active
luteal tissue in control animals (Fig. 3.12). The ovaries contained
several primordial and pre-antral (single and multi-layered) follicles,
and a relatively small number of antral follicles. The appearance of
the luteal tissue suggests that the ovaries were removed during the




Light micrographs of the left testis from a BSA immunised
marmoset (c^6, control)






n=30 MEAN - S.I
1 . CONTROL c3 6 263.6 - 23.3
<S 7 283.3 - 31+.3
2. HIGH </l 139.8 - 21 .li
TITRES
<fk 129.9 - 20.3
136.6 - 21.7
3. LOW 3 2 2b3.6 - 36.6
TITRES
d* 3 230.0 - 28.2
Table 3.1
Seminiferous tubule measurements in control and immunised
male marmosets






Light micrographs of the left testis from an LH-RH immunised
marmoset (d* 1 , high antibody titres)
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Figure 3.11
Light micrographs of the left testis from an LH-RH immunised
marmoset (c^2, low antibody titres)


































































** p<0.01-> (studentsQ t-test)





Light micrographs of the left ovary from two BSA immunised
marmosets (controls)
Haematoxylin and eosin stained, (a) (j>6 x 11.6; (b) ^7 x 10.8
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graafian or pre-ovulatory follicles. In contrast to the controls,
none of the ovaries from LH-RH antibody producers contained luteal
tissue. There were however many follicles present in the ovaries of
all LH-RH immunised animals, although the extent of their development
appeared to be related to the antibody titre. All stages of follicular
development were seen in ovaries from animals with low antibody titres.
Figure 3.13 shows two well developed antral follicles although they
are not as large as a normal pre-ovulatory graafian follicle. There
was also a slight "crowding together" of the follicles (compared with
the controls) suggesting that there may have been a reduction in the
amount of interstitial tissue. High levels of antibody had a more
drastic effect on the ovaries, and only the early stages of follicular
maturation could be observed. The ovary shown in Figure 3.1U contains
many small, poorly developed follicles, the largest of which is at
the pre-antral multi-layered stage. There were no antral follicles,
and the amount of interstitial tissue was greatly reduced.
The effect of immunisation on the response of the pituitary
to exogenous EH-RH is shown in Table 3.3. Animals with high antibody
titres showed a much reduced response at all doses compared with
animals with low antibody titres and with controls. A dose response
relationship was demonstrated by high titre animals, whereas animals
with low titres showed a similar response to all three doses of LH-RH.
However, even in animals with high antibody titres that had been
immunised for lj.0 weeks, the pituitary gonadotrophs still showed some
response to the releasing hormone.
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Figure 3.13
Light micrograph of the left ovary from an LH-RH immunised
marmoset (o 2, low antibody titres)
Haematoxylin and eosin stained, x 20.
marmoset (y %, high antibody titres)




































Response to LH-RH in control and immunised marmosets
Figures represent the increase in LH above pre-injection levels
(i.e. Am)
*
Pre-injection levels were undetectable (< 20ng/ml) and to calculate
AT.Hj a value of 20ng/ml was substituted. A slight underestimation
of Arh values has therefore resulted.
Both pre- and post-injection levels were undetectable.
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The LH-RH analogues tested in this study were D Phe Phe
/f o o /C
D Phe LH-RH (peptide A) and D Phe D Trp D Phe LH-RH (peptide B).
For each analogue eight groups of intact male marmosets
(n=3 per group) received the following treatment:-
Group 1. 0.1ml diluent only (20% propylene glycol in saline).
Group 2. Diluent and 0.5ug LH-RH in 0.1ml saline.
Groups 3-7. Analogue (1.Omg in 0.1ml diluent) and LH-RH, 0, 30, 60,
120 and 2lj_0 min later.
Group 8. Analogue only (1 .Omg in diluent).
Analogue and diluent were given as subcutaneous injections, and LH-RH
was injected intramuscularly. Blood samples were taken as follows:-
Group 1 . Immediately before, and 30 min after the injection of
diluent.
Groups 2-7. Immediately before the administration of diluent or
analogue, and again 30 min after the LH-RH injection.
Group 8. Immediately before and 30, 60, 120 and 2l|.0 mins after the
injection of analogue.
Plasma LH concentrations were measured in all samples.
3.3.b Results
The effects of LH-RH analogues on LH secretion in response to
the administration of exogenous LH-RH are shown in Tables 3.U and 3.5.
Mean (- S.E.M.) increases in LH concentrations above pre-injection
levels are given in Figures 3.15 and 3.16. In the absence of analogue
0.5ug LH-RH induced a marked increase in plasma LH concentrations
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ANIMAL TREATMENT LH (ng/ml) ALH LH (mean -S.E.M.)
0 min. 30
1 33 1+0 -3
2 DILUENT 20 20 0 -2.3-1 o2
3 68 63 -3
3 20 126 106
3 DIL. + LH-RH 31 11 u 83 93.7 - 3.8
6 30 1U6 96
7 6.8 132 83
8 ANALOGUE + LH-RH 36 120 73 73.3 - 6.3
9 0 MIN. 20 82 62
10 21 82 61
11 ANALOGUE + LH-RH 20 36 26 £ • 0 1+ —* o • —\
12 30 MIN. 21 66 33
13 66 98 32
13 ANALOGUE + LH-RH 32 90 38 27.3 - 7.9
13 60 MIN. 20 32 12
16 20 66 36
17 ANALOGUE + LH-RH 63 93 30 39.3 - 3.8
18 120 MIN. 20 62 32
19 32 96 33
20 ANALOGUE + LH-RH 20 66 36 33.3 - 0.7
21 2k0 MIN. 20 66 36
0 30 60 120 230
22 66 66 63 32 32
23 ANALOGUE + DIL. co-3"c—J 29 32
23 <20 <20 <20 <20 <20
MEAN 33.3 33.3 32.0 33.7 33.7
Table 3.3
The effects of D Phe^ Phe^ D Phe^ LH-RH on tonic LH secretion
and LH-RH induced LH release in normal males
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ANIMAL TREATMENT LH (ng/ml) ALH LH(mean -S.E.M.)
0 min. 30
1 1+3 1+0 -3
2 DILUENT 20 20 0 -2.3 - 1 .2
3 68 61+ -1+
1+ 1+7 152 105
5 DIL. + LH-RH 61 165 101+ 105.3 - 0.9
6 62 169 107
7 1+7 117 70
8 ANALOGUE + LH-RH 29 102 73 67.0 - 1+.9
9 0 MIN. 21+ 81 57
10 20 31+ 11+
11 ANALOGUE + LH-RH 20 39 19 22.7 - 6.3
12 30 MIN. 30 65 35
13 37 95 58
11+ ANALOGUE + LH-RH 36 85 1+9 1+6.0 - 7.9
15 60 MIN. 22 53 31
16 20 57 37
17 ANALOGUE + LH-RH 51 100 1+9 39.0 - 5.0
18 120 MIN. 20 52 32
19 1+0 131 91
20 ANALOGUE + LH-RH 20 101+ 81+ 93.8 - 6.5
21 21+0 MIN. 20 126 106
0 30 60 120 21+0
22 37 31 26 < 20 33
23 ANALOGUE + DIL. 26 <20 <20 <20 <20
21+ 21 < 20 < 20 < 20 < 20
*
MEAN 28.3 23.8 22 <20 21+ .3
Table 3.5
2 3 6
The effects of D Fhe D Trp D Fhe LH-RH on tonic LH secretion
and LH-RH induced LH release in normal males
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Figure 3.1 ^
Time course in male marmosets of blockade of LH release in response
to LH-RH by D Phe^ Phe^ D Phe^ LH-RH (1 .Qmg per animal)
Analogue was injected at time 0. Values are mean - S.E.M.
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Time course in male marmosets of blockade of LH release in respons
to LH-RH by D Phe2 D Trp^ D Phe^ LH-RH (1 .Omg per animal)

































































30 min after the injection (see also chapter 1;). Both analogues
suppressed LH-RH induced LH release although not to the same extent.
Peptide A significantly suppressed LH release 30, 60, 120 and 2i|.0 min
after administration, with the greatest suppression (71.9%) occurring
after 60 min. There was no significant difference between LH-RH
induced LH release in the absence of analogue and after simultaneous
administration of LH-RH and analogue. Peptide B significantly
suppressed LH release after 0, 30, 60 and 120 min, but not after
zko min. Maximum suppression, which occurred after 30 min, was
78.1$. Both peptides had a slight, but non-significant (p>0.05,stu¬
dents t-test) inhibitory action on tonic LH secretion, and no effect
of the diluent could be observed.
3.U Discussion
3»U«a Immunisation against LH-RH
The present study describes the effects of active immunisation
against LH-RH in male and female marmoset monkeys. The results
demonstrate that in the marmoset, as shown previously in the rat
(Fraser, Gunn, Jeffcoate and Holland, 197l;a; Fraser, Jeffcoate, Gunn
and Holland, 1975) and rabbit (Fraser, 1975)* the action of LH-RH
can be inhibited by active immunisation. Since antibodies to the
synthetic decapeptide cross-reacted with endogenous LH-RH, it is
possible that the natural marmoset releasing hormone is also a deca¬
peptide, with a structure similar to that of the synthetic preparation
used (Matsuo et_al, 1971). Although there is no direct evidence to
show that immunisation against LH-RH inhibits LH and FSH secretion in
the marmoset, this is clearly the case in the rat (Fraser et al. 197lia;
Fraser, 1975)* and it is inconceivable that the suppression of gonadal
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activity described in antibody producing marmosets is not causally
related to a suppression of gonadotrophin secretion.
The immunogen used in this study, EH-RH conjugated to BSA
by carbodiimide (Fraser, Gunn, Jeffcoate and Holland, 197l;b) was
effective in inducing LH-RH antibody formation in all animals, although
to a much lesser extent in four animals than in the remainder. Since
EH-RH antibodies were not produced by immunisation against BSA, it
is reasonable to assume that the antibodies present in the circulation
of EH-RH immunised animals were produced specifically in response to
the LH-RH immunogen. The usefulness of booster injections is difficult
to assess from the present study since the first booster caused an
accelerated production of antibodies in only some of the animals, and
a second booster in those animals which received one, appeared to
have little effect. Whether a primary immunisation alone is sufficient
to effectively inhibit EH-RH action in the marmoset, as it appears to
be in rodents (Fraser, 1975) remains to be determined. The time at
which antibodies to EH-RH first appear in the circulation of the
marmoset (3-5 weeks after immunisation in high titre animals) is
similar to that in rats (about 3 weeks, Fraser et al, 197Ua). Three
of the 10 animals immunised against LH-RH died during the course of
this study. Autopsy showed that and £ 3 died of a respiratory
infection which is unlikely to have been due to the presence of LH-RH
antibodies since other (non-immunised) animals in the colony were
also affected. The cause of death of £ U is not clear although the
animal was in poor condition as a result of extensive dermal lesions
at the immunisation sites. There were, however, no obvious abnor¬
malities in any of the major abdominal or thoracic organs.
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The observed pattern of testosterone secretion is clearly
different in high titre animals compared with either low titre or
control animals. However the precise nature of testosterone
secretion is not revealed by the sampling frequency used. Testos¬
terone secretion in normal male marmosets is subject to considerable
short term fluctuations (J. P. Hearn and D. H. Abbott, pers. comm.).
The present data do not provide a quantitative account of testos¬
terone production, but merely indicate that elevated testosterone
concentrations were not observed during the periods of high antibody
titre. Although this would strongly suggest that immunisation
against LH-RH suppresses testosterone secretion, thus agreeing with
results in the rat (Fraser et al, 1 97k&; Fraser, 1976b),the possibility
that testosterone secretion in the presence of high levels of anti¬
body was not as consistently low as the present data imply must be
considered. Furthermore, it is not possible to determine whether
testosterone secretion in males with low antibody titres has been
suppressed compared with controls. It would be of interest to know
this in view of the slight, but obvious decrease in testis volume
seen in animals with low antibody titres.
Both macroscopic and microscopic atrophy of the testes was
seen in all LH-RH immunised animals, and was related to the levels of
circulating antibody. The marked atrophication of the testes in high
titre animals was associated with severe impairment of spermato¬
genesis, as revealed by histological examination of testes removed
93 or 67 weeks after immunisation. The tubules contained spermatogonia
and spermatocytes, but there was a marked absence of spermatozoa. In
addition, a reduction in the amount of interstitial tissue suggests
that steroidogenesis was inhibited and thus supports the results on
plasma testosterone concentrations. Similar effects of high levels
of LH-RH antibodies on testicular morphology have been previously
reported in rodents (Fraser et al, 1975a; Fraser, 1975).
In female marmosets, high levels of circulating antibody
were associated with an absence of ovulatory cycles, as evidenced by
low circulating levels of progesterone (with the exception of j 1
before abortion). Several investigators have reported that both
active (Fraser, 1975; 1976b)and passive (Koch, Chobsieng, Zor,
Fridkin and Lindner, 1973; Arimura, Debeljuk and Schally, 1975;
4
Kerdelhue et al, 1975) immunisation against LH-RH in the rat will also
prevent ovulation. It should however be pointed out that since the
luteal phase in the normal marmoset cycle is approximately 10 days
long (Hearn and Lunn, 1975)^the presence of a functional corpora
lutea may have been missed during the period when blood samples were
collected at 5-10 week intervals. The effects of immunisation against
LH-RH on ovulation in the marmoset are complicated by the fact that
anovulatory cycles also occurred in at least one female with low
antibody titres (j 3, and perhaps also j 2, 12-50 weeks after immun¬
isation). Low levels of antibody may, in fact, be capable of
preventing ovulation but other factors, particularly stress imposed
by experimental procedures, should also be considered.
Ovarian histology revealed the presence of luteal tissue in
control but not in LH-RH immunised animals. Since the luteal phase
in the marmoset is much longer than the follicular phase, it is
relatively difficult to obtain ovaries completely devoid of luteal
tissue. The fact that none of the ovaries from immunised animals
contained luteal tissue therefore provides further evidence that
ovulation in these animals had ceased. Despite the absence of
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ovulation, animals with low antibody titres showed continuous
follicular growth to the antral stage. It is unlikely that the
follicular growth was stimulated by the LH-RH-BSA conjugate itself,
since it has been shown to be devoid of LH-releasing activity
(Sandow, Von Rechenberg, Wissmarm, Uhman and Fraser, 1977). It is
therefore probable that the inhibition of LH-RH by low levels of
antibody was incomplete, and that follicular growth occurred in
response to low gonadotrophin levels which were insufficient to
cause ovulation. A more complete inhibition of LH-RH (with corres¬
ponding lower gonadotrophin levels) in animals with high antibody
titres is suggested by the absence of follicular development beyond
the pre-antral stage, and the marked reduction in interstitial
tissue in these animals. Measurement of circulating EH and FSH
concentrations in immunised marmosets is necessary to confirm this.
Pituitary function in immunised animals has been tested by
the administration of exogenous EH-RH. Whereas an apparently normal
response to the ljug dose was observed in low titre animals, EH
release was greatly reduced in high titre animals, and even with a
massive dose of EH-RH (50ug), pituitary response was considerably
diminished. Nevertheless there was a certain amount of EH release,
showing that even in animals with high antibody titres that had been
immunised for approximately lj.0 weeks and were apparently infertile,
the pituitary gonadotrophs were still able to respond to the releasing
hormone. EH release by pituitary gonadotrophs following EH-RH
immunisation has also been demonstrated by administration of high
doses of EH-RH in rats (Fraser, 1976b). A much greater gonadotrophin
release in EH-RH immunised rats has recently been reported using a
highly active analogue of LH-RH (Fraser and Sandow, 1977). In
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addition to having prolonged LH-RH activity the analogue is immuno¬
logically different from LH-RH and can stimulate gonadotrophin
release in immunised animals without interference from the antibody.
The use of such potent LH-RH analogues may be potentially useful for
reversing the effects of immunisation against LH-RH.
Reversability of the effects of immunisation against LH-RH
is an important consideration in evaluating the potential of such a
procedure as a possible form of fertility control. Although
information on reversibility in the present study is incomplete, a
natural reversal following decrease in antibody titres can be seen
in some of the animals. Two immunised females 1, (j> 2) became
pregnant and gave birth to viable offspring, although in one case (<j> 2),
immunisation produced only low levels of antibody. Both of the high
titre males which survived to the end of the study (d* 1 , (^5) showed
clear signs of increased testicular activity following the decline in
antibody titres. In all cases signs of reversal appeared at least
50 weeks after primary immunisation. This period is longer than that
reported by Fraser (I976b)in which signs of reversal appeared 30-31;
weeks after immunisation in male rats, although in this case booster
injections were not given.
3.1;.b Inhibition of LH-RH with inactive analogues
LH release in response to exogenous LH-RH was inhibited by
both analogues tested, but not by the diluent. It is therefore
reasonable to assume that the inhibition was due to a direct antag¬
onism between the peptides themselves and the synthetic releasing
hormone. The exact mechanism by which the analogues exert their
effect is not completely understood, although it is generally assumed
that they bind to pituitary receptor sites, thus competing with LH-RH
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and preventing its action (Ferland, Labrie, Coy, Coy and Schally,
1975; Nishi, Coy, Coy, Arinxura and Schally, 1976). Since the
structures of many of these analogues are based on super-active
analogues, they often possess residual inherent LH-PH activities
(Vilchez-Martinez, Schally, Coy, Coy, Debeljuk and Arimura, 197U).
2 3
However, de la Cruz et_al, (1976) have reported that D Phe Phe D
Phe6 LH-RH (A) was devoid of any such releasing activity when tested
in immature male rats. The present results confirm this observation
2
and also indicate a similar absence of LH releasing activity in D Phe
D Trp3 D Phe6 LH-RH (B).
The data presented here also agree with previous observations
in rats (de la Cruz et al, 1976; Nishi et al, 1976) that the peak
antagonist activity of peptide A was between 30 and 120 min. The
effects of peptide B have not previously been reported. The present
results are insufficient to determine whether there is any significant
difference between the activities of the two analogues tested but
they do suggest that peptide B may cause a more rapid inhibition of
LH release than peptide A. The greatest suppression of LH release by
peptide A (71•9%) is lower than that (92.6%) reported by de la Cruz
et al (1976) in rats. This discrepancy may be explained by the fact
that in the present study the analogue could not be completely
dissolved before use. A suspension would presumably not be absorbed
as rapidly or as effectively as an homogeneous solution. In addition,
the analogue:LH-RH ratio used by de la Cruz et al was greater (2500:1 )
than in the present study (2000:1).
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3.5 Chapter summary
1 . Antibodies to EH-RH can be raised in the marmoset by active
immunisation against a synthetic EH-RH-BSA conjugate. All EH-RH
immunised animals produced antibodies, although in four of the animals
titres remained low.
2. In males, high levels of antibody produced testicular atrophy
and a suppression of testosterone secretion. Seminiferous tubules
were reduced in size, spermatogenesis was severely impaired, and
there was a reduction in the amount of interstitial tissue.
3. Although there was slight reduction in testis volume and
seminiferous tubule diameter in males with low antibody titres,
testosterone secretion and spermatogenesis appeared normal.
U. Progesterone concentrations in females with high antibody
titres suggest that ovulation had ceased. Ovaries were reduced in
size compared with controls and contained many small pre-antral
follicles but no luteal tissue.
5. Anovulatory cycles were also apparent in females with low
antibody titres. The ovaries were also reduced in size and no
luteal tissue could be seen. However, ovarian follicles in these
animals developed to a later stage than in animals with high
antibody titres, suggesting a less complete inhibition of
gonadotrophin secretion.
6. Pituitary EH release in response to exogenous EH-RH was
inhibited in animals with high antibody titres, but apparently not
in animals with low antibody titres.
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7. Although the data are incomplete, the effects of immunisation
against LH-RH in the marmoset appear to be reversible,
8, Antagonistic analogues of LH-RH inhibited LH release in
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lj.,1 Introduction
Secretion of-LH by the pituitary gland is directly related
to hypothalamic LH-RH stimulation. Administration of exogenous
(synthetic) LH-RH has provided the basis for numerous studies on the
characteristics of LH-RH induced LH release, and it is now apparent
that the decapeptide described by Matsuo et al (1971) is effective
in stimulating LH secretion in a variety of mammalian species
including rats (e.g. Schally, Arimura and Kastin, 1973)* sheeP
(e.g. Reeves, Arimura and Schally, 1971)* rhesus monkeys (e.g. Krey
et al. 1973) and humans (e.g. Yen et al, 1973,a).
The secretion of LH in response to LH-RH is, however, profoundly
modified by the action of gonadal steroids, and it is now known that
at least part of this action is focussed directly on the hypophysis
and is reflected in changes in the sensitivity of the gonadotrophs
to LH-RH stimulation. Pre-treatment with gonadal steroids (primarily
oestradiol, but also progesterone) modifies the pituitary response to
a standard dose of LH-RH in the rhesus monkey (Krey et al, 1973) and
human (Lasley et al, 1973; Young and Jaffe, 1976), as well as in rats
and sheep (Debeljuk, Arimura and Schally, 1972b). Steroid induced
changes in pituitary responsiveness to LH-RH, responsible for the
variations in LH release to LH-RH during different phases of the
menstrual cycle (Krey et al, 1973.* Yen et al. 1 973a)* therefore
represent an important mechanism by which the secretion of LH is
regulated by steroid feedback.
The present study describes the LH response to exogenous LH-RH
in the marmoset monkey, and looks at some of the ways in which this
response can be modified by the action of gonadal steroids.
125
U.2 Procedure
Groups of intact male marmosets (n=l± per group) were each
given single rapid intramuscular injections of one of the following
doses of LH-RH in 0.1 ml saline : 0.2, 0.5, 1, 2, 5> 10, 25 ug. Six
intact males received saline alone. Blood samples were taken
immediately" before and 30, li5* 60 and 90 minutes after each injection.
In addition four intact males were given 25 ug LH-RH in 0.1 ml saline
(i.m.) and were bled immediately before and 10, 20, 30 and 90 min.
after each injection. Plasma LH concentrations were measured in all
blood samples.
Pituitary responsiveness to a single rapid injection (i.m.) of
2.0 ug LH-RH in 0.1 ml saline was studied in the following groups of
animals:
Group 1. Intact males (n=l8).
Group 2. Gonadectomised marmosets l|8h (5 males; U females) and
approximately 16 weeks (10 males; 6 females) after bilateral
gonadectomy.
Group 3. Long term gonadectomised marmosets 6 days (5 males; 5
females) and 3 weeks (5 males; 1; females) after the insertion of
oestradiol-17/d implants.
Group U. Long term gonadectomised marmosets (1;. males; Ij. females)
6 days after the insertion of progesterone implants.
Blood samples collected immediately before, and 30, U5, 60
and 90 min after each injection were assayed for LH. 0estradiol*-1 7^
and progesterone were measured immediately before the first injection
of LH-RH.
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Due to differences in pre-injection LH concentrations between
various groups, pituitary responsiveness was measured as the increase
in lh levels above pre-injection levels (Alh), as well as in terms
of absolute concentrations.
h-3 Results
l±.3.a Response to various doses of LH-RH
Rapid increases in plasma LH concentrations were measured
in all animals receiving LH-RH, but not in the animals that were
given saline alone (Fig. U«1). Maximum LH concentrations achieved by
0.3-25 u.g doses of LH-RH were not significantly different from each
other, but they were all significantly higher compared with maximum
LH levels produced by 0.2 ug LH-RH (p<0.05, students t-test). With
all doses used there was a significant increase in plasma LH con¬
centrations by 30 min. after the injections (p<0.05, paired t-test),
although the time at which peak levels of LH occurred became progress¬
ively later as the dosage increased. Thus, maximum LH concentrations
were measured after 30 min. when 0.2, 0.5 and 1.0 ug LH-RH were
administered, after 1;5 min. with 2 and 5 ug LH-RH, after 60 min.with
10 ug LH-RH, and after 90 min. with 25 ug LH-RH. Blood samples taken
at 10 min. intervals for 30 min. after the administrations of 25 ug
LH-RH (Fig. lj..1 ) failed to reveal any significant peak in LH secretion
during this period.
l|.3.b The effects of gonadectomy and steroid treatment on pituitary
responsiveness to LH-RH
From the results shown in Figure U.1 , 2 ug LH-RH was chosen
as the dose to be used in all subsequent LH-RH tests.
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Figure li,1
Mean (- S.E.M.) plasma LH concentrations following i.m. in.iection




Mean (- S.E.M.) LH concentrations in intact males following
administration of LH-RH or saline are shown in Figure U.2. The
hatched area represents the range of EH cmcentrations measured,
and indicates considerable variation in the response to a standard
dose of LH-RH. From the sampling frequency used, it appears that
plasma LH concentrations reach a maximum after min. and remain
elevated until at least 90 min. after the injection. Mean LH con¬
centrations were significantly higher than mean control values at all
times after the injection (p<0.01, students t-test).
Group 2.
Mean (^S.E.M.) plasma LH concentrations following administration
of LH-RH to male and female gonadectomised marmosets are shown in
Figures U-3 and U.f? respectively. LH values for both males and
females show a significantly greater response at all times in animals
gonadectomised for 16 weeks (long term) compared with animals gonad¬
ectomised for 2 days (short term) (Figs. U.U and U.6). Responses
in males and females were not significantly different (p<0.03,
student's t-test). Compared with intact males, ALH values were
significantly greater in long term, but not in short term gonad¬
ectomised males.
Group 3.
The introduction of oestradiol-1 7>S implants into long term
gonadectomised marmosets inhibited pituitary responsiveness to LH-RH.
Plasma LH concentrations following an injection of LH-RH in gonad¬
ectomised animals containing implants for either 6 days or 3 weeks are
shown in Figures h-7 and 1±.9. There was no difference between
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Figure U.2
Response to a single i.m. in.iection of 2ug LH-RH (n=l8). or saline
(n=6) in intact males
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Figure U.3
Response to a single i.m. injection of 2ug LH-RH in males gonadectoTnised
for 2 days (n=U) and 16 weeks (n=10)





























Increase in LH concentrations following 2ug LH-RH in intact males
(n=l8) (A) and males gonadectomised for 2 days (n=U) (B) and 16 weeks
(n=10) (C)
Mean values - S.E.M.
* A vs C : + B vs C : A vs B not significant.
For this figure, and for figures 1±.6, U.8, U.10, lj.,12 and U.13
the levels of significance are indicated;
3 symbols (i.e. *■#*), p<0.001: 2 symbols (i.e. **), p<0.01 :
1 symbol (i.e. ■*■), p<0.05>. (Student's twtest).
MINUTES
Figure U
Response to a single i.m. injection of 2ug LH-RH in females
gonadectomised for 2 days (n=It) and 16 weeks (n=6)
+





























Increase in LH concentrations following 2ug LH-RH in females
gonadectomised for 2 d
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Figure U.7
Response to a single i.m. injection of 2 ug LH-RH in long term
gonadectomised males implanted with oestradiol-113 for 6 days
(n=^) and 3 weeks (n=5)
Values are Mean - S.E.M.
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of the implants. The levels have therefore been combined to produce
mean (±S.E.M.) values of 0.56 - 0.03 ng/ml (males, n=10) and
0.5U - O.Oli ng/ml (females, n=9). In terms of AlH values, the
pituitary" response was significantly lower in implanted animals
(both short and long term) when compared with gonadectomised non-
implanted animals (Figs. 1|.8 and 1|.10). Although AlH values
were significantly lower in long term implanted animals compared
with short term implanted animals in males (significant after 30,
60 and 90 mins) but not in females, there were no significant
differences between male and female responses (p>0.05, student's
t-test, at all times).
Group It
In contrast to the effects of oestrogen, implants of pro¬
gesterone appeared to enhance^ rather than inhibit pituitary responsive¬
ness to LH-RH in long term gonadectomised animals (Fig. ii.11).
Mean (±S.E.M.) progesterone concentrations in males and females
achieved by the implants were 36.1; - 3-3 and 1|2.7 - 5.2 ng/ml
respectively. LH values in progesterone implanted animals were
significantly elevated compared with non-implanted animals after
30, li5 and 60 min. (males), and after U5 60 min. (females)
(Figures 1|.12 and I4.I3). There were no significant differences
between male and female responses (p > 0.05, student's t-test, at all
time s).
li.il Discussion
All the intact male marmosets that received LH-RH, regardless
of the dosage used, showed a marked increase in circulating LH























Increase in LH concentrations following 2ug LH-RH in long term
gonadectomised males not implanted (n=10) (A)« and implanted with
oestradiol-17/d for 6 days (n^!?) (B) and 3 weeks (n=[?) (C)
Mean values - S.E.M.
* A vs B
+ A vs C
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Figure U.9
Response to a single i.m. in.iection of 2ug LH-RH in long term
gonadectomised females implanted with oestradiol-11/3 for 6 days
(n=£) and 3 weeks (n=h)
Values are Mean - S.E.M.






Increase in LH concentrations following 2ug LH-RH in long term
gonadectomised females not implanted (n=6) (A), and implanted
with oestradiol-17/3 lor 6 days (n=$) (B) and 3 weeks (n=U) (C)
Mean values - S.E.M.
* A vs B
+ A vs C
(B vs C, not significant)
O 30 ' 60 90
MINUTES
Figure L.11
Response to a single i.m. injection of 2ug LH-RH in long term
gonadectomised males (n=It) and females (n=lt) implanted with
progesterone for 6 days
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Increase in LH concentrations following 2ug LH-RH in long term
gonadectomised males not implanted (n=10), and implanted with
progesterone for 6 days (n=ij.)
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Increase in LH concentrations following 2ug LH-RH in long term
gonadectoinised. females not implanted (n=6), and implanted with
progesterone for 6 days (n=lx)
Mean values - S.E.M.
that received saline, it is apparent that the responses of the LH-RH
treated marmosets were primarily the result of the injection of
releasing hormone. These observations support the conclusions drawn
from the immunisation study (Chapter 3) that the natural marmoset
releasing hormone may be a decapeptide with a structure at least
similar to that of the synthetic preparation used (Matsuo et al, 1973)-
Dose response characteristics shown in Figure U.1 revealed
little difference between the maximum LH levels achieved in response
to doses of LH-RH ranging from 0.5-25ug. It is possible that the
0.3 ug dose induced a maximum response by the pituitary and that
further increments in the dose of LH-RH would have no further effect
on LH secretion. This eventuality, however, is not supported by the
change in the pattern of LH release, which is clearly taking place
as the dose of LH-RH increases. A more likely explanation may be
that since the frequency and duration of sampling were insufficient
to observe the complete profile of LH-RH induced LH release, other
differences between the responses have not been revealed. In this
respect, when Krey et al (1973) tested increasing doses of LH-RH in
intact female rhesus monkeys, they measured little difference in the
LH response over the first hour, but found that LH levels remained
elevated for progressively greater periods of time as the dose
increased. More recent work in humans (Wang et al, 1976; Hoff et al.
1977) has demonstrated the presence of two functionally separable
pools of pituitary LH, one immediately releasable (pool one, reflecting
sensitivity) and the other requiring continued stimulus input (pool
two, reflecting capacity or reserve). Thus, whereas only the
immediately releasable pool of LH is affected by low doses of LH-RH,
larger doses may provide sufficient stimulus to evoke LH release from
1U3
both pools. This may help to explain the delay in appearance of
peak LH concentrations seen with the higher doses of LH-RH in the
present study, but does not account for the apparent differences in
the initial rate of LH secretion. The present results do nevertheless
show that a wide range of doses of LH-RH will evoke a marked increase
in pituitary LH secretion in the marmoset monkey. Although the
decision to use 2 ug LH-RH for the rest of the study was somewhat
arbitrary, it would not seem unreasonable in view of the (limited)
information presented in Figure I4..I .
Comparison of the responses to LH-RH between intact and long
term gonadectomised males shows a clear augmentation of pituitary
responsiveness in the hypogonadal state. These results are in
agreement with observations in women (Siler and Yen, 1973) in which
a greater response to a single injection of LH-RH is obtained in
patients with hypogonadal function (gonadal dysgenesis, postmenopausal,
and ovariectomised) than in normal subjects during the early
follicular phase. A greater response for LH in patients with gonadal
dysgenesis as compared with normal adult subjects has also been
demonstrated in men (Roth, Kelch, Kaplan and Grumbach, 1972). The
present results suggest that the increase in pituitary responsiveness
to LH-RH does not occur immediately after gonadectomy, since LH release
in males 2 days after gonadectomy was not significantly different
from that in intact animals.
Pituitary responsiveness to LH-RH in intact female marmosets
has not been measured, and therefore cannot be directly compared
with that in gonadectomised animals. If the variability in LH response
in"different stages of the cycle is as great in the marmoset as in
other primate species (Krey et_al, 1973; Yen et al, 1975>a)then it is
114b
imperative to know during which stage of the cycle the experiment is
being performed. Due to the difficulties involved in obtaining this
information in the female marmoset, observations on LH-RH induced
LH release in intact animals have been restricted to males.
Nevertheless, the differences between short and long term gonadec-
tomised females shown in Figure U»5 (c.f. males, Fig. 1;.3) make it
reasonable to assume that pituitary responsiveness to LH-RH is also
augmented in females in the absence of gonadal steroids. In agree¬
ment with observations in castrated rats (Barraclough and Turgeon,
1975), the results for long and short term gonadectomised marmosets
suggest that there is no difference between the sexes in their
pituitary responses to LH-RH.
The enhanced LH response in long term gonadectomised marmosets
may partially be explained in terms of an increased pituitary LH
store, at least the readily releasable component. This interpretation
is consistent with the finding of an increased pituitary LH content
in postmenopausal women (Ryan, 1962) and in castrated rats (Gay
and Hauger, 1977). Furthermore repeated injections of submaximal
doses (10 ug) of LH-RH to hypogonadal women (Lasley et al, 1975)
have revealed a large pool of acutely releasable LH with a relatively
smaller reserve pool, thus indicating a high pituitary sensitivity
but a lower capacity. In this context Wang et al (1975 ) have found
that increased doses of LH-RH to hypogonadal women are not able to
elicit additional LH release, suggesting that pituitary sensitivity
is at a maximum.
The introduction of oestradiol 17^ implants into male and
female gonadectomised marmosets, either for 6 days or for 3 weeks
reduced pituitary responsiveness to LH-RH. All long term implanted
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animals showed a smaller LH response than short term implanted animals
although, due to considerable inter-animal variation in females, the
difference was significant only in males. The levels of circulating
oestrogen achieved by the implants are similar to those found during
the mid-late follicular phase of the normal female cycle (Hearn and
Lunn, 1975). This dose therefore should be considered as being
relatively large, and with respect to circulating levels of oestradiol
in intact male marmosets, is almost certainly pharmacological.
Studies on the effects of oestrogen on the responsiveness of
the anterior pituitary to exogenous LH-RH have been numerous. As
might be expected, the results from these studies have revealed a
whole spectrum of effects, depending upon the dose and duration of
the oestrogen treatment, as well as on the dose and method of LH-RH
administration. It must therefore be appreciated that the effects
of oestradiol-17y5 on pituitary response to LH-RH in the marmoset, as
shown in the present results, relate only to the experimental
conditions described, and that different^and indeed opposite effects
can be expected ■under different circumstances.
Nevertheless, the results clearly indicate that oestrogen
can impair pituitary responsiveness to LH-RH in male and female
marmosets. Similarly, in the ovariectomised rhesus monkey, oestrogen
implants achieving either early or late follicular phase oestradiol-
17/? levels, when maintained for 13 days, reduced LH release in
response to LH-RH. Oestradiol can also impair pituitary responsiveness
to a single injection of LH-RH in normal (Keye and Jaffe, '\97k) and
hypogonadal (Yen, Vandenberg and Siler, 197U) women, and in normal
men (D'Agata, Gulizia, Ando, Vitale and Polosa, 1976). Using pulsed
delivery of sub-maximal doses of LH-RH (10 ug every 2 h) to hypo-
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gonadal women, Lasley et al (1975) have shown that 20 - 50 ug ethinyl
oestradiol/day tor 7 days induces a functional reversal in the
relative activity of the two pools of pituitary LH, with an impediment
of sensitivity and a marked augmentation of pituitary reserve. It is
therefore possible that the response to a single injection of LH-RH
as shown in the marmoset merely represents an impairment in sensitivity,
and that pituitary reserve, had it been measured, may have been
augmented.
With respect to the difference between LH responsiveness in
short term and long term implanted marmosets, Yen, Vandenberg and
Siler (197U) have demonstrated in hypogonadal women that chronic
treatment with low doses of oestrogen result in an initial enhancement
(after 1 and 2 weeks) followed by a progressive diminution of LH-RH
induced LH release. If a lower dose of oestrogen had been used in
the present study, a more striking difference between short term and
long term effects may have been observed.
Circulating progesterone concentrations, maintained at mid
luteal phase levels (Hearn and Lunn, 1975) for 6 days appeared to
enhance, rather than inhibit pituitary responsiveness to LH-RH in both
male and female gonadectomised marmosets. However, the period of
enhancement appears to be relatively transient, since the differences
between implanted and non-implanted animals had disappeared by 90
min after the LH-RH injection.
That physiological levels of progesterone do not impair LH-RH
induced LH release is also suggested by studies in the rhesus monkey
(Krey et al, 1973) and women (Wang et al, 19765 Hoff et al, 1977^
in which pituitary responsiveness to LH-RH is not diminished during
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the mid luteal phase when compared with the early follicular phase
of the menstrual cycle. Furthermore, Lasley et al (1975>) have shown
in women that under conditions in which oestrogen augments LH-RH
induced LH release, progesterone, even in relatively low doses, will
produce a further amplification in pituitary responsiveness. Although
in this case progesterone is acting in combination with oestrogen,
the results do lend some support to the present findings in the
marmoset. In addition, Martin et al (197U) have shown that advances
of spontaneous ovulation by progesterone in rats are accompanied by
a corresponding augmentation of pituitary responsiveness to EH-RH.
The physiological significance of enhanced pituitary responsiveness
to LH-RH by progesterone in male marmosets is not clear.
l+.f? Chapter summary
1 . Intramuscular administration of synthetic EH-RH stimulates
pituitary LH secretion in the marmoset. Although LH release can be
induced by a wide range of doses of EH-RH (0o2 - 2]?ug), peak LH levels
appear to be reached progressively later as the dose increases. This
may reflect the presence of two functionally separable pools of
pituitary EH.
2. Pituitary responsiveness to EH-RH was enhanced by gonadectomy (in
the present study direct evidence for this is restricted to males),
and is probably the result of an increase in the immediately releasable
pool of EH. That the increased pituitary response is likely to reflect
a gradual change in the hypothalamic-pituitary system is suggested by
the fact that EH release in males 2 days after gonadectomy was not
different from that in intact animals.
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3. Pituitary response to LH-RH in long term gonadectomised males
and females was reduced by oestradiol-17/5 concentrations of 5-600
pg/ml maintained for either 6 days or 3 weeks, and slightly enhanced
by progesterone concentrations of approximately ij.0 ng/ml maintained
for 6 days.
k• These results indicate that gonadal steroids can influence LH
secretion by a direct action on the pituitary gland. The importance
of dose and duration of steroid treatment and the mode of EH-RH
administration in determining steroid induced changes in pituitary
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5.1 Introduction
The results from Chapter U indicate that the functional
relationship between hypothalamic LH-RH and pituitary LH secretion
is influenced by gonadal steroids. This influence, directed not only
at the anterior pituitary but also at the hypothalamus, and possibly
other neural centres, forms the basis of what is known as the feed¬
back control of LH secretion. The two components of this feedback
mechanism, negative feedback and positive feedback^will be dealt with
in this chapter (negative feedback) and in Chapter 6 (positive feed¬
back) .
Tonic LH secretion in primates is regulated by a negative
feedback loop existing between the gonads and the hypothalamic-
hypophysial axis (Knobil, 1 971;; Yen et al, 1975a). The interruption
of this negative feedback loop by gonadectomy results in a marked
increase in circulating LH levels in humans (Yen and Tsai, 1971b;
Monroe, Jaffe and Midgley, 1972) and rhesus monkeys (Atkinson et al,
1970), indicating that LH secretion is normally suppressed by gonadal
hormones. This increase in circulating LH concentrations is now known
to be the result of pulsatile discharges of the hormone by the
pituitary gland (Knobil, 1971;).
From studies in the rhesus monkey (Karsch et al, 1973a;Knobil,
197U) and human (Nillius and Wide, 1971; Wang et al, 1975) it has
been clearly demonstrated that oestradiol is extremely effective as
an agent of negative feedback in both males and females. The negative
feedback actions of progesterone and testosterone however are somewhat
confusing and often contradictory when compared to the clearly
suppressive effects of oestradiol on LH. Studies in primates suggest
that progesterone on its own has no significant inhibitory effect on
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LH secretion (Wallach, Root and Garcia, 1970; Karsch et al. 1973a),
whereas physiological doses of progesterone appear to exert a
negative feedback action in the ewe (Karsch et al, 1975; Foster and
Karsch, 1976). Although testosterone is the principal androgen
produced by the testes,and therefore the most logical choice for
negative feedback control of LH in males, experimental evidence to
support this assumption is not convincing (Resko et al. 1977).
Much of the work on negative feedback in primates has been done on
hypogonadal subjects and, particularly in the rhesus monkey, a great
deal of work has been carried out using long term gonadectomised
animals. Although a convenient model, the long term gonadectomised
animal may not necessarily be an accurate model for determining the
negative feedback action of certain steroids.
The present study describes an initial attempt to characterise
some of the relationships between gonadal function and the secretion
of LH in the marmoset monkey, and it also attempts to evaluate the
use of long term gonadectomised animals as models for testing negative
feedback.
5.2 The effect of gonadectomy on LH secretion
5.2.a Procedure
Five adult male and five adult female marmosets were bilaterally
gonadectomised under anaesthesia. Collection of blood began 3 days
before the operations and continued at 3 day intervals for 18 days.
An extra blood sample was taken 25 days after gonadectomy. Results
from one female which died before the experiment was completed have
not been included. Approximately 20 weeks after gonadectomy animals
were bled at 0.5h intervals for La.
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5.2.b Results
Mean RH concentrations (- S.E.M.) before and after gonadectomy
are shown in Figure 5.1. No significant differences between the sexes
in the rates of increase in circulating LH levels after gonadectomy
could be ascertained (p>0.2, student's t-test, at each time). The
rates of increase in the concentration of EH and the maximum
concentrations attained after gonadectomy were similar in all animals.
In both males and females, a clear increase (p< 0.01, paired t-test)
in the level of LH in the plasma was observed by day 3 after gonad-
ectony, and in most animals EH concentrations reached a plateau by
days 9-12. Mean (i S.E.M.) plasma EH concentrations 10 weeks after
gonadectomy (measured in samples taken just before the insertion of
oestradiol-1 7/3 implants, Fig. 5.3) were not significantly higher than
those observed after 15 days (p>0o2, paired t-test).
Plasma EH concentrations in marmosets bled at 0.5h intervals
20 weeks after gonadectomy are shown in Figure 5*2. In each animal,
secretion of LH was episodic with as many as four peaks occurring
within the l|h period. The frequency of the pulsatile discharges of
EH appears to be circhoral in four of the animals. In the remainder
however, the periodicity of EH release cannot be determined from the
sampling frequency used.
5.3 The effect of oestradiol-12A- implants on EH secretion
in gonadectomised marmosets.
5.3.a Procedure
Silastic implants containing crystalline oestradiol-17/S
were introduced into all animals approximately 10 wks after gonad¬
ectomy. Blood samples, taken 3 days before and 0,1,1;, 8, 12, 22,
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Figure 5.1
The effect of gonadectomy on plasma LH concentrations
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Figure 5.2
Plasma LH concentrations in individual male (a) and female (h)
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26 and 36 days after the insertion of the implants were assayed for
LH and oestradiol-1 1/3 . A release rate of 10-20ug oestradiol / day
by the implants was estimated from prior incubation in vitro.
5o3«b Results
The effect of oestradiol-1 1/3 on plasma LH concentrations in
gonadectomised marmosets is shown in Figure 5-3. 2l|h after the
implants were introduced plasma EH concentrations were significantly
elevated (p<0.01 compared with pre-implant levels; paired t-test)
in both males and females. This stimulatory effect of oestradiol on
LH secretion was followed by a marked inhibitory action. Eight days
after the implants were introduced plasma LH concentrations were
significantly depressed and LH levels were undetectable for the rest
of the study. From the sampling frequency used it was not possible
to detect any difference between the LH response in males and females
(the difference between plasma LH levels in male and female marmosets
on day b was not significant; p>0.05 student's t-test). The levels
of oestradiol-11/3 produced by the implants are shown in Figure 5-3.
There was an initial peak in the concentration of plasma oestradiol
on day 1, coincident with the LH peak, followed by a decline to fairly
constant levels with mean (± S.E.M.) values ranging from 0.53
(± 0.05) to 0.61 (± 0.05) ng/ml.
5.U The effects of progesterone, testosterone and dihydro-
testosterone on LH secretion in long term gonadectomised
. marmosets
5-U.a Procedure
Male and female marmosets gonadectomised at least 3 months
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Plasma LH concentrations in male and female long term
gonadectomised marmosets before and after the introduction
of oestradiol-17A Implants. Mean (- S.E.M.) (n=9) plasma
oestradiol-1JJ- concentrations are also shown
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Three groups of animals were given daily sub-cutaneous
injections of 1 .Omg progesterone (P) (group 1j 5 males, 5 females),
0.5mg testosterone (T) (group 2; 1; males, U females) or 0.5mg
dihydrotestosterone (DHT) (group 3; Ij. males, U females) in 0.1ml
arachis oil for 3 days. Blood samples^ taken immediately before each
injection and 2l|h after the last injection^ were assayed for LH, and
either P (group 1 ) or T (group 2).
In addition, two groups of marmosets, each comprising 3 males
and 3 females, were given sub-cutaneous injections of 0.5mg T or
0.5mg DHT in 0.1ml arachis oil every 8h for 32h. Blood samples were
taken every 8h for l|0h, and assayed for EH and T. Control animals
received either 0.1ml arachis oil (3 males, 3 females) or no treatment
(3 males, 3 females) and were bled after 0, 8, 2k, 36 and l±8h.
5.i|.b Results
Injections of arachis oil had no effect on EH secretion. EH
concentrations in oil-treated and non-treated animals have therefore
been combined to produce mean values (Table 5.1). Since LH secretion
in gonadectomised marmosets is episodic, considerable variation
between sequential blood samples is. expected. In an attempt to
distinguish between suppression of EH secretion due to negative
feedback and fluctuations in EH levels associated with pulsatile
release, negative feedback has been defined as a reduction in EH
secretion exceeding two standard deviations below mean control
values. In Figures 5.U - 5.8 the dotted area represents the limits
formed by taking 2 standard deviations above and below the mean
control values, and a fall in EH concentration below this area
following steroid treatment will be classified as negative feedback.
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MIMAL T3ME (HOURS)
0 8 2k 36 1+8
U8 7k 51 52 63
< 71 55 6k 73 73
3 68 60 68 k9 50
Mean (n=3) 62.3 63.0 61.0 58.0 62.0
S.D. 12.5 9.8 8.9 13.0 11.5
Sh 83 72 70 6k 68
5 71 66 67 69 72
6 61 68 k6 50 51
Mean (n=3) 71.7 68.7 61.0 61.0 63.7
S.D. 11.0 3.0 13.1 9.8 11.1
Mean (^6) 67.0 65.8 61.0 59.5 62.8
S.D. 11.7 7.2 10.0 10.5 10.2
-2SD - +2SD U3.6-90.U 51 .li-80.2 1+1 .0-81 .0 38.5-80.5 1+2.1+-83.2
1* 53 69 51 61 68
2I 76 62 1+8 59 56
3 56 U8 73 72 81
Mean (n=3) 61.7 59.7 57.3 6k* 0 68.3
S.D. 12.5 10.7 13.7 7.0 7.2
? ^ 62 k6 56 80 69
5 55 59 67 62 70
6 81 66 6k 59 51
Mean (n=3) 66.0 57.0 62.3 67.0 63.3
S.D. 13.5 10.1 5.6 11 .k 10.7
Mean (n=6)' 63.8 58.3 59.8 65.5 65.8
S.D. 11.8 9.h 9.7 8.6 10.7
-2SD - +2SD Uo.2-87.U 39.5-77.1 1+0.1+-79.2 1+8.3-82.7 1+1+.1+-87.2
Table 5.1
Individual LH concentrations in control gonadectomised male and
female marmosets, receiving arachis oil at time 0 00. or no
treatment. Means, S.D.'s and the limits formed by taking 2 S.D.'s
above and below mean values are al'so given
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The effects of daily injections of P, T and DHT to long term
gonadectomised marmosets are shown in Figures 5«U> 5.5 and 5«6
respectively. From the individual results it can be seen that
although there was considerable fluctuation in LH concentrations, none
of the steroids tested had a negative feedback effect on LH secretion
over the first 2 days. Although control samples were taken only over
the first two days, this was sufficient to show the extent of the
fluctuation in LH concentrations due to episodic or diurnal variation,
and from the individual LH levels shown in Figures 5«U - 5.6, it
would be reasonable to conclude that there was no negative feedback
over the entire 3 day period0 Mean LH concentrations after the
initiation of steroid treatment were not significantly different
from pre-injection values (p>0.05, paired t-test), and comparisons
between LH levels at each of the times during the experiments in
males and females also showed no significant differences (p>0.05,
student's t-test). Circulating levels of progesterone and testos¬
terone achieved by the injections are shown in Figures 5«U and 5«5»
Mean plasma concentrations of P and T 2i|h after each injection were
between 60 and 90 .ng/ml and 5 and 10 ng/ml respectively. Circulating
steroid levels were similar in males and females.
Administration of T and DHT every 8h for 32h also had no
apparent effect on LH secretion in long term gonadectomised
marmosets (Figs. 5.7 and 5.8), and individual results show that there
was no negative feedback in any of the animals tested. There were
no significant differences either between LH levels in males and
females (p>0.05 student's t-test)^or between LH concentrations after
the initiation of steroid treatment and pre-injection values (p>0.05,
paired t-test). Testosterone concentrations 8h after each injection
















The effect of daily s.c. infections of 1 .Omg P in oil on LH
concentrations in long term gonadectomised males (a) and females (b)
LH concentrations are shown as individual, and Mean (- S.E.M.)
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Figure 5.5
The effect of daily s.c. injections of 0.5mg T in oil on LH concen¬
trations in long term gonadectomised males (a) and females (b)
EH concentrations are shown as individual, and Mean (- S.E.M.)





















The effect of dally s.c. injections of O.^mg DHT in oil on LH
concentrations in long term gonadectomised males (a) and females (b)
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The effect of 8h s.c. injections of O.^mg T in oil on LH
concentrations in long term gonadectomised males (a) and females (b)
LH concentrations are shown as individual, and Mean (- S.E.M.) values






























The effect of 8h s.c. injections of O.^mg DHT in oil on LH
concentrations in long term gonadectomised males (a) and females (b)
LH concentrations are shown as individual, and Mean (- S.E.M.) values
(n=3).
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5.5 The effects of progesterone, testosterone and dlhvdrotestosterone
on LH secretion in short term gonadectomised marmosets
5.5.a Procedure
Five adult male and 5 adult female marmosets were bilaterally
gonadectomised and then given daily injections of 1 .0 mg P in 0.1ml
arachis oil for 8 days, beginning on the day of gonadectomy. Blood
samples were taken once daily for 8 days and were assayed for LH and
P. Male and female marmosets which did not receive steroid treatment
following gonadectomy (Fig. 5.1 ) were used as controls.
Two groups of gonadectomised marmosets each comprising 5 males
and 5 females received oestradiol-17implants (releasing 10-20 ug
oestradiol-1 7A /day) 3 weeks before the start of the experiment.
Physiological castration was staged by removing the implants, and
daily injections of 0.5 mg T or 0.5 mg DHT in 0.1 ml arachis oil were
administered for 8 days, beginning on the day when the implants were
removed. Daily blood samples were taken throughout the 8. day period
and were assayed for LH and T. Gonadectomised controls (3 males and
3 females) received similar treatment except that they were not given
steroid injections after the removal of the oestradiol-17/3 implants.
5.5.b Results
Daily injections of progesterone inhibited the post castration
rise in LH levels in male and female marmosets (Fig. 5.9). Mean LH
levels 6 days after gonadectomy were significantly lower in animals
receiving progesterone than in the controls (p<0.05, males:
p<0.01 females, student's t-test), and there was no significant
difference between the LH response in males and females (p>0.05
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Figure 5.9
The effect of daily s.c. injections of 1,0mg P in oil on LH
concentrations in short term gonadectomised males (a) and females (b)
Gonadectomy was performed on day 0.
Progesterone and EH values are Mean - S.E.M.J treated animals
n=5>, controls n=5 (males), n=U (females).
N.S.j *, p <0.05; ** p<0.01, compared with controls.
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were significantly higher than control values (p<0.03, student's
t-test). Mean plasma progesterone concentrations 2l|h after each
injection (approximately 60-90 ng/ml) were similar to those observed
in the experiment on long term gonadectomised animals»
0estradiol-1 7/? implants effectively suppressed LH secretion,
and although circulating levels of oestradiol were not measured,
implants of the same size when used in a previous experiment, produced
mean (i S.E.M.) oestradiol concentrations ranging from 0.33 (- 0.03)
to 0.61 (- 0.03) ng/ml (Fig. 3.3). The pattern of LH secretion after
the removal of oestradiol implants (with no further steroid treatment)
did not differ significantly from that observed after gonadectomy
over the period studied (p>0.03 after 3 and 6 days, student's t-test).
Daily injections of testosterone inhibited the rise of LH
following the removal of the oestradiol implants in females, but not
in males (Fig. 3.10). Whereas mean LH levels in males receiving
testosterone were not significantly different compared with controls
(p>0.2 student's t-test), there was a significant difference between
testosterone treated females and control's on days 2, U (p<0.03),
6 and 7 (p<0.01, student's t-test). Although there was no apparent
difference between circulating testosterone levels in males and
females, LH levels were significantly higher in males than in females
from day 2 onwards (p<0.03, student's t-test).
In contrast to the effects of T, DHT prevented the rise in LH
concentrations following the removal of oestradiol implants in males,
but not in females (3.11). There was a significant difference in
mean LH concentrations between DHT treated males and controls by day
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Figure 5.10
The effect of dally s.c. injections of O.^mg T in oil on LH
concentrations in short term gonadectomised males (a) and females (b)
Oestradiol implants were removed on day 0.
Testosterone and LH values are Mean - S.E.M.; treated
animals n=5>, controls n=3.
N.S.j * p<0.05j ** p<0.01, compared with controls.
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Figure 5.11
The effect of daily s.c. injections of 0.5 mg DHT in oil on LH
concentrations in short term gonadectomised males (a) and females (b)
Oestradiol implants were removed on day 0.
tH values are Mean - S.E.M.j treated animals n=5, controls n=3.
N.S.j ** p<0.01j p <0.001, compared with controls.
00
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5.6 Discussion
Secretion of LH by the pituitary gland, increases markedly
after gonadectomy in male and female marmosets. The greatest
increment in the concentration of LH occurred during the first 3 days^
after which LH levels continued to rise until a plateau was reached
after about 15 days. The initial increase in plasma levels of LH
almost certainly occurred earlier than day 3, but since the first
sample was not collected until this time there are no data to show
this. However, Reeves et al (1972) observed that plasma LH levels
increased within 12h of castration in the ram, and Goldman and Porter
(1970) reported that female hamsters ovariectomised during dioestrus
have markedly increased levels of LH within 3.5b of gonadectomy. In
male and female rhesus monkeys (Atkinson et al, 1970), women (Yen
and Tsai, 1971b) and men (Seyler and Rei chlin, 1 97Ub)increases in plasma
LH levels occur 1-2 days after gonadectomy. In women it has been
shown that during the first week after gonadectomy a significantly
greater rise in LH is observed in those subjects ovariectomised during
the follicular phase than in those ovariectomised during the luteal
phase of the menstrual cycle (Yen and Tsai, 1971b). In the present
study, the exact stage of the cycle at which ovariectomy was performed
was not inown and it is therefore not possible to determine whether
the rate of increase in LH levels in the marmoset varies according to
the stage of the cycle at which ovariectomy is performed. In agreement
with work on the rhesus monkey (Atkinson et al. 1970) there does not
appear to be a sex difference in the rate of increase in LH levels
after gonadectomy in the marmoset.
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Blood samples collected at 0.5h intervals revealed an episodic
release of LH in gonadectomised marmosets. Fluctuations in plasma
LH levels have been observed in a number of other species (see page 8
for references) although the frequency of the discharges appears to
vary between species. In the present study the rhythm of EH discharge
was circhoral (as in the rhesus monkey, Dierschke et al 1970) in
U animals, but appeared to be irregular in the remainder. Reeves
et al (1972) and Dierschke et al (1970) showed in the ewe and rhesus
monkey respectively that regular periods of EH discharge could be
detected only when the sampling frequency was of the order of every
10-20 min. Hourly blood samples were initially taken in these species
(Atkinson et al. 1970; Reeves et al, 1972) and in both cases EH
discharges appeared completely random. If a greater sampling
frequency had been used in the present study a regular (circhoral)
period of LH discharge may have been observed in more of the animals.
Implantation of silastic capsules containing crystalline
oestradiol-1 7/S inhibited EH secretion in male and female gonad¬
ectomised marmosets. This demonstration of a negative feedback
effect of oestradiol confirms earlier reports (Lt gan, Gay and
Midgley, 1973; Karsch et al, 1973a)that this steroid is capable, on
its own, of restoring the negative feedback loop between the gonad
and the hypothalamo-hypophysial axis which is interrupted by gonad-
ectomy. The rate of oestradiol released by the implants, estimated
to be between 10 and 20 ug/day, produced plasma oestradiol concen¬
trations (after the peak on day 1) similar to those found in the late
follicular phase of the ovarian cycle in the intact female marmoset
(Kearn and Lunn, 1973). Coincident with the peak in oestradiol-1 7/^
levels on day 1 was a marked increase in LH secretion in all animals,
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indicating that oestradiol-1 7/3 is capable of exerting both negative
and positive feedback actions. Furthermore the results obtained here
suggest that castrated male (as well as castrated female) marmosets
are sensitive to a positive feedback action of oestrogen, and will
release LH when stimulated with this hormone.
Detailed analysis of the effects of oestradiol on LH secretion,
particularly work on the rhesus monkey (Karsch et al, 1973a),has shown
that the negative feedback control system governing LH secretion is
remarkably sensitive to small changes in plasma oestradiol concen¬
trations, and that irrespective of duration, negative feedback can be
induced by considerably lower circulating levels of oestradiol than
positive feedback. Thus,if lower levels of oestrogen had been used
in the present study it is probable that only the negative feedback
response would have been observed, although the suppression of LH
levels may not have been as marked.
In contrast to the inhibitory efficacy of oestradiol-11/S ,
progesterone, testosterone and dihydrotestosterone, under the exper¬
imental conditions described, had no apparent negative feedback effect
on LH secretion in long term gonadectomised marmosets. The definition
of negative feedback used in this study may be considered to be
severe, but it is not unreasonable in view of the considerable
fluctuations in LH levels associated with pulsatile secretion.
Furthermore, there was no decrease in mean LH concentrations with any
of the steroids administered during the test period. The possibility
that negative feedback did occur but was not detected is therefore
unlikely^ but should not be completely excluded.
The levels of progesterone and testosterone shown in Figures
5.1; and 5.5 represent the hormone concentrations 2l;h after the
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injections, and it must therefore be assumed that the maximum levels
achieved were considerably higher than is shown. Since progesterone
concentrations 2l\h after the injection were approaching the upper
limit of mid luteal phase levels, the maximum concentrations achieved
would almost certainly have been supraphysiological. Testosterone
concentrations 2ljh after each injection however, were at the lower
end of the normal male range, and may not have been elevated for long
enough to suppress LH. However, testosterone concentrations when
maintained in the region of i|.0 ng/ml (by 8h injections) were also
unable to inhibit EH secretion. Dihydrotestosterone concentrations
were not measured. However, since the treatment with dihydrotes¬
tosterone was identical to that of testosterone, the effects of the
two hormones may be compared, albeit with caution.
There is a strong possibility that the injections of steroids
were not continued for long enough to inhibit LH secretion. However
studies on long term gonadectomised rhesus monkeys have also failed
to demonstrate a negative feedback effect of progesterone either with
physiological doses maintained for several months (Karsch et_al, 1973a)
or with pharmacological doses maintained for 2 weeks (Yamaji et al,
1972). Similarly, physiological doses of testosterone when maintained
for 3 weeks were unable to suppress EH secretion in long term gonad¬
ectomised male rhesus monkeys (Resko et al, 1976). Nevertheless, it
should be emphasised that a more complete examination using several
doses and duration of treatment is necessary before any firm conclusions
regarding the negative feedback action of any of the steroids tested
in long term gonadectomised marmosets can be drawn.
In contrast to the apparent ineffectiveness of progesterone,
testosterone and dihydrotestosterone to suppress LH secretion in
17h
long term gonadectomised marmosets, all three steroids had a negative
feedback action in short term gonadectomised animals. The results
for progesterone agree with the observations of Karsch et al (1976)
which showed that treatment with progesterone immediately following
gonadectomy prevented the typical post castration rise in circulating
LH levels in the ewe. They are however, in contrast to the obser¬
vations in the long term ovariectomised rhesus monkey (Yamaji et al,
1972; Karsch et al, 1973a)from which it was concluded that progesterone
alone is physiologically inert in the control of tonic LH secretion
in primates. It is unlikely that these contrasting observations are
due simply to methodological or species differences, but they may be
related to the interval between gonadectomy and the initiation of
progesterone treatment. In this regard, the efficacy of another
ovarian steroid, oestradiol-1 7 Z3 , to inhibit LH secretion appears to
decrease with time after ovariectomy in sheep (Brown, Cumming, Goding
and Hearnshaw, 1972) as well as in rats (Legan and Karsch, 1975).
Although there is a clear difference between the feedback
effects of exogenous progesterone in long term and short term
gonadectomised marmosets, the results do not necessarily imply that
progesterone normally exerts a negative feedback action in intact
animals. Maximum progesterone concentrations were almost certainly
supr^physiological, and the possibility that the exogenous progesterone
was converted to another steroid which was active in suppressing LH
secretion cannot be excluded. Nevertheless, the results indicate that
under the experimental conditions described, progesterone treatment
can exert a negative feedback effect on LH secretion in the marmoset.
They also suggest that it may be misleading to interpret the negative
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feedback properties of progesterone in long term gonadectomised
animals as representing the effects of the hormone in other physio¬
logical conditions.
The feedback effects of testosterone and dihydrotestosterone
also appear to be different in long term and short term gonadectomised
marmosets. However, conclusions based on the present results must
be tempered by the fact that, due to a shortage of animals available
for experimentation, castration was physiologically staged by removing
the suppressive effects of oestradiol-1 7/3 implants, and that actual
gonadectomy was not performed. Although the implants chronically
suppressed EH secretion, the hormonal environment under these conditions
is not the same as in intact animals, and the levels of circulating
oestradiol produced by the implants (assumed to be in the region of
0.5 - 0.6 ng/ml) would almost certainly be well in excess of the levels
of endogenous oestradiol in intact male marmosets. As oestradiol has
been shown to increase the number of androgen receptors in the chick
oviduct (Harrison and Toft, 1973)* the possibility that oestrogens
affect the sensitivity to androgens in the marmoset cannot be excluded.
Nevertheless, the results show that under the experimental
conditions testosterone and dihydrotestosterone were able to exert a
negative feedback effect on LH secretion. The reason why testosterone
was effective in only the females and dihydrotestosterone in only the
males is not clear from the data. The feedback effect of testosterone
may be due to the hormone per _se, or it may be due to some other
steroid to which testosterone is converted. Since testosterone can
be converted to oestradiol-1 7/3, either in the peripheral circulation
(Longcope, Kato and Horton, 1969) or in the brain (Ryan, Naftolin,
Reddy, Flores and Petro, 19725 Naftolin, Ryan, Davies, Reddy, Flores,
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Petro, White, Kuh^ Takaoka and Wolin, 1975), oestradiol-1 7/3 may be
responsible for mediating the negative feedback effects of testosterone.
In this regard, it has been shown that gonadectomised male rhesus monkeys
are less sensitive to the negative feedback action of low doses of
oestradiol than gonadectomised females (Steiner et al. 1976).
Whether or not the effects of testosterone in the present study were
mediated through oestrogen, larger doses and more prolonged treatment
may have prevented the rise in LH levels in males as well as in
females. Although physiological doses of testosterone alone do not
appear to exert a negative feedback effect on EH secretion in either
long term or short term gonadectomised male rhesus monkeys (Resko
et al, 1976j 1977), testosterone has been shown to synergise with
sub-threshold doses of oestradiol (Resko et al, 1977). In accord with
the present results, Resko et al (1977) found that the.feedback
efficacy of testosterone (albeit in combination with oestradiol) was
related to the interval between gonadectomy and the initiation of
steroid treatment, and that EH secretion was inhibited only in short
term gonadectomised animals.
Dihydrotestosterone is a substance with a reduced A-ring
which is not convertible to oestradici-1 7/S ,or other known oestrogens
(ito and Horton, 1971). It is therefore reasonable to assume that the
feedback effects of dihydrotestosterone in the marmoset are due to a
direct action of androgens. The present results in short term gonad¬
ectomised male marmosets confirm earlier reports in intact men
(btewart-Bentley et al, 1973) and in castrated male rats (Swerdloff,
Walsh and Odell, 1972) that dihydrotestosterone is capable of
suppressing EE secretion^ and that conversion of androgens to oestrogens
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may not necessarily be required to inhibit EH secretion. The feed¬
back properties of dihydrotestosterone in females have not been
previously reported.
5.7 Chapter summary
1 . Bilateral gonadectoiry in the marmoset results in an increase in
circulating LH concentrations indicating that LH secretion is normally
suppressed by the action of gonadal steroids.
2. The elevated LH concentrations in the "open-loop" situation are
the result of pulsatile discharges of the hormone which in some of
the animals appear to occur approximately once an hour.
3. Chronic treatment of long term gonadectomised animals with late
follicular phase (approximately 5>00pg/ml) levels of oestradiol-17/3
(achieved with implants) inhibits LH secretion in males and females,
although this suppressive effect was preceeded in all animals by a
surge of LH 2l|h. after insertion of the implants.
Under the experimental conditions described, P, T and DHT were
able to prevent the post "castration" rise in LH levels in some animals,
but showed no apparent inhibitory effect in long term gonadectomised
marmosets. These results suggest that the sensitivity of the
hypothalamic-pituitary system to negative feedback may decrease as the
interval from castration increases.
5>. Although these results demonstrate a negative feedback action of
all the steroids tested, definition of their physiological roles in
the control of tonic LH secretion in the marmoset (particularly of
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6.1 Introduction
In addition to a negative feedback mechanism described in
Chapter 3j the secretion of EH is also regulated by positive feed¬
back. Evidence to date suggests that the most important steroid with
respect to positive feedback is oestradiol-17/6 , and it is well
established that the pre-ovulatory rise in circulating oestradiol-1 7/6
represents the critical stimulus for the initiation of the midcycle
surge in women (Vande Wiele et al, 1970) and rhesus monkeys (Ferin
et al, 197Ua)as well as in rats (Ferin et al, 1969) and sheep (Goding
et al, 1969). Progesterone and androgens may also be important in
regulating the preovulatory EH surge}although the way in which they
influence LH secretion is not yet clear. Thus progesterone can
trigger an acute surge of LH, either in oestrogen primed hypogonadal
women (Odell and Swerdloff, 1968) and men (Stearns et al, 1973),or
during the late follicular phase in normally cycling women (Yen et al,
1973a),but it can also effectively block the positive feedback action
of oestrogen (Netter et al, 1973; Clifton et al, 1973). Similarly,
testosterone can either induce a positive discharge of EH in ewes
(Clarke, 1976) or inhibit EK release in response to oestrogen
stimulation in the female rat (Klawon, Sorrentino and Schalch, 1971).
The experiments described in this chapter were designed to determine
the characteristics of oestrogen induced positive feedback in the
marmoset, and to look at the ability of physiological levels of
progesterone, testosterone and dihydrotestosterone to induce,or modify
oestrogen induced,positive feedback.
Elevated concentrations of oestradiol (achieved with implants)
induced a positive discharge of EH in gonadectomised male as well as
gonadectomised female marmosets (Chapter 3). This observation is of
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interest in determining whether positive feedback in response to
oestrogen is a sexually dimorphic characteristic in primates, as it
is in rats (Gorski, 1971) and sheep (Karsch and Foster, 1975).
Although it has been suggested (e.g„ Knobil, 197U) that sexual
dimorphism in the LH response to oestrogen does not exist in primates,
experimental evidence to support this has not been too convincing.
The action of oestradiol-1 7/8 on LH release in gonadectomised and
intact male marmosets has therefore been examined.
The following experiments were done:
1 . The EH response to oestradiol benzoate (ODB) in gonadectomised
male and female, and intact male marmosets was measured.
2. The effects of testosterone (T), dihydrotestosterone (DHT)
and progesterone (P) on ODB induced EH release in gonadectomised
marmosets was determined.
3. T, DHT and P were also tested for their capacity to induce LH
release in gonadectomised animals.
Eighteen gonadectomised marmosets (9 males and 9 females) were
used in the experiments. In the course of the study each animal was
used several times. However, care was taken to.ensure that the
period between two successive experiments on the same animal was as
long as possible (> 2 weeks). For the purposes of this study positive
feedback (negative feedback) has been defined as an increase (decrease)
in plasma EH concentration exceeding two standard deviations above
(below' the corresponding mean control value. While lesser responses,
both negative and positive, may reflect genuine feedback effects, it
was felt necessary to impose the rigorous definition using two
standard deviations in order to avoid any confusion of feedback effects
with episodic LH secretion.
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6.2 The effects of a single injection of oestradiol benzoate
on LH secretion in male and female gonadectomised
marmosets
6.2„a Procedure
Four male and four female gonadectomised marmosets each
received a single subcutaneous injection of 35 ug ODB in 0.1 ml arachis
oil. Blood samples were taken immediately before the injection and
at 12h intervals for 81th.
In addition, four male and four female gonadectomised animals
each received a similar injection and were bled at [|h intervals for
36h. All blood samples were assayed for LH and oestradiol-170 .
Six gonadectomised animals (3 ,males and 3 females) received
a single injection (s.c.) of 0.1ml arachis oil and were bled
immediately before and 8, 20, 21]., 28, 36 and lj.8h after the injection.
Six further animals (3 males and 3 females) received no injection
and were bled at the same times. These twelve animals served as
controls for gonadectomised animals throughout the study.
6.2.b Results
LH levels in controls are shown in Tables 6.1 and 6.2. There
was no significant difference in mean LH levels (at individual times)
between males (or females) which received oil and those which did not.
LH levels in oil-treated and non-treated animals have therefore been
combined (Tables 6.1 and 6.2). The limits formed by two standard
deviations above and below the mean control values are shown in the
figures as broken lines.
The change in LH concentrations in response to a single
injection of ODB in gonadectomised marmosets is shown in Figure 6.1.
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ANIMAL TIME (HOURS)
0 8 20 2k 28 36 U8
1* U8 7b 57 51 69 52 63
2* 71 35 U8 6b 6b 73 73
3* 68 60 71 68 62 b9 50
Mean (n=3) 62.3 63.0 58.7 61.0 65.0 58.0 62.0
S.D. 12.£ 9.8 11.6 8.9 3.6 13.0 11.5
S.E.
. 7U2 5.7 6.7 5.1 2.1 7.5 6.7
h 83 72 75 70 b9 61* 68
3 71 66 57 67 50 69 72
6 61 68 60 U6 70 50 51
Mean (n=3) 71.7 68.7 61.0 61.0 56.3 61.0 63.7
S.D. 11.0 3.0 9.6 13.1 11.8 9.8 11.1
S.E. 6 .U 1.7 5.6 7.5 6.8 5.7 . 6.U
Mean (n=6) 67.0 65.8 61.3 61.0 60.7 59.5 62.8
S.D. 11 .7 7.2 . 9.9 10.0 9.2 10.5 10.2
S.E. U.7 2.9 U.o U.o 3.7 U.3 U.1
-2S.D. - U3.6- 51 .U- U1.5- U1 .o- 1*2.3- 38.5- 1*2.1*-
+2S.D. 90.U 80.2 81.1 81 .0 79.1 80.5 83.2
Table 6.1
Individual LH concentrations in control gonadectomised male
marmosets, receiving arachis oil at time 0 00, or no
treatment. Means, S.E.'s, 'S.D.'s and the limits formed by
taking two S.D.'s above and below mean values are also given
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ANIMAL TIME (HOURS)









































































































































Individual LH concentrations in control gonadectomised female
marmosets, receiving arachis oil at time 0 (■*), or no
treatment. Means, S.D.'s, S.E.'s and the limits formed by
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Figure 6.1
LH and oestradiol concentrations in gonadectomised males (a) and
females (b) after a single s.c. injection of 35ug ODB in oil
Individual results for LH; oestradiol values are Mean -S.E.M. (n=U)
Throughout this chapter the dotted areas represent the limits
formed by 2 S.D.'s above and below the mean control values.
35pgOD
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A biphasic response with an initial suppression of LH secretion
followed by an abrupt increase in tH secretion can be clearly seen.
In all females LH levels were reduced 12h after the oestrogen
injection, although in only one case did levels fall below the
defined control limits. Following the suppression of LH secretion
there was a marked increase of LH between 12 and 2l|h after the
oestrogen injection, and a positive feedback response was observed
in all females. Maximum LH levels occurred after 2ljh, after which
LH secretion declined rapidly. A similar pattern of LH release was
seen in gonadectomised male marmosets. An initial suppression of LH
occurred after 12h (all males showed negative feedback)^after which
LH secretion increased to reach a peak after 2l|h. Only three males,
however, showed positive feedback. Circulating oestradiol levels
achieved by the injection were approximately 2.0 ng/ml after 1 2h
and declined progressively thereafter. Oestradiol concentrations
were similar in males and females. Figure 6.2(a) compares the mean
LH levels in males and females with their respective controls. In
both males and females mean LH concentrations 2lj.h after the injection
of oestrogen were significantly higher than control values. With
the exception of levels after 1 2h there was no significant difference
in mean LH concentrations between males and females throughout the
8iih period (Fig. 6.2(b)).
The effect of a single injection of ODB on LH concentrations
over a 36h period is shown in Figure 6.3• The patterns of LH secretion
are similar to those shown previously (Fig. 6.1). As plasma oestradiol
concentrations rose LH levels initially fell and remained suppressed
between ij. and 1 2h after the injection. LH levels fell below two
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Mean (- S.E.M.) EH concentrations in gonadectoniised. males (n=li') and
females (n=li) end, in respective controls (males and females. n=6).
The following notation will apply throughout this chapter
N.S.; p<0.05j **■, p<0.01; ***, p< 0.001, compared
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Figure 6.3
LH and oestradiol concentrations in gonadectomised males (a) and
females (b) after a single injection of 35>ug ODB in oil
Individual results for LH; oestradiol values are Mean -S.E.M. (n=U).
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»
in all animals after 8h, and three males and three females showed
positive feedback,with maximum EH levels occurring after 2ljh.
Although there was an increase in LH secretion following the initial
negative response in the remaining two animals, this is not inter¬
preted as clear positive feedback. Maximum observed oestradiol-17A
concentrations (approximately 1 .75 ng/ml) occurred 8h after the
injection. In all animals mean EH levels 8h after the ODB injection
were significantly lower than mean control levels, whereas after 2i|h
mean EH concentrations were significantly higher than mean control
values only in females (Fig. 6.5(a)). There was, however, no
significant difference in the LH response between males and females
(Fig. 6.5(b)).
6.3 The effects of a single injection of oestradiol benzoate
on EH secretion in intact male marmosets
6.3.a Procedure
Sixteen intact males received single injections (s.c.) of
35ug ODB in 0.1ml arachis oil and were bled immediately before and
8, 20, 25, 28, 36 and 58h after the injection. Blood samples from
ten animals were assayed for EH and oestradiol-17/S (Group 1) and
samples from the remaining six animals were assayed for LH, oestradiol-
17/# and testosterone (Group 2).
Six intact males received a single injection of 0.1ml arachis
oil and six animals received no injection. Blood samples, collected
as above, were assayed for LH, and served as controls.
6.3.b Results
EH concentrations in controls are shown in Table 6.3. There








































Mean (- S.E.M.) LH concentrations in gonadectomised males (n=k) and
females (n=I|.) and in res-pective controls (males and females. n=6)
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ANIMAL TIME(HOURS)
0 8 20 21* 28 36 1*8
1* 29 1*6 1*7 1*7 27 Ul* 35
2* 28 31* 31 20 27 52 1*1
3* 36 38 1*1 55 60 1*6 56
1** 1*3 36 1*2 27 20 31 1*8
5* 69 62 30 31* 1*2 61 57
6* 36 51* 52 1*3 31 27 31
Mean (n=6) bo.2 1*5.0 1*0.5 37.7 37.3 1*3.5 1*1*.7
SD 15.1 11.1 8.7 13.1 13.6 12.8 10.8
SE 6.2 1*.6 3.5 5.3 5.6 5.2 l*.l*
1 b6 31 51* 61 59 1*9 37
2 63 59 37 1*1 35 66 1*9
3 38 1*3 1*1 37 29 39 36
h 21 1*1 31* 1*3 ' 31 1*2 1*1
5 72 61 1*2 1*7 57 51* 68
6 h9 1*6 32 29 1*9 32 38
Mean (n=6) 1*8.2 1*6.8 1*0.0 1*3.0 1*3.3 1*7.0 1*1*.8
SD 18.1 11.1* 7.9 10.7 13.3 12.0 12.3
SE 7.3 1*.7 3.2 l*.l* 5.5 1*.9 5.0
Mean (n=12) bb.2 1*5.9 1*0.3 1*0.3 1*0.3 1*5.2
.
1*1*.7
SD 16.1* 10.8 7.9 11.7 13.2 12.0 11.0
SE 1*.7 3.1 2.3 3.1* 3.8 3.5 3.2
-2 SD - 11.1*- 21*.3- 21*. 5- 16.9- 13.9- 21 - 22.7-
+2 SD 77 67.5 56.1 63.7 66.7 69.2 66.7
Table 6.3
Individual LH concentrations in control intact male marmosets,
receiving arachis oil at time 0 (*). or no treatment. Means.
S.E.'s. S.D.'s and the limits formed by taking 2 S.D.'s above
and below mean values are also given
between males which received oil and those which did not. LH levels
in oil-treated and non-treated animals have therefore been combined.
The change in LH secretion in group 1 animals in response
to oestrogen is shown in Figure 6.5« A decrease in EH secretion was
observed 8h after oestrogen administration in eight animals, although
this decrease could be classified as negative feedback in only four
animals. In two animals EH levels were undetectable before and 8h
after the oestrogen injection and therefore no change in LH secretion
could be observed. Following the initial suppression of LH, five
animals responded with a clear positive discharge of EH, maximum
LH levels occurring after 28-36h. In the other five animals the
maximum LH levels attained remained within the defined control limits.
Maximum observed oestradiol levels, with a mean value of approximately
1.8ng/ml, were attained 8h after the injection. Compared with mean
control values, mean LH levels in animals receiving ODB were sig¬
nificantly lower after 8h and significantly higher after 28h (Fig.
6.6).
LH levels in animals in group 2 are shown in Figure 6.7. LH
levels were suppressed after 8h in all animals although this suppression
could be classified as negative feedback only in one animal- In the
four animals which showed positive feedback maximum LH levels were
attained after 28h. The elevated levels of oestradiol caused a
suppression of testosterone secretion and circulating levels were
markedly reduced 8h after the injection. The length of time for which
testosterone levels were reduced cannot be determined from the bleeding
schedule used, although levels had returned to pre-injection values















EH and oestradiol concentrations in intact males after a single s.c.
injection of 3:? ug ODB in oil
Individual results for LH are shown in 2 graphs; oestradiol values
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Figure 6.7
LH. oestradiol and testosterone concentrations in intact males
after a single s.c. injection of 31>ug ODB in oil
Individual results for LH; oestradiol and testosterone values
are Mean - S.E.M. (n=6).
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levels in animals receiving ODB were significantly lower after 8h
and significantly higher after 2h, 28, 36 and U8h (Fig. 6.8). Mean
LH concentrations in all sixteen intact males were not significantly
different from those in gonadectomised females (Fig. 6.U) at any time
after the injection of oestrogen (Fig. 6.9)
6.h The effects of testosterone, dihvdrotestosterone and progesterone
on oestradiol induced LH release in gonadectomised marmosets
6.U.a Procedure
Three groups of gonadectomised marmosets, each comprising
four males and four females were given a single injection (s.c.) of
35u.g ODB in 0.1ml arachis oil, followed immediately and after 8h by
a single injection (s.c.) of 0.5mg T/injection (group 1), 0.5mg
DHT/injection (group 2) or 1 .Qmg P/injection (group 3) in 0.1ml
arachis oil. A fourth group (four males and four females) received
progesterone implants (1 x 5>0mg plus 1 x 25mg) 8 days before the
oestradiol injections. Blood samples were taken immediately before
and 8, 20, 2l|, 28, 36 and l|8h after the oestrogen -injections, except
that no U8h sam, les were taken in groups 3 and 1|. The doses of




EH concentrations after oestradicl and testosterone injections
are shown in Figures 6.10 and 6.11. There was an initial fall (after
8h) in LH levels in all animals although only three males and three
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Mean (- S.E.M.) LH concentrations in intact males (n=l6). and
gonadectomised males (n=li) and females (n=U)
There were no significant differences between the groups at










































LH. oestradiol and testosterone concentrations in gonadectomised
males after a single s.c. injection of 3^ug ODB in oil and s.c.
injections of O.^mg T in oil after 0 and 8 h.
Individual results for LHj oestradiol and testosterone values
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Figure 6.11
LH, oestradiol and testosterone concentrations in gonadectomised
females after a single s.c. injection of 3^ug ODB in oil and s.c.
injections of O.^mg T in oil after 0 and 8h.
Individual results for LH; oestradiol and testosterone values
are Mean - S.E.M. (n=U).
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feedback after 2l|h although in one animal maximum LH levels occurred
after 28h. Maximum EH levels exceeded two standard deviations above
mean control values in all males but in one case the pre-injection
level was also above the control limits. In three males maximum EH
levels were attained after 28h whereas in one animal EH levels were
highest after 21;h. Mean oestradiol levels of approximately 2.0ng/ml
were reached after 8h and were similar to the levels obtained in the
absence of testosterone (c.f. Figs. 6.1 and 6.3). Mean testosterone
levels were similar in males and females, with maximum concentrations
(approximately 20ng/ml) occurring between 8 and 20h after the first
injection. Figure 6.1 2(a) compares mean EH concentrations in
experimental animals with those of the controls. EH levels were
significantly lower than control values after 8h and significantly
higher than control values after 20, 2b, 28, 36 and l|8h in both males
and females. The response in females did not differ significantly
from the response in males, except at 20h after the oestrogen injection
(Fig. 6.12(b)). Thus, 'under the experimental conditions described
testosterone does not appear to inhibit oestrogen induced positive
feedback.
Group 2
Negative feedback occurred after 8h in all males and in three
females (Fig. 6.13 ). The level of EH was considerably reduced in
the remaining female although it did not fall outside the defined
control limits. All males showed positive feedback and maximum EH
levels were attained after 2lih. Three females showed a positive
discharge of EH and maximum EH levels occurred after 2l;h in two animals
and after 28h in one animal. 0estradiol-1 7/6 levels were similar
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Figure 6.12
Mean (- S.E.M.) LH concentrations in gonadectoraised males (n=k)
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Figure 6.13
LH and oestradiol concentrations in gonadectomised males (a)
and females (b) after a single s.c. injection of 3£ug ODB in oil
and s.c. injections of O.^mg DHT in oil after 0 and 8h
Individual results for LH; oestradiol values are Mean - S.E.M.
(n=U).
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are compared with mean control values in Figure 6-1U(a) . LH levels
in males and females were significantly lower than control values
after 8h. LH levels were significantly higher than control values
after 20, 2k, 28 and 36h in males and after 2k and 28h in females.
There were no significant differences in mean LH levels between males
and females (Fig. 6.lU(b).
Group 3
All animals showed negative followed by positive feedback
(Figure 6.15). Apart from two males and one female in
which LH levels were highest after 28h, maximum LH concentrations
occurred after 2lfh. Oestradiol levels were similar to those obtained
in all previous experiments. The injections of progesterone achieved
circulating levels of approximately 35>ng/ml between 8 and 20h after
the first injection, after which levels declined fairly rapidly. Mean
LH concentrations in males and females were significantly lower after
8h and significantly higher thereafter compared with mean control
values (Fig. 6.16(a)). There was no significant difference in mean LH
concentrations between males and females, after the oestrogen
injection (Fig. 6.16(b).
Group Ij.
All animals showed negative feedback 8h after the injection
of oestrogen (Figure. 6.17) • • However, maximum LH levels
exceeded two standard deviations above mean control values only in
one male (after 28h) and one female (after 20h). Oestradiol con¬
centrations were similar to those obtained in previous experiments.
Although progesterone concentrations varied throughout the experiment
(more so in the females) the levels achieved by the implants
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Figure 6.Ill
Mean (- LH concentrations in gonadectomised males (n=ikl
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Figure 6.1 5
LH. oestradiol and progesterone concentrations in gonadectomised
males (a) and females (b) after a single s.c. in.iection of l^ug
ODB in oil and s.c. injections of 1 .Omg P in oil after 0 and 8h.
Individual results for LH; oestradiol and progesterone values





Mean (- S.E.M.) LH concentrations in gonadectomised males (n=L)
and females (n=ii) and in respective controls (males and females.
n=6).
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Figure 6.17
LH, oestradiol and progesterone concentrations in gonadectomised
males (a) and females (b) after a single s.c. injection of 3c>ug
ODB in oil to animals containing 75>mg progesterone implants
Individual results for LH; oestradiol and progesterone values
are Mean - S.E.M. (n=U).
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injections (group 3). Mean LH concentrations in males and females
were significantly lower than mean control values after 8h, but
thereafter there was no significant difference between control and
experimental animals (Fig. 6.18(e)). There was also no significant
difference in the LH response between males and females (Fig. 6.18(b).
6.5 The effects of injections of testosterone, dihydrotestosterone
and progesterone on LH release in gonadectomised marmosets
6.5.a Procedure
Two groups of gonadectomised marmosets each comprising three
males and three females were given two subcutaneous injections of
either 2.5mg T/injection (group 1) or 2 ,5mg DHT/injection (group 2)
in 0.1ml arachis oil at time 0 and after 8h. Each animal was bled
immediately before and 8, 20, 2b, 28 and 36h after the first injection.
In addition two groups (groups 3 and 1;) of gonadectomised marmosets
(three females per group) were given two subcutaneous injections of
2.0mg P/injection in 0.1 ml arachis oil at time 0 and after 8h.
Animals in group U were implanted with oestradiol capsules 8 days
before the injections. Animals were bled as in groups 1 and 2
except that an extra blood sample was collected after ii8h.
6.5.b Resuits
Group 1
Testosterone failed to induce negative feedback in any of the
animals (Fig. 6.19 )• None of the females showed a positive discharge
of LH although positive feedback occurred in two of the males after
2i|h. Circulating levels of testosterone obtained with the injections
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Figure 6.18
Mean (- S.E.M.) LH concentrations in gonadectomised males (n=U)




































LH and testosterone concentrations in gonadectomised males (a)
and females (b) after s.c. injections of 2.c?mg T in oil at 0 and 8h.
Individual results for LH; testosterone values are Mean - S.E.M.
(n=3).
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90-100 ng/ml were recorded after 8h. It is likely that the second
injection of testosterone produced a further increase in circulating
testosterone levels but there were no blood samples to show this.
There were no significant differences either in mean LH levels in
males and females compared with control values (Fig. 6.20(a))or between
male and female responses (Fig. 6.20(b)).
Group 2
Injections of DHT did not induce negative or positive feedback
in any of the animals (Fig. 6.21). • There was no significant
difference in mean EH levels between experimental and control animals
(Fig. 6.22(a)), and the response in males did not differ significantly
from the response in females (Fig. 6.22(b).
Groups 3 and 1;
Females receiving progesterone only did not show negative or
positive feedback (Fig. 6.23) . In the presence of oestrogen
however, similar concentrations of. progesterone (maximum observed
levels were approximately 80-90 ng/ml) produced a clear increase in
EH concentrations in two of the animals (Fig. 6.21; ). Maximum EH
levels were attained 2l|h after the first injection. Circulating
levels of oestradiol achieved by the implants were of the order of
0.5 ng/ml. As the control values are not applicable to animals in
group 1;, where LH levels have been chronically suppressed with
oestrogen, the standard definition of positive feedback cannot be
used in this case. Nevertheless a marked increase in EH secretion
could clearly be seen in two animals. As EH secretion was already
chronically suppressed with oestrogen implants, no further negative
feedback action could be observed. Progesterone therefore was seen
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Figure 6.20
Mean (- S.E.M.) LH concentrations in gonadecuomised males (n=3)
and females (n=3) and in respective controls (males and females.
n=6)»
Figure 6.21
LH concentrations in gonadectomised males (a) and females (b)
after s.c. injections of 2.E>mg DHT in oil at 0 and 8h.
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Figure 6.22
Mean (- S.E.M.) LH concentrations in gonadectomised males (n=3l
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Figure 6.23
LH and progesterone concentrations in gonadectomised females after
s.c. infections of 2.0mg P at 0 and 8h.





























LH. oestradlol and progesterone concentrations in gonadectomised
female marmosets after s.c. infections of 2.0mg F at 0 and 8h
in animals containing oestradiol implants
Individual results for LH; oestradiol and progesterone values
are Mean - S.E.M. (n=3).
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6.6 Discussion
A single injection of ODB had a biphasic effect on EH
secretion in ovariectomised marmoset monkeys, with a negative feedback
action characteristically preceeding the positive feedback effect.
The initial suppression of EH secretion,which appears to occur as
early as Ifh after the administration of oestrogen,is followed by an
abrupt increase in EH secretion, and maximum EH concentrations occur
approximately 2i|h after the injection of ODB. A similar biphasic
response to oestrogen is well documented in other primate species,
although the EH surge occurs earlier in the marmoset than in the rhesus
monkey and women, in which maximum EH concentrations are observed
between 36 and U8h (Karsch, Dierschke, Weick, Yamaji, Hotchkiss and
Knobil, 19735 Karsch et al, 1973a), and 72 and 96h (Yen and Tsai,
1972^ Monroe et al, 1972) respectively after administration of
oestrogen.
The dose of ODB administered produced a sustained rise in
peripheral plasma oestradiol concentrations to give maximum levels
similar to those (0.8 - 2.0 ng/ml) found in intact females immediately
before the spontaneous EH surge in the normal cycle (Hearn and Lunn,
1979). Although oestradiol concentrations fell progressively after
8h, the observed positive discharges of EH cannot be associated with
an "escape" from the negative feedback action of this hormone, since
in general oestradiol levels remained in excess of 1.0 ng/ml until
after the EH surge had occurred.
It can be seen from Figure 6.1 and 6.3 that positive and
negative feedback was not observed in all the females tested. The
failure of some animajLS to show negative feedback is probably due
to the rather severe criteria which have been used in the definition
of negative feedback. Thus EH levels in all treated animals were
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lower after 8h compared with the pre-injection values, although in
three cases these levels were less than two standard deviations below
the mean control values. Failure to induce positive feedback in
100$ of animals has also been reported in studies on rhesus monkeys
(Yamaji et al, 1971 Karsch et al, 1973b) and as it does not, at
least in the present study, appear to be associated with differences
in circulating levels of oestradiol, individual variation in hypo¬
thalamic and/or pituitary thresholds of sensitivity to oestradiol may
provide an explanation.
The pattern of LH release in gonadectomised male marmosets
following an injection of ODB was broadly similar to that described
for gonadectomised females. However^the LH response to ODB was more
varied in intact males than in gonadectomised animals, and maximum
concentrations of EH in the intact males which showed positive feed¬
back were attained slightly later (28-36h) than in gonadectomised
animals (2l|h). Nevertheless the mean concentrations of LH following
ODB in the intact males tested were not significantly different from
those observed in either male or female gonadectomised animals. The
o
incidence of positive feedback in intact males ( /16), however^was
S 1
lower than in gonadectomised animals ( /8 males; /& females), although
due to the small number of animals used it is difficult to know whether
this represents a real difference. From the present data it is not
possible to make a detailed quantitative comparison between male and
female responses to 0DB5for this would require a larger number of
animals and the use of various doses of ODB. Although it is tempting
to conclude that male marmosets show a female-type LH response to an
oestrogen challenge, all that can be said is that male marmosets
possess central nervous systems and/or pituitary mechanisms for the
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release of LH after an oestrogen stimulus, and that the capacity to
display positive feedback does not appear to be a sexually dimorphic
characteristic in the marmoset monkey.
The fact that maximum levels of EH occurred later in intact
males than in gonadectomised animals may indicate a difference in the
type of response, suggesting a possible difference in sensitivity to
the oestrogen stimulus. Since there was no difference in the time at
which maximum LH concentrations were achieved between male and female
gonadectomised animals, any differences in the response of intact
males may be due to an action of testicular steroids. Thus testos¬
terone and/or some other testicular product may influence hypothalamic
and/or pituitary mechanisms thus causing a delay in the production of
an LH discharge. Knobil (1971±) has suggested that testosterone is
responsible for abolishing the positive feedback response to oestrogen
in intact male rhesus monkeys, and the release of LH in response to
oestrogen,which has been observed in intact men (DBrner et al, 1975;
Kulin and Reiter, 1976)^was considerably diminished compared with
that in women.
In the present study testosterone concentrations following
an injection of ODB were markedly reduced during the initial stages
of the LH response (Fig.6.7 ). However, when elevated concentrations
of testosterone were maintained for 20-2Uh after the administration
of oestrogen to gonadectomised animals, positive feedback was not
inhibited. It would therefore seem that the expression of positive
feedback is not prevented by the presence of testosterone, and although
in four animals maximum LH concentrations occurred after 28h (Fig. 6. IO)
the data are insufficient to conclude that elevated testosterone
levels delayed the appearance of the LH surge. Exposure to
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testosterone for several days before (as well as following) the
injection of oestrogen (similar to the situation in intact males) may
have a more marked effect on the pattern of EH release, although this
remains to be determined.
The effect of dihydrotestosterone (a potent, non-aromatisable
androgen) on oestrogen induced EH release was also tested and found
to be ineffective in blocking the positive feedback response.
Although circulating levels of dihydrotestosterone were not measured
the dose administered was the same as for testosterone. It is there¬
fore unlikely that the inability of dihydrotestosterone to block
positive feedback was due to the dosage being inadequate to produce
sufficiently elevated circulating levels, although the exposure time
may not have been long enough.
Studies on the effect of progesterone on oestrogen induced
EH release in rhesus monkeys and women have produced interesting, yet
confusing, results. In the present study progesterone treatment
(either with injections or implants) did not inhibit the initial
negative feedback action of oestradiol on EH secretion. Whether
progesterone synergises the negative feedback action of oestradiol,
as suggested in ovariectomised rhesus monkeys (Dierschke et_al, 1973)*
is not clear from these results in the marmoset. Simultaneous
administration of oestrogen and progesterone in ovariectomised rhesus
monkeys advances the time of the EH surge (Clifton et al, 1975)^whereas
in the present study progesterone did not have this effect. Although
progesterone implants were used by Clifton et al (as opposed to
injections in this study) circulating progesterone concentrations in
both experiments were in the mid-range of luteal phase levels, and
differences in the relative concentrations of progesterone is an
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unlikely explanation for the different observations. Perhaps the
relationship between progesterone and oestradiol levels is of
importance,and it may be possible that the circulating levels of
oestradiol achieved in the rhesus monkey were more susceptible to a
synergistic action of progesterone.
As progesterone can inhibit oestrogen induced LH release in
intact female rhesus monkeys (Spies and Niswender, 1972; Hess and
Resko, 1973; Dierschke et al, 1973) and women (Netter et al. 1973);
but not in ovariectomised rhesus monkeys (Clifton et al. 197f>)j if has
been suggested that the ovary is necessary either directly or indirectly
for the blocking effect of progesterone (Clifton et al, 1973).
However this argument does not hold for the present data on the
marmoset. Progesterone implants (achieving circulating concentrations
similar to those obtained by injection) when maintained in position
for 8 days before, and during the oestrogen provocation test,
inhibited the positive feedback action of ODB. Two animals showed
positive feedback, although maximum LH concentrations achieved were
considerably lower than usual. Although it cannot be said that this
regimen of progesterone treatment completely abolishes oestrogen
induced positive feedback it is reasonable to conclude that it markedly
reduces the positive response (mean LH concentrations 2l±, 28, 36h
after the injection of oestrogen are significantly lower with this
treatment (p< 0.(^students t-test), than those observed with
oestrogen and progesterone injections (c.f. Figs. 6.16 and 6.18).
The length of exposure of the hypothalamic-pituitary system to
progesterone may therefore be of importance in determining its
inhibitory influence on oestrogen induced positive feedback.
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In addition to its inhibitory effect, progesterone may, under
certain conditions have a stimulatory action on EH release. Thus
progesterone can trigger an acute surge of LH after oestrogen priming
in hypogonadal women (Odell and Swerdloff, 1968$ Leyendecker et al,
1972) and castrated men (Stearns et al, 1973)j and a similar effect has
also been demonstrated in the late, but not in the early follicular
phase in normally cycling women (Yen et al, 1973a). In "the present
study progesterone induced EH release in two of the three females with
oestrogen implants, but no stimulatory effect could be observed in
the females without oestrogen. Although inconclusive, the data on
the marmoset tend to support the theory that oestrogen is necessary
for progesterone to stimulate EH secretion. Since plasma progesterone
concentrations are slightly elevated around the time of periovular
EH release in rhesus monkeys (Weick, Dierschke, Karsch, Butler,
Hotchkiss and Knobil, 1973) and women (Johansson and Wide, 1969), the
possibility that progesterone may act synergistically with oestrogen
must be considered.
The ability of testosterone to induce positive feedback has
not previously been reported in primates. A single injection of
testosterone can cause ovulation in anoestrous ewes (Radford and
Wallace, 1971 )and can elicit a similar EH response to oestradiol-1 7/3
in ovariectomised ewes (Clarke, 1976). At the dose rates employed in
the present study, testosterone induced positive feedback in 2 out of
3 males, but surprisingly, it was ineffective in the females. Although
not enough animals were tested in this study to say definitely that
testosterone will not induce EH release in female marmosets, similar
results have been obtained in gonadectomised rhesus monkeys (Martensz,
pers. comm.). The reason for this apparent difference is, however,
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obscure. Although a periovulatory rise in testosterone secretion has been
observed in rhesus monkeys (Hess and Resko,1973)* women (Vermeulen & Verdonck,
1976) and baboons (Goncharov et al. 1976) its significance is not
yet clear, and it may be worth noting that in female rats, immun¬
isation against testosterone did not affect pre-ovulatory EH release
or ovulation (Gay and Tomacari, 197l+)«. It is possible that testos¬
terone may exert a specific effect on LH secretion per se^or by
acting as a precursor for oestrogen synthesis in the brain (Naftolin
et al, 1975, 1976). The fact that dihydrotestosterone, a non-
aromatisable androgen, did not induce positive feedback in any of the
marmosets tested may be interpreted to mean that the positive action
of testosterone on LH release is mediated through oestrogens.
Clarification of this point and the role of testosterone in controlling
EH secretion in female primates must await the results of more
detailed experiments. With respect to the observations described
in Chapter 5, it is of interest to note that neither testosterone
nor dihydrotestosterone had a negative feedback effect on EH secretion
in this particular study.
In conclusion, the action of oestradiol-1 7/S appears to be
an important component of the positive feedback control of EH secretion
in the marmoset. Furthermore, oestradiol-17,4 will induce a positive
discharge of EH in males, as well as females. More detailed inves¬
tigation is required to determine the physiological role of other
steroids in regulating the pre-ovulatory EH surge.
6.7 Chapter Summary
1 . A single injection of ODB, achieving circulating levels similar
to those seen in intact females immediately before the mid-cycle EH
22h
surge, had a biphasic effect on EH secretion in ovariectomised
marmosets, with a negative feedback action characteristically
preceeding the positive feedback effect. Under the experimental
conditions, negative feedback could be seen by Uh after the injection,
while maximum LH levels occurred after 2kh.
2. Similar oestrogen treatment also induced negative followed by
positive feedback in castrated and intact male marmosets, although
maximum EH concentrations appear to occur slightly later in intact
animals (after 28h) than in gonadectomised animals (after 2l|h).
3. Neither T nor DHT inhibited ODB induced LH release in gonadec¬
tomised animals, and the apparent delay in the appearance of peak
EH levels in intact males could not, from the present results, be
attributed to an action of these androgens.
1|. Whereas injections of T induced LH release, albeit only in some
males, no effect of DHT could be observed. This may indicate that
the action of T was mediated through conversion to oestrogen, but
clarification of this point is required.
5- Oestrogen induced positive feedback was apparently inhibited by
long term prior exposure of the hypothalamic-pituitary system to luteal
phase levels of P, but not when the hormone was injected simultaneously
with the oestrogen.
6. P can induce EH release, but seemingly only when oestrogen is also
present.
7. As in most of the experiments described in this study only a
single dose and duration of steroid treatment was tested, interpretation









The purpose of these studies was to investigate some of the
mechanisms controlling LH secretion in the marmoset monkey. Since it
is the first study in a new world primate, much of the work is pre¬
liminary and is limited to providing basic information for future and
more rigorous investigation. However, the study was also designed to
extend some previous observations made in the rhesus monkey and human,
with an aim to furthering the understanding of the control of LH
secretion in primates.
The results obtained demonstrate that synthetic LH-RH induces
a marked increase in pituitary LH secretion and this, together with
the data on inhibition of LH-RH, provides evidence that LH secretion
in the marmoset is stimulated by LH-RH and that the releasing hormone
has an important physiological role in the control of LH secretion in
this species. The data also suggest that the endogenous releasing
hormone in the marmoset closely resembles the decapeptide described
by Matsuo et al (1971), and that the relative insensitivity of the
rhesus monkey to the administration of synthetic LH-RH (Ehara et al,
1972; Arimura et al, 1973) cannot be adequately explained in terms
of dissimilarities between the synthetic peptide and simian LH-RH.
Whilst LH secretion in the marmoset is directly related to
LH-RH stimulation, the function of the hypothalamic-pituitary system
appears to be profoundly modified by the action of gonadal steroids.
This action, which forms the basis of feedback mechanisms, completes
the hypothalamic-pituitary-gonadal system which regulates LH secretion
in primates. In agreement with the well established theory of steroid
feedback, both positive and negative feedback mechanisms operate in
the marmoset.
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An increase in circulating LH concentrations following
gonadectomy provides clear evidence that LH secretion in the marmoset
is normally suppressed by gonadal steroids (Hodges, 1978). That
this negative feedback action is at least partially directed at the
pituitary gland is suggested by an enhanced responsiveness to exogenous
LH-RH in gonadectomised animals, which is probably due to an increase
in pituitary EH content similar to that reported after castration in
humans (Ryan 1962) and rats (Gay and Hauger, 1977). An increase in
EH-RH secretion^as described in long term castrated rats (Seyler,
Mitnick, Gordon and Reichlin, 1973) and men (Seyler and Reichlin,
197U) may also contribute to the increased EH secretion through a
self-priming action on the pituitary, resulting in a large readily
releasable pool of EH with a lower pituitary reserve (Lasley et al,
1975; Hoff et al, 1977).
The elevated EH concentrations in gonadectomised marmosets
appear to be the resultant of rhythmic pulsatile discharges of the
hormone by the pituitary gland. This so called episodic type of
secretion, previously reported in various other species (see Chapter
1 for references) is most likely to reflect a pulsatile secretion of
EH-RH from hypothalamic neurons. Thus, in the "open loop" situation
pulsatile secretion of EH appears to reflect a basic functional
rhythmicity in the hypothalamic-pituitary system. 'Whether this persists
in the presence of steroid action, as in intact marmosets, remains to
be determined.
Of the gonadal steroids involved in regulating EH secretion
in the marmoset, oestradiol-1 appears to be particularly effective
in both males and females. Since the enhanced pituitary responsiveness
to ER-RH caused by gonadectomy can be functionally reversed by
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oestradiol alone, with a resulting suppression of LH secretion, it
is apparent that oestradiol is involved in the negative feedback
control of LH secretion in the marmoset, and a direct inhibitory action
on the pituitary indeed represents an important component of this
control mechanism. While it is clear that the chronic effects of
oestradiol-17 are inhibitory, the shorter term stimulation of LH
release described in Chapter Ij. is consistent with observations in
rhesus monkeys (Knobil, 197k) and humans (Yen et al, 1975a),that
oestrogen induced effects on LH secretion are time and dose related.
In this respect it is worth reiterating that attempts to correlate
the feedback effects of oestradiol, or indeed any other steroid, with
changes in pituitary responsiveness to LH-RH are also complicated by
the apparent existence of two functionally separable pools of pituitary
LH (Wang et al, 1976 ; Hoff et al, 1977). The mode of administration
of LH-RH is clearly important in obtaining an accurate reflection of
pituitary function, and this should be considered in any subsequent
studies on pituitary response to LH-RH in the marmoset. Thus a
procedure which would discriminate between pituitary sensitivity and
reserve should, if possible, be adopted. As few as two injections of
a sub-maximal dose of LH-RH (e.g. 0.2 ug) 90 min apart should, with
carefully timed blood sampling, be sufficient to gain considerable
additional information on steroid induced changes in pituitary response
to LH-RH.
Definition of the feedback roles of other steroids in con¬
trolling tonic LH secretion in the marmoset is not. possible from the
present, rather preliminary data, and must await a more thorough
investigation. In addition to dose and duration of treatment, an
important consideration when testing the feedback properties of
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these steroids appears to be the interval between castration and the
initiation of treatment. The results in the marmoset confirm
previous observations in rats (Swerdloff and Walsh, 1973; Legan and
Karsch, 1975; Zanisi and Martini, 1975)? sheep (Brown et al. 1972;
Karsch et al, 1976) and rhesus monkeys (Resko et al, 1977), that the
inhibitory effects of steroid hormones (including oestradiol, pro¬
gesterone and testosterone) on gonadotrophin secretion decrease as
the post-castration time increases. However, as yet there has been
no adequate explanation to account for these apparent changes in
feedback sensitivity. One possible explanation is that in the absence
of normal levels of circulating steroids,there is a gradual depletion
in the number of specific receptors for these steroids in the pituitary
and/or hypothalamus. It would thus be expected that an increase in
the interval from castration will be associated with a progressive
decline in the receptor population. A reduction in circulating steroid
hormone binding globulin after castration may also be a possibility.
Seyler and Reichlin (1975b)have reported that although castration in
men results in an increase in LH-RH secretion, the increase could not
be detected until 30 days after castration. These observations, if
correct, may be extended to other species and the possibility that
the relative ineffectiveness of steroids to inhibit EH release in long
term castrates may be related to the delayed increase in EH-RH
secretion is worth consideration. It would be interesting to see
whether implants of the steroids used in this study, in physiological
doses which are effective in preventing the post castidxion EH rise,
would maintain low levels of EH over an extended period, or whether
a change in the sensitivity of the hypothalamic-pituitary axis to
negative feedback would still occur, with a resulting gradual rise in
EH concentration, despite a constant level of circulating steroid.
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From the present results it is reasonable to assume that
oestradiol-17plays a major role in the feedback control of tonic
EH secretion in female marmosets. The significance of the apparent
negative feedback action of progesterone in the marmoset is not clear,
and there is not yet sufficient information to define the physio¬
logical role (if any) of progesterone in regulating tonic EH secretion
in this species. If progesterone is of importance, it may be assumed
that since the progesterone treatment used in this study enhanced
pituitary responsiveness to EH-RH, any inhibition of EH secretion is
likely to involve an action at the hypothalamic level.
Although oestradiol-11/& can also inhibit EH secretion in
male marmosets, the physiological significance of testicular oestrogen
is not fully understood. A combined action of androgens and oestrogens
is more likely to reflect the feedback control of EH secretion in
males, rather than any individual action, and in this respect Resko
et al (1977) have demonstrated a synergistic role of testosterone and
oestradiol in male rhesus monkeys. Testosterone can reduce pituitary
responsiveness to LH-RH in male rats (Debeljuk, Arimura and Schally,
1972a; Cheung and Davidson, 1977) and men (Muhlen and Kobberling,
1973), and the effects of testosterone and other androgens on LH-RH
induced EH release in the marmoset should also be investigated. This
may provide useful information on the feedback roles of androgens, and
would in fact be a practical method for testing negative feedback in
intact marmosets.
It is well established that for a variety of species (see
Chapter 1) the pre-ovulatory rise in circulating oestradiol-17/
represents the critical stimulus for the initiation of the mid-cycle
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LH surge. Oestradiol-17/2 will also induce a positive discharge of
LH in female marmosets, and it is therefore likely that oestradiol-17/3
plays an important role in initiating the pre-ovulatory LH surge in
this species. This stimulatory or positive feedback action of
oestradiol on LH secretion was followed (Chapter £) and invariably
preceded (Chapter 6) by a decline in circulating LH attributable to
the negative feedback action of the steroid. In agreement with
observations in the rhesus monkey (Knobil, 197b) and women (Yen et al,
1975a)>the positive feedback effect of oestradiol-1 7/& in the marmoset
is not simply a function of some threshold plasma concentration of
the steroid, but must also be critically dependent on a time component.
At present however, neither the precise duration of the effective
stimulus nor its threshold level have been determined.
The precise mechanisms involved in controlling the midcycle
LH surge in the marmoset, as well as in other species, remain unclear,
and in particular the roles of progesterone and androgens have not
been adequately explained. Under the experimental conditions described
in Chapter 6, testosterone and dihydrotestosterone neither inhibited
nor enhanced oestrogen induced positive feedback. A midcycle
elevation in testosterone, dihydrotestosterone and androstenedione has
been reported in certain primates (see Chapter 1 for references),and
it would seem unlikely that these androgens are physiologically
totally inert with respect to the midcycle gonadotrophin surge. Thus
they may have a permissive role, and in this regard Martensz et al
(1976) have reported that elimination of androstenedione by immun¬
isation inhibited oestrogen induced LH release in ewes.
The role of progesterone in the pre-ovulatory LH surge remains
an enigma. In agreement with previous observations in other species,
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the present data confirm that under the appropriate experimental
conditions, progesterone can either induce positive feedback (Odell
and Swerdloff, 1 9685 Yen et al. 1 975a),or inhibit oestrogen induced
positive feedback (Netter et al, 19735 Dierschke et al, 1973)-
Furthermore^from the results in the marmoset, it would appear that
whereas long term previous exposure of the hypothalamic-pituitary
system to physiological levels of progesterone inhibits oestrogen
induced LH release, progesterone, when administered simultaneously
with oestrogen, shows no apparent inhibition. Although these obser¬
vations are consistent with the ideas formulated from other studies
that luteal phase progesterone blocks oestrogen induced positive
feedback (Dierschke et al, 1973); whereas peri-ovulatory progesterone
may actually enhance the later stages of the mid cycle surge (Johansson
and Wide, 19695 Leyendecker, Wardlaw and Nocke, 1972), results
obtained in gonadectomised animals may not be entirely relevant to the
situation during the cycle, and should therefore be viewed with
caution.
Positive feedback was for a long time considered to be
exclusively a female characteristic, although the adaptive significance
of this is not obvious. Positive feedback is necessary for ovulation
to occur, but the persistence of the response in the male would not
interfere with normal testicular function. In recent years it has
been suggested that the ability of the hypothalamic-pituitary unit to
discharge LH in response to oestrogen may not be a sexually dimorphic
characteristic in primates, as it is in rats and sheep. The present
data confirm this and provide the clearest demonstration to date of a
positive feedback effect of oestradiol-11/3 on LH secretion in a male
primate (Hodges and Hearn, 1978). Although the data from the rhesus
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monkey and men are not as convincing, there are indications that with
respect to oestrogen induced LH release in males, primates may in
fact differ from rats and sheep.
One possible explanation for this difference may arise from
the fact that in primates, unlike rats and sheep, exposure to androgen
during the critical period of development does not necessarily affect
normal ovarian cyclicity during later life (see Chapter 1 for references).
Several studies have suggested that when rats are exposed to testos¬
terone during the critical stage of neural differentiation, the
region of the brain which is rendered inoperative is the pre-optic
area (POA) (Barraclough, 1966; Gorski, 1971; Libertun, Timiras and
Kragt, 1973), and it is well established (Schwartz, 1969; Norman,
Blake and Sawyer, 1973) that in rodents the initiation of the pre¬
ovulatory gonadotrophin surge is dependent on a signal generated by
the POA of the brain. Thus surgical isolation of the POA from the
medial basal hypothalamus (MBH) blocks the cyclic surge of gonado¬
trophin secretion and ovulation in the rat (Halasz and Gorski, 1967;
Blake, Weiner, Gorski and Sawyer, 1972). In contrast, the work of
Krey et al (1975) has shown that deafferentation of the MBH in the
rhesus monkey does not have this effect, and they suggest that intact
connections from the POA to the MBH are not required for the expression
of the positive feedback action of oestrogen on EH and FSH secretion
in this species. If therefore the POA is also the target for androgen
action during the critical period in the rhesus monkey and other
primates, then the ability to respond to positive feedback would not
necessarily be abolished.
Furthermore, Knobil (197U) has postulated that in primates,
the "clock" or "Zeitgeber" which determines the timing of ovulation
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is not resident in the brain, as it appears to be in the rat (Everett
1961, 196b), but lies in the ovary. Thus in primates, where
environmental stimuli (directed at the brain) appear to have become
less important in controlling reproduction than in species like rats
and sheep, functional differentiation between "male" and "female" at
the neural level may not be so essential.
Whether or not the centres regulating positive feedback in
the male have developed differently in all primates than in rats and
sheep, it appears that oestrogen induced EH release in male marmosets
is much more pronounced than in male rhesus monkeys or men. Although
there is no obvious reason for this, the distinctive embryology of the
marmoset may help to provide a partial explanation. Marmosets are
unique among primates because of their high incidence of twinning and
the presence of placental vascular anastomoses that occur between
the twin foetuses (Wislocki, 1939; Gengozian, 1971). Furthermore,
although this situation invariably leads to haemopoietic chimaerism,
there is no evidence of freemartinism (Benirschke and Brownhill,
1962). Thus a rather special arrangement exists in the marmoset
which allows normal and independent development of male and female
co-twins despite their intimate relationship afforded by a common blood
supply. Whether this unique relationship in utero has any direct
relevance to the persistence of a positive feedback mechanism in the
male, however, remains to be determined.
Although the intact male marmoset possesses the potential to
display positive feedback, it would seem doubtful that this potential
is ever realised during the normal course of LH secretion. Since
ovarian function is almost certainly necessary to activate the
positive feedback mechanism, if the practical problems could be
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overcome, it would be interesting to see whether a cyclic pattern
of LH secretion could be obtained in a castrated male marmoset
implanted with ovaries.
Although there are many aspects of the control of LH secretion
in the marmoset still to be investigated, the present study establishes
the importance of the hypothalamic-hypophysial-gonadal system in
this species, and describes some of the ways in which the various
components of this system interact. The marmoset is the first new
world primate to be subjected to detailed endocrinolpgical.'investig¬
ation, and an understanding of its reproduction is therefore of certain
academic interest alone. In addition, the similarities in the control
of LH secretion which exist between the marmoset and other primates
may allow an application of studies in the marmoset to certain
aspects of reproduction in the human. One such application may lie
in the development of new methods of human fertility control.
The results described in Chapter 3 indicate that active
immunisation against LH-RH is an effective way of suppressing gonadal
activity in the marmoset (Hodges and Hearn, 1977). The persistence
of a certain amount of gonadal function, particularly in the
animals with low antibody titres, would suggest that gonadotrophin
secretion was not completely abolished, although data on the degree
of inhibition of LH and FSH secretion in the marmoset are not available
to confirm this. Clearly this requires further investigation and
when an assay for measuring marmoset FSH becomes available, useful
information on the effects of LH-RH immunisation on both LH and FSH
secretion may be obtained from studies on castrated animals.
The apparent lack of species specificity of LH-RH and the
observed breakdown of the hypothalamic-pituitary-gonadal axis
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described in this study by immunisation against LH-RH may provide a
method by which this can be achieved in several species, being
particularly useful when hypophysectomy or gonadectomy are undesirable.
Thus in addition to potential application as a form of contraception,
inhibition of LH-RH may be useful in the veterinary field, and
clinically, in the treatment of certain forms of breast cancer,
precocious puberty and excessive and frequent menstruation towards
the end of reproductive life.
However, for any practical application of EH-RH inhibition to
be acceptable, particularly in fertility control, reversibility of
the effects would be essential. In the present study natural
reversal seems to occur following the decline of antibody titres,
but as the data are incomplete a much more rigorous investigation is
required to determine whether completely normal gonadal function is
restored following a period of prolonged suppression. Although
gonadotrophin secretion has been induced in immunised rats with
immunologically cross reactive fragments of LH-RH (Fraser, 1977) and
with super active LH-RH analogues (Fraser and Sandow, 1977),it is
not yet known how the gonads respond to the gonadotrophic stimulus.
One further consideration which at present precludes the
acceptability of immunisation against LH-RH as a method of fertility
control is the necessity for adjuvants. Freunds complete adjuvant is
most effective (Fraser, 1976b)but cannot be used in human or
vetinerary work. A dilemma exists in that the properties'which make a
good adjuvant also contribute to side effects. In the marmoset, the
use of Freunds adjuvant induced the formation of lesions at the
immunisation sites, and clearly other effective but harmless adjuvants
need to be developed.
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In view of the rather drastic effects of immunisation against
LH-RH, antagonistic analogues of EH-RH have recently attracted
considerable attention as an alternative form of LH-RH inhibition.
The two analogues tested in the present study both suppress LH-RH
induced LH release, but the rapid degradation of these substances
in vivo reduces their effectiveness. Howeve^ repeated injections of
these peptides can block ovulation in the rat ( de la Cruz et al. 19765
A. V. Schally, pers comm)jand with the synthesis of much longer
acting compounds which is already in progress, use in humans may be
feasible.
Thus it may still be possible to develop a new approach to
contraception by LH-RH inhibition, achieved either immunologically
or by the use of competitive LH-RH antagonists. Total suppression of
the testis would be necessary in the male to ensure infertility,
and this would probably be undesirable. In the female, however, it
may be possible to suppress the ovary to a level which would effect¬
ively prevent ovulation, but would still allow some follicular
development and oestrogen secretion.
7.2 Conclusion
LH-RH has an important physiological role in controlling LH
secretion in the marmoset monkey, although the relationship between
the hypothalamus and the pituitary gland is profoundly influenced by
the feedback actions of steroid hormones. Thus LH secretion is
normally suppressed by gonadal steroids which act, at least in part,
directly on the pituitary gland. Oestradiol-1 7/? probably represents
a major component of this negative feedback mechanism in females, and
may also be important in males, where presumably it acts in association
with androgens. Although progesterone has been shown to inhibit LH
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secretion, the physiological significance of this action remains to
be determined. By means of a separate feedback mechanism oestradiol-
17/S will also induce a positive discharge of LH. This action of
oestradiol-174 is almost certainly responsible for initiating the
pre-ovulatory LH surge in females, although in the normal cycle,
other steroids may be important in modulating this positive feedback
action. The persistence of a positive response to oestrogen in
males suggests that in the marmoset, the ability to discharge LH
in response to oestrogen is not a sexually dimorphic characteristic,
although the involvement of the response in the control of LH
secretion in males is unlikely.
The hypothalamic-hypophysial-gonadal system, responsible for
controlling LH secretion in the marmoset can be disrupted by inhibition
of LH-RH action, achieved either immunologically by active immun¬
isation, or by the use of competitive antagonistic analogues of LH-RH.
These procedures may find an application in vetinerary and clinical
treatment of reproductive disorders, and may eventually provide a new
approach to contraception in the human.
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